date,year,company,event,category,snippet,source_url
2015-01-01,2015,Abivax,Pavel Prochazka – Clinical Science Liaison,Clinical_Milestone,... obefazimod led to a compelling pooled 16.4% (p<0.0001) placebo ... Academy of Sciences of the Czech Republic. říjen 2012 – leden 2015 2 roky 4 měsíce.,https://cz.linkedin.com/in/pavel-prochazka-9750b52b
2015-06-08,2015,Abivax,Alger American Asset Growth Fund,Financial_Performance,"Abivax SA Sponsored ADR, 0.51%, 0.00%, 0.51%. Cameco Corporation, 0.51%, 0.00%, 0.51%. Cidara Therapeutics, Inc. 0.50%, 0.00%, 0.50%. Martin Marietta Materials, ...",https://www.alger.com/Pages/Products.aspx?productCode=KQ1AA_E
2015-07-17,2015,Abivax,Kewill Appoints Paul Ilse to Board of Directors,Corporate_Action,Ilse joined Francisco Partners in 2015 with a focus on software and services. Ilse brings nearly 20 years of executive leadership experience to the Kewill ...,https://finance.yahoo.com/news/kewill-appoints-paul-ilse-board-130000806.html
2015-11-05,2015,Abivax,Genmab,General_Update,"Born from a serendipitous scientific discovery in Montpellier, Abivax has evolved into one of France's most promising global biotechs. ... Investment is flowing ...",https://pharmaboardroom.com/directory/genmab/
2015-11-15,2015,Abivax,Abivax (ENXTPA: ABVX): Investor Relations Program,Clinical_Milestone,"Abivax is a phase 3 ready clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, ...",https://www.lifesciadvisors.com/case-study/abivax-enxtpaabvx-investor-relations-program/
2016-03-16,2016,Abivax,European Life Science CEO Forum & Exhibition,General_Update,"Akaal Pharma has created a pipeline of novel small molecule drugs for the treatment of Psoriasis, Atopic Dermatitis, Multiple Sclerosis (MS), Ulcerative Colitis ...",https://www.sachsforum.com/uploads/5/1/9/6/51964431/elsceo_conference_guide.pdf
2016-05-17,2016,Abivax,A Look At All Of Pfizer's Acquisitions Over The Past 2 Years,Corporate_Action,"Pfizer Inc. (NYSE: PFE) is back on the M&A hunt, having agreed to acquire Anacor Pharmaceuticals Inc (NYSE: ANAC) for $5.2 billion.",https://finance.yahoo.com/news/look-pfizers-acquisitions-over-past-152244227.html
2016-05-28,2016,Abivax,WORLD CHINESE JOURNAL OF DIGESTOLOGY Shijie ...,Clinical_Milestone,"junction cancer (ToGA): a phase 3, open-label, randomised controlled trial ... 2016; 3: 14 [PMID: 27002817 DOI: 10.1186/s40348-. 016-0041-y]. 26 Bik EM ...",https://bsdwebstorage.blob.core.windows.net/ejournals-1009-3079/WCJDv24i15.pdf
2016-08-16,2016,Abivax,HEGCF – MyOptique Acquired by Essilor,Clinical_Milestone,"... Ulcerative Colitis. View Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral ...",https://www.claret-capital.com/articles/hegcf-myoptique-acquired-by-essilor/
2016-09-15,2016,Abivax,"New Jersey Orthodontist Pat Cuozzo, DDS Achieves 10th ...",General_Update,"Nearly 7,000 dentists were surveyed for this year's Top Dentists list and more than 600 nominees were chosen for inclusion. Dr. Cuozzo says part of his ...",https://finance.yahoo.com/news/jersey-orthodontist-pat-cuozzo-dds-110100538.html
2016-10-14,2016,Abivax,Alger Capital Appreciation Institutional Fund - ACIZX,General_Update,"Holdings ; Abivax SA Sponsored ADR, 0.53%, 0.00% ; HEICO Corporation Class A, 0.52%, 0.06% ; Constellation Energy Corporation, 0.49%, 0.00% ; Eli Lilly and Company ...",https://www.alger.com/pages/Products.aspx?productCode=2146
2016-12-06,2016,Abivax,The Best and Worst Run States in America: A Survey of All 50,General_Update,"This year, for the fifth year in a row, North Dakota ranks as the best run state in the country. For the second consecutive year, New Mexico ranks worst.",https://finance.yahoo.com/news/best-worst-run-states-america-110022696.html
2017-01-01,2017,Abivax,The Anti-Hiv Candidate Abx464 Dampens Intestinal ...,General_Update,by K Chebli · 2017 · Cited by 40 — ABX464 treatment strongly attenuated DSS-induced colitis in mice and produced a long-term protection against prolonged DSS-exposure after drug cessation.,https://pubmed.ncbi.nlm.nih.gov/28687795/
2017-01-01,2017,Abivax,The Anti-Hiv Candidate Abx464 Dampens Intestinal ...,General_Update,by K Chebli · 2017 · Cited by 40 — ABX464 treatment strongly attenuated DSS-induced colitis in mice and produced a long-term protection against prolonged DSS-exposure after drug cessation.,https://www.nature.com/articles/s41598-017-04071-3
2017-01-01,2017,Abivax,RNA sequencing analysis of activated macrophages ...,General_Update,by L Manchon · 2017 · Cited by 5 — A comprehensive RNA-seq data resource was provided on the anti-inflammatory properties of ABX464 that warrant exploration in both HIV and inflammatory ...,https://www.nature.com/articles/sdata2017150
2017-02-12,2017,Abivax,James Tisch's epic explanation for why he's reluctant to ...,General_Update,"Loews Corporation CEO James Tisch, however, isn't crazy about letting cash out the door this way. Tisch offered a very detailed and colorful explanation.",https://finance.yahoo.com/news/james-tischs-epic-explanation-for-why-hes-reluctant-to-buy-back-stock-or-acquire-companies-162511879.html
2017-02-28,2017,Abivax,Alger Capital Appreciation Institutional Fund - ACAYX,General_Update,"Holdings ; Abivax SA Sponsored ADR, 0.53%, 0.00% ; HEICO Corporation Class A, 0.52%, 0.06% ; Constellation Energy Corporation, 0.49%, 0.00% ; Eli Lilly and Company ...",https://www.alger.com/pages/Products.aspx?productCode=2846
2017-03-28,2017,Abivax,Study Details | NCT03093259 | ABX464 in Subjects With ...,Clinical_Milestone,"This Phase IIa study is an 8-week, double-blind, placebo-controlled, randomized study aiming at evaluating the safety and the efficacy of ABX464 given once ...",https://clinicaltrials.gov/study/NCT03093259
2017-05-02,2017,Abivax,French HIV Cure Reduces Viral Reservoirs for the First ...,Clinical_Milestone,Abivax has announced results from a Phase IIa trial that reveal the first proof in human of viral load reduction of hidden HIV reservoirs.,https://www.labiotech.eu/trends-news/abivax-hiv-cure-viral-reservoir/
2017-06-14,2017,Abivax,Abivax IPO Closing on Nasdaq Global Market,Financial_Performance,Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market ... The offering price was set at $11.60 per ADS in the U.S. Offering and a ...,https://ir.abivax.com/news-releases/news-release-details/abivax-announces-closing-its-initial-public-offering-nasdaq-0
2017-06-14,2017,Abivax,Abivax Announces Temporary Trading Halt of its Ordinary ...,Clinical_Milestone,"Based in France and the U.S. , Abivax's lead drug candidate, obefazimod (ABX464), is in Phase 3 clinical trials for the treatment of moderately to severely ...",https://ir.abivax.com/news-releases/news-release-details/abivax-announces-temporary-trading-halt-its-ordinary-shares
2017-09-27,2017,Abivax,French Gene Therapy for Wilson's Disease gets Orphan ...,Clinical_Milestone,"Vivet Therapeutics has been granted Orphan Drug Designation for its gene therapy for Wilson's disease, VTX-801, by both the FDA and the European Commission.",https://www.labiotech.eu/trends-news/vivet-therapeutics-wilsons-disease/
2017-10-24,2017,Abivax,Best Solar Energy Podcasts (2026),General_Update,"Two investment bankers weekly explore how tech, finance, markets and regulations are radically redefining the world of energy: Renewable Energy, ...",https://player.fm/podcasts/Solar-Energy
2017-11-08,2017,Abivax,EVOTEC AG ANNOUNCES FIRST NINE-MONTH 2017 ...,Clinical_Milestone,"Through the acquisition of Aptuit in August 2017, Evotec extended its value chain offering in early drug discovery to pre-clinical enabling activities (“INDiGO”) ...",https://www.eqs-news.com/news/corporate/evotec-ag-ergebnisse-fuer-die-ersten-neun-monate-2017-und-corporate-update/c4f32995-4327-43dd-bef9-fe87d6005f7e_en
2017-12-07,2017,Abivax,Inside Elliott Management: How Paul Singer's Hedge Fund ...,Financial_Performance,"The merger passed. Elliott, in a rare surrender, sold its shares a few weeks later. But the story doesn't end there. As South Korean authorities unraveled ...",https://finance.yahoo.com/news/inside-elliott-management-paul-singer-113009805.html
2017-12-12,2017,Abivax,Sabina Comis,Corporate_Action,"Sabina Comis, Global Managing Partner, advises French and international companies, family offices, private equity funds and investment banks.",https://www.dechert.com/people/c/sabina-comis.html
2017-12-15,2017,Abivax,Abivax Spots an Extra Benefit of its Potential HIV Cure,General_Update,Phase IIa data confirms that Abivax's potential HIV cure not only reduces viral reservoir but it also has anti-inflammatory effects.,https://www.labiotech.eu/trends-news/hiv-cure-inflammation-abivax/
2018-01-11,2018,Abivax,Kelly Mahon Tullier: EVP & General Counsel at Visa,General_Update,Kelly Mahon Tullier is executive vice president and general counsel at San Francisco-based Visa. Tullier graduated from Louisiana State University…,https://finance.yahoo.com/news/kelly-mahon-tullier-executive-vice-070806809.html
2018-01-16,2018,Abivax,Two Proteins in the Brain Could Protect Against and Repair ...,General_Update,ulcerative colitis. Abivax pulls in €49.2M but needs more to complete ulcerative colitis program. NLS Days Malmo 2022 ...,https://www.labiotech.eu/trends-news/parkinsons-disease-proteins-therapy/
2018-01-25,2018,Abivax,British Biotech Treats First Phase III Patient in its Critical ...,Clinical_Milestone,The company plans to enroll 138 patients in the Phase III study to assess REX-001's efficacy and safety in terms of ulcer healing and amputation-free survival.,https://www.labiotech.eu/trends-news/critical-limb-ischemia-trial-rexgenero/
2018-02-28,2018,Abivax,Biotechnology Stocks Directory at Global Investor Ideas,Clinical_Milestone,"(Nasdaq: ABVC) is a clinical-stage biopharmaceutical company focused on development of therapeutic solutions in oncology/hematology, the central nervous system ...",https://globalinvestorideas.com/stocks-directories/biotechnology/
2018-03-14,2018,Abivax,The 50 Most Powerful Latinas in Business,General_Update,"This year, the nominees for our Most Powerful Latina list nearly doubled, with 15 business leaders joining the list for the first time, including Jessica Alba, ...",https://finance.yahoo.com/news/50-most-powerful-latinas-business-120040715.html
2018-03-16,2018,Abivax,ABIVAX gibt Jahresergebnis 2017 und Unternehmens- ...,General_Update,Veröffentlichung der Top-Line-Ergebnisse der Phase-2-Proof-of-Concept-Studie mit ABX464 zur Behandlung von Colitis ulcerosa in H2 2018; Start einer klinischen ...,https://www.eqs-news.com/news/corporate/abivax-gibt-jahresergebnis-2017-und-unternehmens-update-bekannt/014f3b3d-6b3d-4815-ae71-3777485bfcd7_en
2018-04-16,2018,Abivax,Bitcoin exchange Coinbase is on a buying spree,Corporate_Action,"Coinbase added a new head of M&A and has rapidly ramped up its buying activity. Its latest acquisition: Earn.com, which offers ways to earn bitcoin for ...",https://finance.yahoo.com/news/bitcoin-exchange-coinbase-buying-spree-212430165.html
2018-04-30,2018,Abivax,Stock market news history at 2018-01-03 - MarketScreener,Clinical_Milestone,ABIVAX : to Initiate Long-Term Extension Study of ABX464 in Patients with Ulcerative Colitis. 18-01-04. Regulatory press release: Completed enrollment in ...,https://www.marketscreener.com/news/history/2018/4-juillet/?p=27
2018-05-10,2018,Abivax,French indices - Experts Comptables Paris,General_Update,"This is what the company list looked like on 30 April 2018. Changes are published on Euronext.com. COMPANY, ISIN, TRADING LOCATION. ADP, FR0010340141, Euronext ...",http://www.experts-comptables-paris.com/french-indices/
2018-06-17,2018,Abivax,a. Azithromycin b. Amoxicillin c. Ceftazidime d. Levofloxacin 7. ...,Clinical_Milestone,After⏲Hours 4:01 $ABVX - Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod Its First-in-Class ...,https://www.facebook.com/groups/190453254308553/posts/1913426635344531/
2018-07-11,2018,Abivax,HIV pipeline 2018: full version,Clinical_Milestone,"High efficacy in phase 3 studies resulted in few cases of viral failure (n=13 in naive studies with viral load >200 copies/mL), none of which resulted in ...",https://i-base.info/htb/34488
2018-07-25,2018,Abivax,Abivax - Forum,General_Update,ABIVAX is een innovatief biotechnologisch bedrijf dat zich richt op het immuunsysteem om virale ziekten te elimineren met behulp van zijn unieke antivirale ...,https://www.beursduivel.be/forum/Topic/1350517/Franse-aandelen_Abivax.aspx
2018-09-04,2018,Abivax,Abivax reports impressive results in clinical phase 2a trial of ...,Clinical_Milestone,"Abivax reports impressive results in clinical phase 2a trial of ABX464 as an oral treatment for ulcerative colitis patients. September 4, 2018. PDF Version.",https://abivax.gcs-web.com/news-releases/news-release-details/abivax-reports-impressive-results-clinical-phase-2a-trial-abx464
2018-09-04,2018,Abivax,"Abivax posts ulcerative colitis data, commits to phase 2b",Clinical_Milestone,Abivax has posted data from a phase 2a trial in patients with moderate-to-severe ulcerative colitis that are refractory to anti-TNF antibodies or ...,https://www.fiercebiotech.com/biotech/abivax-posts-ulcerative-colitis-data-commits-to-phase-2b
2018-10-02,2018,Abivax,Why Amazon Might Acquire Lions Gate Entertainment,Financial_Performance,"In the first half of 2018, buybacks were up more than 80% year over ... Naturally, that cash-heavy, big-M&A backdrop lends itself to a bunch of M&A rumors.",https://finance.yahoo.com/news/why-amazon-might-acquire-lions-120005126.html
2018-10-15,2018,Abivax,Alger Focus Equity SMA Composite,General_Update,"Abivax SA Sponsored ADR, 0.67%, 0.00%, 0.67%. Intuitive Surgical, Inc. 0.65%, 0.59 ... Effective October 2018, the composite name changed from Alger Capital ...",https://www.alger.com/pages/Products.aspx?productCode=CapAppFSMA
2018-11-01,2018,Abivax,Abivax SA Share Price | EURONEXT:ABVX Stock News,Clinical_Milestone,"Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical ... ulcerative colitis. Its initial focus is on inflammatory bowel diseases ...",https://www.ii.co.uk/shares/abivax-sa/EURONEXT:ABVX
2018-12-31,2018,Abivax,European Biotech's Biggest News of 2018,Corporate_Action,"The Belgian biotech Ablynx, after rejecting an acquisition offer from Novo Nordisk in January, was acquired instead by Sanofi for €3.9B. This proved to be a ...",https://www.labiotech.eu/best-biotech/biggest-news-2018-crispr/
2019-01-01,2019,Abivax,Both Anti-Inflammatory and Antiviral Properties of Novel ...,Clinical_Milestone,by A Vautrin · 2019 · Cited by 83 — ABX464 which binds to cap binding complex (CBC) has demonstrated safety and efficacy in a phase 2a proof-of-concept clinical trial in patients with Ulcerative ...,https://pubmed.ncbi.nlm.nih.gov/30692590/
2019-01-01,2019,Abivax,Both anti-inflammatory and antiviral properties of novel ...,General_Update,"by A Vautrin · 2019 · Cited by 83 — ABX464 is a novel drug candidate for treating patients infected with human immunodeficiency virus (HIV) and patients with ulcerative colitis (ABIVAX, data in ...",https://www.nature.com/articles/s41598-018-37813-y
2019-01-01,2019,Abivax,The IBD Therapeutic Pipeline is Primed to Produce,Clinical_Milestone,"by CA Steiner · 2019 — 78,79 A phase III clinical study demonstrated increased rates of symptomatic remission as well as histological remission compared to placebo in patients with ...",https://practicalgastro.com/wp-content/uploads/2019/07/IBD-Therapeutic-Pipeline-Is-Primed-To-Produce.pdf
2019-01-01,2019,Abivax,Hunain Sarwar - Consultant at McKinsey & Company,Corporate_Action,"- Mergers and Acquisitions. Best in Programme Prize, Responsibility Day Case 2019. Copenhagen Business School. sep. 2019. ""This prize is awarded to the winning ...",https://dk.linkedin.com/in/hunain-sarwar-54b38b174
2019-02-06,2019,Abivax,Kreos Capital Has Launched EUR 700 Million (USD 800 ...,Financial_Performance,"Kreos VI has already started to deploy capital in January 2019 and Kreos ... Abivax (EPA: ABVX), SolarEdge (NASDAQ: SEDG), Heptagon (ams AG, SWX: AMS) ...",https://www.prnewswire.com/news-releases/kreos-capital-has-launched-eur-700-million-usd-800-million-kreos-capital-vi-863979067.html
2019-03-08,2019,Abivax,HIV Drug Shows Promise for Treating Ulcerative Colitis ...,General_Update,"Over the six months, the patients showed no serious side effects, and their disease symptoms improved. This long-term improvement distinguishes Abivax's drug ...",https://www.labiotech.eu/trends-news/ulcerative-colitis-abivax-hiv/
2019-03-14,2019,Abivax,Abivax 2018 Financial Results and Operations Update,General_Update,"The financial statements for 2018, approved by the Company's Board of Directors on March 12, 2019, have been audited and the certification report is being ...",https://ir.abivax.com/static-files/0f1cba42-d6b8-4885-95d5-f2c84e29c94c
2019-03-15,2019,Abivax,Alger Focus Equity Fund,General_Update,"Holdings ; Abivax SA Sponsored ADR, 0.82%, 0.00% ; Constellation Energy Corporation, 0.79%, 0.00% ; Robinhood Markets, Inc. Class A, 0.77%, 0.04% ; MongoDB, Inc.",https://www.alger.com/pages/Products.aspx?productCode=KQ1FI3
2019-04-10,2019,Abivax,The LME's New Cobalt Contract: A History of ...,General_Update,"Following extensive engagement with the market, on 11 March 2019, we launched a cash-settled LME Cobalt (Fastmarkets MB) contract, to complement our existing ...",https://finance.yahoo.com/news/lmes-cobalt-contract-history-cobalt-130000903.html
2019-04-15,2019,Abivax,A Turning Story Towards Inflammatory Diseases - Abivax,Clinical_Milestone,"• Phase 2b study protocol in 232 patients with moderate to severe ulcerative colitis ... Phase 3. Phase 2b start in Q2, 2019. Phase 2a start in Q3, 2019.",https://www.abivax.com/wp-content/uploads/2019/04/Abivax_Corporate_presentation_07.04.2019.pdf
2019-06-10,2019,Abivax,Novel oral drug shows early promise for IBD,General_Update,"Among a group of 32 patients with ulcerative colitis, the investigative drug ABX464 showed a decrease in Mayo score of over 50% and a drop in fecal calprotectin ...",https://www.mdedge.com/content/novel-oral-drug-shows-early-promise-ibd
2019-06-11,2019,Abivax,Novel oral drug shows early promise for IBD | MDedge,General_Update,"Among a group of 32 patients with ulcerative colitis, the investigative drug ABX464 showed a decrease in Mayo score of over 50% and a drop in fecal calprotectin ...",https://blogs.the-hospitalist.org/content/novel-oral-drug-shows-early-promise-ibd
2019-07-01,2019,Abivax,Alger Mid Cap Focus Composite - Institutional Investors,General_Update,"Abivax SA Sponsored ADR, 1.40%, 0.00%, 1.40%. Martin Marietta Materials ... The Composite creation date is July 1, 2019 and inception date is July 1, 2019.",https://www.alger.com/pages/Products.aspx?productCode=MidCapFRep
2019-07-11,2019,Abivax,ABIVAX Completes €12 Million Capital Raise Entirely ...,General_Update,"Net proceeds of €12 million provide the Company with additional funding to implement its strategy, conduct its operations and reinforce its financial structure.",https://www.truffle.com/news/abivax-completes-e12-million-capital-raise-entirely-subscribed-by-sofinnova-partners-at-market-price
2019-09-15,2019,Abivax,The European landscape of listed biotech companies,Financial_Performance,"The first listings of biotech companies (our universe) were only recorded in the late 90s, so roughly 20 years ago.",https://biotechradar.eu/wp-content/uploads/reports/European%20landscape%20listed%20biotech-2018%20Review-Biotellytics-biotechradar.eu.pdf
2019-10-21,2019,Abivax,ABIVAX Reports Impressive 12-month Efficacy and Safety ...,General_Update,"First evidence of long-term efficacy of ABX464 in ulcerative colitis. Endoscopy at Month 12 was performed in 16 / 19 patients, of whom 12 (75%) achieved ...",https://abivax.gcs-web.com/news-releases/news-release-details/abivax-reports-impressive-12-month-efficacy-and-safety-data
2020-01-01,2020,Abivax,Deep Remission at 1 Year Prevents Progression of Early ...,General_Update,"by RC Ungaro · 2020 · Cited by 255 — We associated induction of deep remission in early, moderate to severe CD with decreased risk of disease progression over a median time of 3 years.",https://www.sciencedirect.com/science/article/abs/pii/S0016508520303905
2020-01-01,2020,Abivax,Vedolizumab treatment persistence and safety in a 2‐year ...,Clinical_Milestone,by S Danese · 2020 · Cited by 18 — Vedolizumab was shown to be effective and safe for patients with ulcerative colitis (UC) or Crohn's disease (CD) in the GEMINI phase 3 and long‐term safety (LTS) ...,https://pmc.ncbi.nlm.nih.gov/articles/PMC7839669/
2020-01-01,2020,Abivax,A Post Hoc Analysis From the CALM Study - Oxford Academic,Clinical_Milestone,by W Reinisch · 2020 · Cited by 41 — The CALM study was a randomized phase 3 trial in patients with CD that evaluated 2 treatment algorithms—one based on a “tight control” (TC) algorithm that ...,https://academic.oup.com/ibdjournal/article/26/10/1562/5762686
2020-02-12,2020,Abivax,About,General_Update,"Hypatia Capital is an asset management firm investing in women in leadership. Our vision in is one of equality. We believe in talent, drive and stellar ...",https://hypatiacapital.com/about/
2020-02-26,2020,Abivax,Coronavirus - Articles - Page 527,Clinical_Milestone,"Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcus, Dialectic, Novavax, Promis, Pvp Biologics, ...",https://www.bioworld.com/articles/topic/517&page=533?page=527
2020-04-22,2020,Abivax,Abstract Funding Sources* AGA Oral and Poster ...,General_Update,"* Information contained in this report is current as of April 22, 2020. Page 2. AGA Oral Presentations. Page 3. Abstract ...",https://ddw.org/wp-content/uploads/2020/04/2020-AGA-Abstract-Funding-Report-PDF.pdf
2020-06-01,2020,Abivax,Alger Large Cap Growth SMA Composite,Financial_Performance,Primarily invests in equity securities of US large cap companies identified through our fundamental research as demonstrating promising growth potential.,https://www.alger.com/Pages/Products.aspx?productCode=LrgCapSMA
2020-06-18,2020,Abivax,Belgian mRNA Vaccine for Covid-19 Receives €34M ...,General_Update,The vaccine consists of mRNA molecules encoding tumor antigens along with a combination of three other mRNA molecules designed to activate the immune system.,https://www.labiotech.eu/trends-news/etherna-covid-19-mrna/
2020-06-29,2020,Abivax,ABX464 in Phase 2a Trials for RA,Clinical_Milestone,"The most recent phase 2a, clinical trial of ABX464 is examining 50 and 100 mg oral doses administered daily in combination with methotrexate.3 To be eligible ...",https://www.the-rheumatologist.org/article/abx464-in-phase-2a-trials-for-ra/
2020-07-02,2020,Abivax,Abivax doses first patient in phase 2b/3 COVID-19 clinical ...,Clinical_Milestone,French biotech company Abivax has treated the first patient in a phase 2b/3 study of its experimental anti-inflammatory drug ABX464 in COVID-19 patients.,https://pmlive.com/pharma_news/abivax_doses_first_patient_in_phase_2b3_covid-19_clinical_trial_1344037/
2020-09-11,2020,Abivax,Tagresults - MarketingReport,Clinical_Milestone,"French clinical-stage biotech Abivax secures €75 million for ... Obefazimod, as a treatment for ulcerative colitis and other chronic inflammatory diseases.",https://marketingreport.one/tagresults.html?phenomena=Healthcare&page=10
2020-10-09,2020,Abivax,KPMGValuationDataSourceCom...,General_Update,"94. ABIVAX Société Anonyme. 95. Abko Co., Ltd. 96. ABL Bio Inc. 97. Able C&C Co., Ltd. 98. ABM Industries Incorporated.",https://files.atlas.kpmg.com/cmsmedia/docs/default-source/deal-advisory_neu/kpmg-valuation-data-source-unternehmens%C3%BCbersicht.pdf?sfvrsn=2208fcb3_2
2020-10-29,2020,Abivax,Abivax announces the success of its oversubscribed ...,Clinical_Milestone,"September 2, 2020. Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2A maintenance study · July 31, 2020 ...",https://www.truffle.com/news/abivax-announces-the-success-of-its-oversubscribed-capital-increase
2020-12-14,2020,Abivax,Mesoblast Provides Topline Results From Phase 3 Trial of ...,Clinical_Milestone,"Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure. Mesoblast Limited. December 14, 2020 8 min read.",https://finance.yahoo.com/news/mesoblast-provides-topline-results-phase-222700875.html
2020-12-28,2020,Abivax,Abcellera IPO rockets upward with $555.5M in gross ...,Financial_Performance,"Abcellera Biologics Inc. had finally closed its IPO on the Nasdaq, hoovering up gross proceeds of $555.5 million.",https://www.bioworld.com/articles/501807-abcellera-ipo-rockets-upward-with-5555m-in-gross-proceeds
2021-01-01,2021,Abivax,Induction and Long-term Follow-up With ABX464 for ...,Clinical_Milestone,by S Vermeire · 2021 · Cited by 55 — Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of Phase IIa Trial. Gastroenterology. 2021 Jun;160(7):2595-2598 ...,https://pubmed.ncbi.nlm.nih.gov/33662385/
2021-01-01,2021,Abivax,Induction and Long-term Follow-up With ABX464 for ...,General_Update,by S Vermeire · 2021 · Cited by 55 — The induction population was 62.5% men with a mean ± standard deviation age of 43.3 ± 16.2 years (Supplementary Table 1); 78.3% of patients receiving ABX464 ...,https://www.gastrojournal.org/article/S0016-50852100459-5/fulltext
2021-01-01,2021,Abivax,Journal Pre-proof,Clinical_Milestone,"by S Vermeire · 2021 · Cited by 55 — 2 Preclinically, ABX464 attenuated DSS-induced colitis in mice and produced long-term protection and decreased miR-124 levels after stopping treatment. This ...",https://www.sciencedirect.com/science/article/pii/S0016508521004595/pdf?md5=95df54df8c1cf58ec9d9f9bb3bc63fae&pid=1-s2.0-S0016508521004595-main.pdf
2021-01-05,2021,Abivax,Abivax publishes review in Drug Discovery Today on ...,Clinical_Milestone,"Abivax, a clinical stage biotechnology company, is mobilizing the body's natural immune machinery to treat patients with chronic inflammatory diseases, viral ...",https://ir.abivax.com/news-releases/news-release-details/abivax-publishes-review-drug-discovery-today-mechanism-action
2021-02-15,2021,Abivax,Symbol Security Cusip ISIN AAAIF ALTERNATIVE ...,General_Update,NHMAF NIHON M&A CENTER INC. J50883107. JP3689050007. NHNKY NIHON KOHDEN CORP-ADR. 65412C108. US65412C1080. NHOLF. SOMPO HOLDINGS ... Data edizione: Febbraio 2021.,https://www.allianzbank.it/content/dam/onemarketing/azit/allianzbank-it/trasparenza/altre-informazioni-ai-sensi-della-normativa-finanziaria/Lista-Azioni-Negoziabili.pdf
2021-02-19,2021,Abivax,S-1,Financial_Performance,We have applied to list our common stock on the Nasdaq Global Market under the symbol “RXDX.” We are an “emerging growth company” under applicable Securities ...,https://www.sec.gov/Archives/edgar/data/1718852/000119312521049126/d14529ds1.htm
2021-05-03,2021,Abivax,Clinical Trials register - Search for ABX464,Clinical_Milestone,The European Union Clinical Trials Register allows you to search for protocol and results information on EU/EEA interventional clinical trials.,https://www.clinicaltrialsregister.eu/ctr-search/search?query=ABX464
2021-05-21,2021,Abivax,Tony Gibney Joins InflaRx Board of Directors,General_Update,... M&A advisory transactions for US and European clients. Mr. Gibney's appointment was approved by InflaRx's shareholders at the 2021 annual shareholder meeting.,https://finance.yahoo.com/news/tony-gibney-joins-inflarx-board-113000982.html
2021-05-25,2021,Abivax,Abivax reports excellent efficacy and safety of ABX464 in ...,Financial_Performance,"A seven- to ten-fold increase in miRNA-124 levels was observed ... The trading of the Abivax shares on Euronext Paris will resume on Tuesday, May 25, 2021.",https://abivax.gcs-web.com/news-releases/news-release-details/abivax-reports-excellent-efficacy-and-safety-abx464-phase-2b
2021-06-03,2021,Abivax,Why Etsy's Acquisition of Depop Is Bigger Than You Think,Corporate_Action,"The transaction, which is expected to close at the end of the third quarter, would allow Depop to continue operating out of London as a standalone marketplace ...",https://finance.yahoo.com/news/why-etsy-acquisition-depop-bigger-192332351.html
2021-06-10,2021,Abivax,https://static.quandl.com/coverage/XNYS_tickers.csv,General_Update,"... Abivax (ABVX) ABW_P_RA_,ASBC Capital I (ABWpRA_) ABY,Abitibi Consolidated Inc. (ABY) AC,Associated Capital Group Inc (AC) ACA,Arcosa Inc (ACA) ACA_1 ...",https://static.quandl.com/coverage/XNYS_tickers.csv
2021-06-29,2021,Abivax,https://static.quandl.com/coverage/XASE_tickers.csv,General_Update,"... Abivax (ABVX) ABY,Abitibi Consolidated Inc. (ABY) ABY_1,AB Svensk Exportkredit (ABY) ABY_2,Atlantica Yield plc (ABY) AC,Associated Capital Group Inc (AC) ...",https://static.quandl.com/coverage/XASE_tickers.csv
2021-06-30,2021,Abivax,Tesla's rival Xpeng prices Hong Kong IPO at HK$165 per ...,Financial_Performance,"A dual-primary listing will enable these companies to be eligible for inclusion in Hong Kong exchange's Stock Connect, which enables mainland Chinese investors ...",https://finance.yahoo.com/news/teslas-rival-xpeng-prices-hong-093000308.html
2021-07-14,2021,Abivax,Pfizer The Netherlands,General_Update,"Investment is flowing in, M&A ... Born from a serendipitous scientific discovery in Montpellier, Abivax has evolved into one of France's most promising global ...",https://pharmaboardroom.com/directory/pfizer-netherlands/
2021-07-31,2021,Abivax,Principais Auditorias na Indústria Farmacêutica,General_Update,Encontrar estratégias e oportunidades para promover Marcas com ações de marketing exclusivas é algo que um BI pode fazer pela Indústria Farmacêutica.,https://brazilsfe.blogspot.com/2021/07/Principais-Auditorias-na-Industria-Farmaceeutica.html
2021-09-07,2021,Abivax,ABX 464 - New Drug Approvals,Clinical_Milestone,"In May 2021, Abivax communicated the top-line results of its randomized, double-blind and placebo-controlled Phase 2b induction trial conducted in 15 European ...",https://newdrugapprovals.org/2021/09/07/abx-464/
2021-09-14,2021,Abivax,Abivax provides an update on the ABX464 clinical data and ...,Clinical_Milestone,"Abivax provides an update on the ABX464 clinical data and development strategy in ulcerative colitis ... For the launch of its phase 3 program in UC, Abivax ...",https://abivax.gcs-web.com/news-releases/news-release-details/abivax-provides-update-abx464-clinical-data-and-development
2021-09-20,2021,Abivax,VOSS Solutions Acquires LayerX Technologies,Clinical_Milestone,"Portfolio News. Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 ...",https://www.claret-capital.com/articles/voss-solutions-acquires-layerx-technologies/
2021-10-15,2021,Abivax,S-1/A,Financial_Performance,We have applied to list our common stock on the Nasdaq Global Market under the symbol “VTYX.” We are an “emerging growth company” and a “smaller reporting ...,https://www.sec.gov/Archives/edgar/data/1851194/000119312521299315/d160345ds1a.htm
2021-11-16,2021,Abivax,EasyFi Lending Protocol is Now Live,General_Update,"The EasyFi Lending protocol went live late evening of 15th Nov 2021. Announcing this, Anshul Dhir, COO & Co Founder, EasyFi Network said, ""Six money markets on ...",https://finance.yahoo.com/news/easyfi-lending-protocol-now-live-082000971.html
2021-11-30,2021,Abivax,HealthTech Innovation Days,General_Update,"Pierre Courteille from Abivax moderated our discussion. I think it was a great mix of different perspectives – how we innovate in universities, academic medical ...",https://htfc-eu.com/wp-content/uploads/2021/11/Brochure-post-HTID3.pdf
2021-12-09,2021,Abivax,VitalHub Announces That Ontario HIV Treatment Network ...,General_Update,"A Five-Year Agreement Will Ensure Ontario AIDS Service Organizations Get the Streamlined Case Management Software They Need. TORONTO, Dec. 09, 2021 (GLOBE ...",https://finance.yahoo.com/news/vitalhub-announces-ontario-hiv-treatment-123000310.html
2021-12-15,2021,Abivax,Abivax to present at the J.P. Morgan 40th Annual Healthcare ...,Clinical_Milestone,"During 2021, Abivax was able to compile an impressive clinical data package for ABX464, including the 3-years phase 2a maintenance study update as well as the ...",https://ir.abivax.com/news-releases/news-release-details/abivax-present-jp-morgan-40th-annual-healthcare-conference
2021-12-16,2021,Abivax,11 High-Yield Savings Accounts That Have Beaten the ...,Financial_Performance,"11 High-Yield Savings Accounts That Have Beaten the Stock Market. Shutterstock.com. Joel Anderson. December 16, 2021 6 min read ... ABVX ABIVAX Société Anonyme ...",https://finance.yahoo.com/news/11-high-yield-savings-accounts-183555794.html
2022-01-01,2022,Abivax,"Safety, Efficacy of ABX464 (obefazimod) for Rheumatoid Arthritis",Clinical_Milestone,by C Daien · 2022 · Cited by 30 — ABX464 (obefazimod) is a first-in-class drug candidate for treating patients with active rheumatoid arthritis. ABX464 upregulates the biogenesis of the mRNA ...,https://pmc.ncbi.nlm.nih.gov/articles/PMC9279835/
2022-01-01,2022,Abivax,"ABX464 (obefazimod) for moderate-to-severe, active ...",Clinical_Milestone,"by S Vermeire · 2022 · Cited by 65 — All doses of ABX464 significantly improved moderate-to-severe, active ulcerative colitis compared with placebo, as measured by changes in MMS from baseline to ...",https://pubmed.ncbi.nlm.nih.gov/36075249/
2022-01-01,2022,Abivax,"ABX464 (obefazimod) for moderate-to-severe, active ...",Clinical_Milestone,"by S Vermeire · 2022 · Cited by 65 — All doses of ABX464 significantly improved moderate-to-severe, active ulcerative colitis compared with placebo, as measured by changes in MMS from baseline to ...",https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00233-3/abstract
2022-01-19,2022,Abivax,Abivax's phase 1/2 clinical study results of ABX196 in liver ...,Clinical_Milestone,"Abivax's phase 1/2 clinical study results of ABX196 in liver cancer to be presented on Jan. 21, at ASCO GI Cancers Symposium 2022. ABIVAX / Key word(s): Study ...",https://www.eqs-news.com/news/corporate/abivaxs-phase-1-2-clinical-study-results-of-abx196-in-liver-cancer-to-be-presented-on-jan-21-at-asco-gi-cancers-symposium-2022/7c739f32-44b1-493b-8cca-53054928d776_en
2022-01-24,2022,Abivax,Enerflex Ltd. and Exterran Corporation to Combine ...,Financial_Performance,Enerflex will continue to trade on the Toronto Stock Exchange (“TSX”) and intends to apply to either the New York Stock Exchange (the “NYSE”) or the NASDAQ ...,https://finance.yahoo.com/news/enerflex-ltd-exterran-corporation-combine-120200356.html
2022-03-16,2022,Abivax,Abivax reports 2021 financial results and operations update,Clinical_Milestone,"ABIVAX. Corporate. Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral ...",https://www.eqs-news.com/news/corporate/abivax-reports-2021-financial-results-and-operations-update/fb9807b4-92a0-4b99-a9bd-c456473b80a4_en
2022-04-06,2022,Abivax,Abivax reports excellent one-year efficacy and safety data of ...,Clinical_Milestone,Interim analysis demonstrates best-in-class clinical remission in 55.3% of 217 ulcerative colitis (UC) patients (full analysis set) after 48 weeks of ...,https://ir.abivax.com/news-releases/news-release-details/abivax-reports-excellent-one-year-efficacy-and-safety-data
2022-04-12,2022,Abivax,Setting the pace …,Financial_Performance,• Steady progress within operational venturing strategy (e.g. Exscientia NASDAQ listing). • NASDAQ listing ​with total gross proceeds of $ 500 m. Lowlights.,https://www.evotec.com/uploads/download-files/IR-ESG-DE/Analystenpr%C3%A4sentation_Ergebnis_Gesch%C3%A4ftsjahr_2021.pdf
2022-04-26,2022,Abivax,EvotecSE_Annual_Report_2021.pdf,Financial_Performance,"resulting from the NASDAQ listing in the US in November 2021. In terms of cash outflow, the financing of subsidiaries of € 74.7 m was the largest item. The ...",https://www.evotec.com/uploads/download-files/IR-ESG/2022/EvotecSE_Annual_Report_2021.pdf
2022-05-12,2022,Abivax,Revere Securities LLC Announces Acquisition of NorthStar ...,Corporate_Action,"Revere Securities LLC Announces Acquisition of NorthStar Investment Banking. Newsfile Corp. May 12, 2022 3 min read.",https://finance.yahoo.com/news/revere-securities-llc-announces-acquisition-200700052.html
2022-05-30,2022,Abivax,"BARCLAYS Cours Action BARC, Cotation Bourse LSE",General_Update,"La banque britannique Barclays a annoncé mardi qu'elle discutait avec la banque d'affaires américaine Lehman Brothers, qui a déposé lundi son bilan, de l' ...",https://www.boursorama.com/cours/1uBARC.L/
2022-06-13,2022,Abivax,Alger Dynamic Opportunities Fund,General_Update,"Alger SICAV is a collective investment undertaking under the form of an umbrella fund, organized as a societe d'investissement a capital variable (SICAV).",https://www.alger.com/pages/Products.aspx?productCode=KQ1CA_E
2022-06-22,2022,Abivax,The 8 Biggest Biotech Medical Fails of 2016 in Europe,Clinical_Milestone,"Abivax announced in June that its Phase III trial evaluating ABX203 as a Hepatitis B treatment was going to fail. Consequently, its stock price dropped by ...",https://www.labiotech.eu/trends-news/biotech-medical-fails-2016/
2022-06-30,2022,Abivax,Marco Hazan,Corporate_Action,Advising an investment fund on its acquisition of a minority stake in an innovative French company specialising in the design and manufacture of ground robots ...,https://www.reedsmith.com/our-people/marco-hazan/
2022-07-11,2022,Abivax,CLINICAL STUDY PROTOCOL ABX464-104,Clinical_Milestone,ABX464-N-Glu is pharmacologically active and also binds to the CBC leading to an increase in miR124 expression. Page 16. ABIVAX. Clinical Study Protocol. Study ...,https://cdn.clinicaltrials.gov/large-docs/96/NCT04023396/Prot_000.pdf
2022-07-21,2022,Abivax,Vicebio exits stealth to work on next generation RSV vaccine,General_Update,Vicebio has launched to accelerate the development of novel vaccines against life-threatening respiratory viral infections.,https://www.labiotech.eu/trends-news/respiratory-vaccines-viral/
2022-07-26,2022,Abivax,New Therapeutics Options in Rheumatoid Arthritis Pipeline ...,Clinical_Milestone,"Psoriatic Arthritis Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and ...",https://www.prnewswire.com/news-releases/new-therapeutics-options-in-rheumatoid-arthritis-pipeline-as-120-key-companies-are-working-on-drug-profiles--delveinsight-301593370.html
2022-07-29,2022,Abivax,Samoëns passe à l'heure américaine Les coureurs ...,General_Update,"2022, contre -1,50 % en 2e instance, n'a pas impacté. Wall Street ni le billet vert. Ce dernier se raffermit à. 1,0480 USD pour un euro. CAC 40. -0,90 % à 6 ...",https://www.les-black-panthers.org/FootUS/wp-content/uploads/2022/07/30-JUIN.pdf
2022-08-04,2022,Abivax,Abivax phase 3 program with obefazimod in ulcerative colitis ...,Clinical_Milestone,Phase 3 clinical induction study protocols for obefazimod in ulcerative colitis (UC) are approved by central US IRB (Institutional Review Board).,https://abivax.gcs-web.com/news-releases/news-release-details/abivax-phase-3-program-obefazimod-ulcerative-colitis-progresses
2022-08-04,2022,Abivax,Abivax phase 3 program with obefazimod in ulcerative ...,Clinical_Milestone,"Abivax is listed on Euronext compartment B (ISIN: FR0012333284 – Mnémo: ABVX). Based in Paris and Montpellier, Abivax has two drug candidates in clinical ...",https://www.eqs-news.com/news/corporate/abivax-phase-3-program-with-obefazimod-in-ulcerative-colitis-progresses-with-us-irb-approval/7f205fbc-5d3a-4365-86dc-91b0eb134799_en
2022-08-16,2022,Abivax,Vinci Partners Completes Acquisition of SPS Capital,Corporate_Action,"The Transaction, which was announced on July 28, 2022, closed today and has an initial cash component, with an additional consideration in VINP's Class A common ...",https://finance.yahoo.com/news/vinci-partners-completes-acquisition-sps-230000918.html
2022-09-01,2022,Abivax,Abivax announces successful oversubscribed €49.2 million ...,General_Update,The funding consists of a €46.2 million reserved equity capital increase and a €2.9 million issuance of royalty certificates.,https://sofinnovapartners.com/news/abivax-announces-successful-oversubscribed-eur49-2-million-crossover-financing-with-top-tier-u-s-and-european-biotech-investors
2022-09-02,2022,Abivax,Abivax: Successful EUR 49.2M Financing with Biotech Investors,General_Update,"The successful completion of an oversubscribed EUR 49.2M financing with high-quality US and European biotech specialist investors, led by TCGX.",https://ir.abivax.com/news-releases/news-release-details/abivax-announces-successful-oversubscribed-eur-492m-cross-over
2022-09-05,2022,Abivax,Abivax: first US patient enrolled in global phase 3 program ...,Clinical_Milestone,"The phase 3 program aims to confirm the excellent results from its phase 2b open-label maintenance study reported in April 2022, including the full set of 217 ...",https://abivax.gcs-web.com/news-releases/news-release-details/abivax-first-us-patient-enrolled-global-phase-3-program
2022-09-05,2022,Abivax,Abivax phase 2b study results of obefazimod (ABX464) in ...,Clinical_Milestone,"Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology. September 6, 2022. PDF Version.",https://ir.abivax.com/news-releases/news-release-details/abivax-phase-2b-study-results-obefazimod-abx464-ulcerative
2022-09-06,2022,Abivax,Abivax pulls in €49.2M but needs more for ulcerative colitis ...,General_Update,French biotech company Abivax has completed an oversubscribed €49.2 million ($49 million) financing round from European and U.S. investors.,https://www.labiotech.eu/trends-news/abivax-financing-ulcerative-colitis/
2022-09-12,2022,Abivax,Management Team,General_Update,"At Providence Greg raised multiple rounds of equity investment, identifying and bringing in a new lead investor in the company's largest private round to date.",https://curevovaccine.com/management-team/
2022-09-15,2022,Abivax,Abivax presents first-half 2022 financial results and ...,Clinical_Milestone,"In June, Abivax announced that “obefazimod” was confirmed as international nonproprietary name (INN) for drug-candidate ABX464. Obefazimod has officially ...",https://www.eqs-news.com/news/corporate/abivax-presents-first-half-2022-financial-results-and-operations-update/2103acfe-439c-4a8b-ab7c-aff0ed7e0ca3
2022-10-07,2022,Abivax,Hallmark Announces Sale of its Excess and Surplus Lines ...,Corporate_Action,"Core Specialty's acquisition and assumption of the E&S businesses and the related assets and liabilities will be effective as of September 30, 2022. Certain key ...",https://finance.yahoo.com/news/hallmark-announces-sale-excess-surplus-160000074.html
2022-10-15,2022,Abivax,First US patient enrolled in Abivax's phase 3 trial of ...,Clinical_Milestone,"The phase 3 ABTECT program is intended to confirm results from its phase 2b open-label maintenance study, which reported clinical remission in 55.3% of UC ...",https://www.healio.com/news/gastroenterology/20221014/first-us-patient-enrolled-in-abivaxs-phase-3-trial-of-obefazimod-for-ulcerative-colitis
2022-10-15,2022,Abivax,Linknovate | Profile for Gilead Sciences,General_Update,"Participant inclusion criteria for both groups included men or women of any race or ethnicity, 18–75 years of age, who were able and willing to provide ...",https://www.linknovate.com/affiliation/gilead-sciences-41890/all/?query=isp
2022-10-26,2022,Abivax,10 Best Dow Jones Dividend Stocks that Hedge Funds Love,Financial_Performance,"For this list, we selected dividend stocks that are popular among hedge funds. We analyzed Insider Monkey's Q2 2022 database for measuring hedge fund sentiment ...",https://finance.yahoo.com/news/10-best-dow-jones-dividend-184726849.html
2022-11-28,2022,Abivax,MERFX Has More Merger Arb Opportunity Than Meets the ...,Corporate_Action,"Megadeals accounted for 28 percent of 2022 deal value through Q3 2022 versus 23 percent a year earlier. There were 34 through October, compared with 37 ...",https://finance.yahoo.com/news/merfx-more-merger-arb-opportunity-133746049.html
2022-12-07,2022,Abivax,Solactive GBS Global Markets Small Cap USD Index TR,General_Update,The index intends to track the performance of the small cap segment covering approximately the largest 85% - 99% of the free-float market capitalization.,https://www.solactive.com/Indices/?index=DE000SLA7794
2022-12-20,2022,Abivax,Abivax receives FDA agreement on pediatric development ...,Clinical_Milestone,Obefazimod is currently in Phase 3 clinical trials for the treatment of ulcerative colitis (“ABTECT program”) with the first patient enrolled in the United ...,https://ir.abivax.com/news-releases/news-release-details/abivax-receives-fda-agreement-pediatric-development-plan
2022-12-29,2022,Abivax,Regulatory data of biopharma companies in 2022,Clinical_Milestone,"Abivax SA, of Paris, Obefazimod, Binds to the RNA cap binding protein (CBC 80/20) complex of RNA, Ulcerative colitis, U.S. institutional review board approved ...",https://www.bioworld.com/content/regulatory-data-2022
2023-01-01,2023,Abivax,S1095 Obefazimod in Patients With Moderate-to-Severe...,Clinical_Milestone,"by S Vermeire · 2023 — Results from this 96-week analysis of the OL maintenance Phase 2b study confirmed long-term efficacy of obefazimod 50 mg od, with durable clinical remission.",https://journals.lww.com/ajg/fulltext/2023/10001/s1095_obefazimod_in_patients_with.1634.aspx
2023-01-05,2023,Abivax,Abivax publishes novel data with respect to obefazimod's anti ...,Clinical_Milestone,"The median increases were 13-fold for the 25 mg group, 25-fold for the 50 mg group and 25-fold for the 100 mg group, while no upregulation was observed in the ...",https://ir.abivax.com/news-releases/news-release-details/abivax-publishes-novel-data-respect-obefazimods-anti
2023-01-07,2023,Abivax,BAKER BROS. ADVISORS LP 13F Stock Portfolio Holdings,Financial_Performance,"Discover BAKER BROS. ADVISORS LP's 13F stock holdings, portfolio composition, and market value. Explore key shares, investment trends, and market insights ...",https://www.insidearbitrage.com/holdings/0001263508/baker-bros-advisors-lp/
2023-01-18,2023,Abivax,7 Little-Known Stocks That Will Make You Rich in 10 Years,Financial_Performance,"Given enough page turns on the calendar, however, Ormat may justify its inclusion ... ABVX ABIVAX Société Anonyme 131.10 -7.24 (-5.23%) · Most active · ONDS ...",https://finance.yahoo.com/news/7-little-known-stocks-rich-195748823.html
2023-02-22,2023,Abivax,Abivax announces successful oversubscribed EUR 130M ...,General_Update,Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European Biotech investors.,https://abivax.gcs-web.com/news-releases/news-release-details/abivax-announces-successful-oversubscribed-eur-130m-cross-over
2023-02-23,2023,Abivax,Abivax SA Raises €130m to Advance Obefazimod ...,Clinical_Milestone,French Abivax SA has raised €130m capital led by TCGX to accelerate Phase III testing of its ulcerative colitis candidate obefazimod extend its cashflow.,https://www.truffle.com/news/abivax-sa-raises-eur130m-to-advance-obefazimod-to-phase-iii
2023-03-01,2023,Abivax,Modulating the Immune System to Fight Chronic Inflammatory ...,Clinical_Milestone,"Apolit et al.: ABX464 (obefazimod) up-regulates miR-124 to reduce pro-inflammatory markers in inflammatory bowel diseases, Clinical and Translational ...",https://www.abivax.com/wp-content/uploads/2023/03/Corporate_Presentation_Abivax_March2023.pdf
2023-03-07,2023,Abivax,VEON confirms revised timing for effectiveness of ratio ...,Financial_Performance,"As VEON announced previously on 5 October 2022, the Listing Qualifications Department of The Nasdaq Market granted VEON an additional grace period through 3 ...",https://finance.yahoo.com/news/veon-confirms-revised-timing-effectiveness-153000419.html
2023-03-15,2023,Abivax,Guilhem Richard Lawyer / Attorney,Corporate_Action,Guilhem Richard is a partner in Goodwin's Life Sciences and Technology groups. He specializes in capital markets and corporate finance.,https://www.goodwinlaw.com/en/people/r/richard-guilhem
2023-04-12,2023,Abivax,ABTECT Program (ABX464 Treatment Evaluation for ...,Clinical_Milestone,"Abivax reports excellent efficacy and safety of obefazimod (ABX464) in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3, (May 2021).",https://www.crohnscolitisfoundation.org/clinical-trials-community/featured-research/abtect-program-abx464-treatment-evaluation-ulcerative
2023-04-15,2023,Abivax,The 7 Best Cannabis Stocks to Buy for April 2023,Financial_Performance,"While Marimed is pursuing growth opportunities, organic as well as mergers and acquisitions (or M&A), one can argue that the company is a takeover target itself ...",https://finance.yahoo.com/news/7-best-cannabis-stocks-buy-004335552.html
2023-04-19,2023,Abivax,abivax reports 2022 financial results,Clinical_Milestone,These new financial resources will be mainly used to continue our Phase 3 clinical program with obefazimod for the treatment of UC patients. The successful ...,https://ir.abivax.com/static-files/250aa4ff-664e-44a7-9ad4-fbd6cf8640c2
2023-04-25,2023,Abivax,Gene therapy and chemotherapy may be new ...,General_Update,New research has identified a potential therapeutic target and developed a unique delivery system to treat osteosarcoma.,https://www.labiotech.eu/trends-news/gene-therapy-chemotherapy-osteosarcoma-treatment-option/
2023-06-08,2023,Abivax,Abivax stock included in MSCI Indexes | Corporate,Financial_Performance,"Abivax, founded by Truffle Capital, is listed on Euronext compartment B (ISIN: FR0012333284 – Mnémo: ABVX). Based in Paris and Montpellier, Abivax's lead drug ...",https://www.eqs-news.com/news/corporate/abivax-stock-included-in-msci-indexes/648996ce-4560-456e-9b01-1a33dbb41283
2023-07-17,2023,Abivax,Claret Capital Partners Supports Zen Educate,Corporate_Action,"July 17 2023 – Zen Educate, an online platform that connects schools with teachers, have agreed a debt financing facility led by the Fund, to support the London ...",https://www.claret-capital.com/articles/claret-capital-partners-supports-zen-educate/
2023-07-20,2023,Abivax,IPO Tracker | IPO Readiness at Goodwin,Financial_Performance,Our team of sophisticated capital markets lawyers have extensive experience across the full breadth of equity and debt capital markets.,https://www.goodwinlaw.com/en/resource/ipo-readiness/ipo-tracker
2023-08-11,2023,Abivax,"Financings for Aug. 11, 2023",Financial_Performance,"Abivax SA, of Paris, said it plans to conduct a registered public offering of its ordinary shares, in the form of American depositary shares, in the U.S., ...",https://www.bioworld.com/articles/699855-financings-for-aug-11-2023
2023-08-21,2023,Abivax,Abivax secures up to EUR 150M from two structured debt ...,General_Update,Abivax or the Company today announced that it has concurrently signed two structured debt financing transactions for a total amount of up to EUR 150M.,https://ir.abivax.com/news-releases/news-release-details/abivax-secures-eur-150m-two-structured-debt-financing
2023-09-07,2023,Abivax,Abivax provides business and operational update,Clinical_Milestone,Optimize Opportunity in IBD in the Near Term with Phase 3 Data Beginning in 2025—Overcome limitations of currently available treatments for UC to establish ...,https://ir.abivax.com/news-releases/news-release-details/abivax-provides-business-and-operational-update
2023-09-09,2023,Abivax,ABX464 for UC - Abivax,Clinical_Milestone,"1,200 moderate to severe UC patients across 36 countries will take part in the pivotal Phase 3 program which consists of two induction studies and a subsequent ...",https://www.abivax.com/pipeline/abx464-ibd-uc/
2023-09-21,2023,Abivax,Abivax presents first-half 2023 financial results | Corporate,General_Update,"As of August 2023, Abivax had EUR 118M cash on hand (unaudited) and expects its current cash runway to finance its operations through Q2 2024. With an ...",https://www.eqs-news.com/news/corporate/abivax-presents-first-half-2023-financial-results/1c29bacb-715c-43d3-886a-abb6067215fb_en
2023-09-21,2023,Abivax,Abivax presents first-half 2023 financial results | Corporate,Clinical_Milestone,... Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. More information on the Company is available at www.abivax.com.,https://www.eqs-news.com/news/corporate/abivax-presents-first-half-2023-financial-results/1c29bacb-715c-43d3-886a-abb6067215fb
2023-10-02,2023,Abivax,Release Details - Investor Relations | Abivax,Clinical_Milestone,Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023 ; Obefazimod in patients with moderate-to-severe ...,https://ir.abivax.com/news-releases/news-release-details/abivax-highlights-obefazimod-ulcerative-colitis-program-new-data
2023-10-02,2023,Abivax,Two biotechs go public while Apnimed bides its time,Clinical_Milestone,"Abivax's efforts center on immunology med obefazimod, currently being tested in a phase 3 trial for patients with ulcerative colitis. A phase 2 study ...",https://www.fiercebiotech.com/biotech/abivax-lexeo-go-public-while-least-one-other-biotech-bides-its-time
2023-10-18,2023,Abivax,Abivax Readies $250 Million U.S. IPO For Drug Pipeline ...,Financial_Performance,Abivax has filed proposed terms to raise $250 million in an IPO to fund the development of its treatment candidates for chronic inflammatory diseases.,https://seekingalpha.com/article/4641637-abivax-readies-250-million-us-ipo-for-drug-pipeline
2023-10-19,2023,Abivax,Abivax announces the pricing of its Initial Public Offering on ...,General_Update,"The offering price per ADS corresponds to the offering price of €10.9864 per ordinary share based on the October 19, 2023 exchange rate of €1.00 = $1.0559.",https://ir.abivax.com/news-releases/news-release-details/abivax-announces-pricing-its-initial-public-offering-nasdaq
2023-10-19,2023,Abivax,"Weekly Update – October 23, 2023",Corporate_Action,Last week saw $143 million in M&A deals announce across six deals. The largest was an acquisition of Yingu Pharma in China and an unsolicited offer by Concentra ...,https://www.stifel.com/newsletters/investmentbanking/bal/marketing/healthcare/biopharma_timopler/biopharmamarketupdate_10.23.2023.pdf
2023-10-20,2023,Abivax,Abivax Announces the Pricing of its Initial Public Offering ...,Financial_Performance,"The ADSs have been approved for listing on the Nasdaq Global Market and are expected to begin trading on October 20, 2023 under the ticker symbol ""ABVX"". The ...",https://finance.yahoo.com/news/abivax-announces-pricing-initial-public-131500673.html
2023-10-26,2023,Abivax,Annual report and audited financial statements,General_Update,This annual report and audited financial statements (the “Report and Financial Statements”) may be translated into other languages. Any such.,https://www.ishares.com/uk/individual/en/literature/annual-report/ishares-vii-plc-en-annual-report-2023.pdf
2023-11-01,2023,Abivax,"Team - Eledon Pharmaceuticals, Inc ...",General_Update,Eledon has built a team of proven professionals and industry leaders with deep expertise and impressive track records in developing novel therapeutics.,https://eledon.com/team/
2023-11-11,2023,Abivax,Carmat,General_Update,"The original version of this Universal Registration Document in French was filed on April 21, 2023 with the French financial markets authority (Autorité des ...",https://www.victrex.com/-/media/downloads/literature/enterprise/changemaker_carmat_artificial-heart_literature_2023.pdf
2023-11-16,2023,Abivax,"Optimism at Jefferies, but don't expect IPO boost soon— ...",Clinical_Milestone,"France's Abivax raised over $235 million from its Nasdaq listing, which the Paris-based company will partly use to complete the phase 3 development of ...",https://ftp.fiercediversityinclusion.com/biotech/optimism-jefferies-conference-dont-expect-biotech-ipo-boost-next-year-says-sofinova-chair
2023-11-16,2023,Abivax,"Optimism at Jefferies, but don't expect IPO boost soon— ...",Financial_Performance,"France's Abivax raised over $235 million from its Nasdaq ... Fierce Biotech M&A Tracker 2023: BMS, AbbVie drop billions for neuropsychiatry biotechs.",https://www.fiercebiotech.com/biotech/optimism-jefferies-conference-dont-expect-biotech-ipo-boost-next-year-says-sofinova-chair
2023-11-21,2023,Abivax,Innovation Summit,Financial_Performance,"He led. Medicxi's investment in Aura Biosciences. (NASDAQ:AURA), New Amsterdam. (NASDAQ:NAMS) and Abivax (Euronext:ABVX). Giovanni currently serves on the ...",https://www.cancerresearchhorizons.com/sites/default/files/2023-11/Innovation%20Summit%202023%20-%20programme%20%281%29.pdf
2023-11-24,2023,Abivax,Biotech IPOs in 2023: Shaping the Future of Innovation,Clinical_Milestone,"Price on November 24, 2023: $10.16​​ As a clinical-stage entity, Abivax is actively assessing its leading drug candidate, obefazimod, in Phase III clinical ...",https://xtalks.com/biotech-ipos-in-2023-shaping-the-future-of-innovation-3392/
2023-11-28,2023,Abivax,Biopharma's top 5 IPOs of 2023 (so far),Financial_Performance,"Abivax, a French-based biotech whose lead program targets ulcerative colitis, also raised $236 million after going public in the EU and U.S.. But neither ...",https://www.pharmavoice.com/news/biggest-biopharma-ipo-2023-kenvue/700762/
2023-12-04,2023,Abivax,"Marc de Garidel, Abivax | How to make two Billion-dollar ...",Financial_Performance,"He made two billion dollar exits. He was a CEO of a French biopharma Epson and now made the biggest IPO ever for a French biotech on the NASDAQ with, with ...",https://flot.bio/episode/marc-de-garidel-abivax-exit/
2024-01-01,2024,Abivax,Structure activity relationship and target prediction for ...,Clinical_Milestone,"by HT Shanley · 2024 · Cited by 4 — 46, 47, 48, 49 ABX464 (called obefazimod; Abivax, France) has recently undergone phase II clinical trials as a treatment of ulcerative colitis, and, is ...",https://www.sciencedirect.com/science/article/pii/S0968089623003887
2024-01-01,2024,Abivax,Structure-activity relationship and target investigation of 2- ...,Clinical_Milestone,"by HT Shanley · 2024 · Cited by 10 — To contribute to the discovery of new anthelmintic entities, we recently evaluated a quinoline derivative (ABX464, called obefazimod; Abivax, France, Fig. 1) ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC10845918/
2024-01-01,2024,Abivax,Etrasimod for the Treatment of Ulcerative Colitis: Analysis of ...,Clinical_Milestone,"by M Regueiro · 2024 · Cited by 13 — This is a post hoc analysis of two phase 3 clinical trials with 12 and 52 weeks of duration, respectively. However, it is worth noting that the 2.5-year pooled ...",https://academic.oup.com/ecco-jcc/article/18/10/1596/7663764
2024-01-01,2024,Abivax,Risankizumab for Ulcerative Colitis: Two Randomized ...,Clinical_Milestone,by E Louis · 2024 · Cited by 115 — This report describes the results of 2 phase 3 trials that evaluated the efficacy and safety of risankizumab compared with placebo as an induction and a ...,https://jamanetwork.com/journals/jama/fullarticle/2821291
2024-01-01,2024,Abivax,September 2024 Newsletter,Corporate_Action,Day 4 was chaired by Rosa Qian as she navigated us through mergers and acquisitions with respect to pharmacovigilance.,https://www.linkedin.com/pulse/september-2024-newsletter-truliant-consulting-pksle
2024-01-05,2024,Abivax,Finance Report 2023,Financial_Performance,"However, Europe's two new Nasdaq-listed biotechs could signal a slowly improving public market for 2024. ... One of these listings was Abivax, a French ...",https://biotechfinance.org/finance-report-2023/
2024-01-22,2024,Abivax,Abivax provides 2024 strategic outlook and lays out key ...,Clinical_Milestone,"Based in France and the US, Abivax's lead drug candidate, obefazimod (ABX464), is in Phase 3 clinical trials for the treatment of moderately to severely active ...",https://ir.abivax.com/news-releases/news-release-details/abivax-provides-2024-strategic-outlook-and-lays-out-key
2024-03-28,2024,Abivax,"Biopharmaceutical Sector - Weekly Update – April 1, 2024",Clinical_Milestone,The largest M&A transaction announced in Q1 2024 was Gilead's $4.2 billion purchase of CymaBay. ... Industry News. 60. Page 61. FDA Approves Merck Lung Disease ...,https://www.stifel.com/newsletters/investmentbanking/bal/marketing/healthcare/biopharma_timopler/biopharmamarketupdate_04.01.2024.pdf
2024-04-05,2024,Abivax,Abivax to Present Three Abstracts for Obefazimod in ...,Clinical_Milestone,"Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024. Professor Bruce E. Sands , MD to present oral presentation of ...",https://ir.abivax.com/news-releases/news-release-details/abivax-present-three-abstracts-obefazimod-ulcerative-colitis-ueg
2024-04-17,2024,Abivax,1. EN_UNIVERSAL REGISTRATION DOCUMENT 2023,General_Update,"This Universal Registration Document was filed on 17 April. 2024, with the French Financial Markets' Authority (AMF), as the competent authority under (EU) ...",https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2024/04/17154251/EN_UNIVERSAL-REGISTRATION-DOCUMENT-2023-BD.pdf
2024-04-17,2024,Abivax,Abivax 2025 Company Profile: Stock Performance & ...,Financial_Performance,Abivax's most recent deal was a Merger/Acquisition with Prosynergia for . The deal was made on 01-Apr-2022. Company Name Prosynergia. Deal Date 01-Apr-2022.,https://pitchbook.com/profiles/company/61495-21
2024-05-02,2024,Abivax,Inflammatory Bowel Disease Market To Exhibit Significant ...,General_Update,"Prominent companies working in the domain of inflammatory bowel disease, including Arena Pharmaceuticals, Pfizer, Abivax, Janssen (Johnson and Johnson), Celgene ...",https://finance.yahoo.com/news/inflammatory-bowel-disease-market-exhibit-170000201.html
2024-05-17,2024,Abivax,S-1,Financial_Performance,"We have applied to list our common stock on the Nasdaq Global Market under the symbol “RAPP.” We believe that upon the completion of this offering, we will meet ...",https://www.sec.gov/Archives/edgar/data/2012593/000119312524141704/d803738ds1.htm
2024-05-29,2024,Abivax,Harnessing small molecules to treat chronic inflammatory ...,General_Update,Learn how Abivax's small molecule treatment could benefit UC patients and why these drugs hold promise to treat autoimmune diseases.,https://www.europeanpharmaceuticalreview.com/article/229550/harnessing-small-molecules-to-treat-chronic-inflammatory-diseases/
2024-06-04,2024,Abivax,SEC Filing - Investor Relations | Abivax,Financial_Performance,"18. Delegation of authority to the Board of Directors to carry out a capital increase by issuing shares, equity securities giving access to other equity ...",https://ir.abivax.com/node/11076/html
2024-06-04,2024,Abivax,Form 6-K for Abivax SA filed 06/04/2024,Clinical_Milestone,"increase by issuing shares, equity securities giving access to other equity ... Obefazimod, Abivax's lead investigational drug candidate, is an orally ...",https://ir.abivax.com/static-files/f61d4b44-1331-4c52-aa02-f1e84a7e3397
2024-06-10,2024,Abivax,universal registration document - 2023,General_Update,"This Universal Registration Document was filed on April 19, 2024 with the Autorité des Marchés Financiers. (AMF), as the competent authority in respect of (EU) ...",https://www.carbios.com/wp-content/uploads/2024/06/CARBIOS_DEU%202023_EN_WEB.pdf
2024-06-13,2024,Abivax,NCT06456593 | Efficacy and Safety of Obefazimod in ...,Clinical_Milestone,"This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the ...",https://clinicaltrials.gov/study/NCT06456593
2024-06-30,2024,Abivax,FRANKLIN TEMPLETON INVESTMENT FUNDS,Financial_Performance,This report shall not constitute an offer or a solicitation of an offer to buy shares of Franklin Templeton Investment Funds (the “Company”).,https://www.franklintempleton.lu/download/en-lu/annual-report/3757eacf-e66b-4e66-a067-34a5c185ac4a/FTIF-annual-report-en.pdf
2024-07-15,2024,Abivax,Abivax Provides Operational and Key Program Update,Clinical_Milestone,"Phase 2 clinical trials in patients with UC have generated positive data, resulting in the initiation of a pivotal global Phase 3 clinical trial program (ABTECT ...",https://ir.abivax.com/news-releases/news-release-details/abivax-provides-operational-and-key-program-update
2024-07-31,2024,Abivax,Annual report and audited financial statements,General_Update,It is noted that the audit report included in the financial statements is relevant to the company and not to individual funds. For the financial year ended 31 ...,https://www.ishares.com/ch/individual/en/literature/annual-report/ishares-vii-plc-annual-report-en-ch-31-jul-24.pdf
2024-08-14,2024,Abivax,"AI: This ""Bubble"" Is Stuffed With Money - Chaotropy",Clinical_Milestone,Abivax's obefazimod offers a novel oral approach to treat ulcerative colitis by activating miR-124 to downregulate specific pro-inflammatory pathways. Following ...,https://www.chaotropy.com/ai-this-bubble-is-stuffed-with-money/
2024-08-16,2024,Abivax,Rise8 Ranks No. 268 on the 2024 Inc. 5000 as one of ...,General_Update,"268 on the 2024 Inc. 5000's annual list of the fastest-growing private ... ABVX ABIVAX Société Anonyme 132.59 -5.75 (-4.16%) · LIF Life360, Inc. 64.18 ...",https://finance.yahoo.com/news/rise8-ranks-no-268-2024-130000571.html
2024-09-15,2024,Abivax,Advances in MicroRNA Therapeutics: From Preclinical to ...,Clinical_Milestone,ABX464 (Obefazimod) is Abivax's most advanced small molecule drug candidate into Phase 3 clinical development for the treatment of moderately to severely active ...,https://liebertpub.com/doi/10.1089/hum.2024.113
2024-09-17,2024,Abivax,Overview of financing options for French biotech companies,General_Update,"This was the case for Abivax in September 2022 and Inventiva in August 2023, which raised a total of 49.2 million euros and 35.1 million euros, respectively.",https://www.dechert.com/knowledge/onpoint/2024/9/overview-of-financing-options-for-french-biotech-companies.html
2024-09-21,2024,Abivax,BiotechTV | Brights Minds,General_Update,"Two veterans from MPM have launched a new VC firm, Vie Ventures, that will focus on investing in the I&I space - and it will leverage collaborations with ...",https://www.biotechtv.com/bright-minds
2024-09-25,2024,Abivax,Abivax Provides Update on Ulcerative Colitis (UC ...,Clinical_Milestone,Abivax is actively conducting preclinical studies with multiple oral and injectable therapies and will report additional data in Q4 2024.,https://ir.abivax.com/news-releases/news-release-details/abivax-provides-update-ulcerative-colitis-uc-combination-therapy
2024-09-30,2024,Abivax,Is It Too Late to Buy Alibaba Stock? Insights and Trends,Financial_Performance,"From trading at a lower band in late September, the bounce back to 107.33 on Sep 27, 2024, underscores a brisk volatility in response to market stimuli.",https://www.timothysykes.com/news/alibaba-group-holding-limited-american-depositary-shares-each-representing-eight-baba-news-2024_09_30/
2024-10-03,2024,Abivax,Abivax Reports Positive Interim Efficacy and Safety Analysis of ...,General_Update,"Patient retention rates were high, with only 12% (16/130) of patients discontinuing in the first year and 5% (6/114) discontinuing during the second year of ...",https://ir.abivax.com/news-releases/news-release-details/abivax-reports-positive-interim-efficacy-and-safety-analysis
2024-10-03,2024,Abivax,Abivax Announces First Patient Enrolled in ENHANCE-CD ...,Clinical_Milestone,This trial has 3 treatment phases: a 12-Week Induction Phase ... phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis.,https://firstwordpharma.com/story/5901248
2024-10-03,2024,Abivax,Abivax reports positive interim results for obefazimod,Clinical_Milestone,French drug developer Abivax today announced the results of an interim efficacy and safety analysis of an open-label maintenance (OLM) study that enrolled ...,https://www.thepharmaletter.com/abivax-reports-positive-interim-results-for-obefazimod
2024-10-15,2024,Abivax,Corporate Presentation - Investor Relations | Abivax,Clinical_Milestone,"opportunity for obefazimod and projections of market share, expectations for potential patent term extensions for obefazimod, Abivax's cash runway, and ...",https://ir.abivax.com/static-files/ecf996c4-f156-4dac-8e1e-5c4e7cfb8e7d
2024-11-12,2024,Abivax,LGBTQ+ Board Diversity: Shaping the Future of Business,Financial_Performance,"LGBTQ+ diversity policies across listed companies since its implementation (1,691 Nasdaq-listed companies are now LGBTQ+ inclusive at the board level). But ...",https://outleadership.com/wp-content/uploads/2024/11/outquorum_report_2024.pdf
2024-12-03,2024,Abivax,LSX awards the crème de la crème of dealmaking,Corporate_Action,"Ranging from “Seed-Stage Finance Raise of the Year” to “M&A Deal of the Year,” the awards celebrated a diverse array of accomplishments in 2024.",https://www.bioxconomy.com/business-strategy/lsx-awards-the-cr-me-de-la-cr-me-of-dealmaking
2024-12-09,2024,Abivax,Acquiring companies offer bonuses to M&A pros,Financial_Performance,The recent surge in acquisitions puts a premium on recognizing the heavy workload of employees who help execute the deals.,https://finance.yahoo.com/news/acquiring-companies-offer-bonuses-m-091540808.html
2024-12-13,2024,Abivax,EQUITY RESEARCH,General_Update,"The group sold part of its position in Cathay Biotech during FY2024 to 31 March, retaining a 6% stake. The share's retracement from its high points in 2021 is ...",https://www.hbmhealthcare.com/sites/default/files/downloads/ck-uploads/cic-market-solution-hbmn-report-dec-2024.pdf
2024-12-15,2024,Abivax,Pharming's Bold Move: Acquisition of Abliva AB,Corporate_Action,"The acquisition is expected to close in the second quarter of 2024, subject to customary closing conditions and regulatory approvals.",https://www.ainvest.com/news/pharming-s-bold-move-acquisition-of-abliva-ab-24121010d48a35eda55a8f05/
2024-12-27,2024,Abivax,Regulatory data of biopharma companies in 2024,Clinical_Milestone,"Abivax SA, of Paris, Obefazimod, Binds to the RNA cap binding protein (CBC 80 ... Deals and M&A · Financings · Newco news · Opinion · Regulatory · Science.",https://www.bioworld.com/content/regulatory-data-2024
2025-01-09,2025,Abivax,Abivax Achieves Key Milestone in Phase 3 ABTECT Trial ...,Clinical_Milestone,"Enrollment completion expected in Q2 2025. Top-line results for the 8-week induction trial anticipated in Q3 2025, with 44-week maintenance data on track for Q2 ...",https://ir.abivax.com/news-releases/news-release-details/abivax-achieves-key-milestone-phase-3-abtect-trial-enrollment
2025-04-29,2025,Abivax,Abivax Announces Completion of Enrollment for the Phase 3 ...,Clinical_Milestone,"Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis. April 29, 2025. PDF ...",https://ir.abivax.com/news-releases/news-release-details/abivax-announces-completion-enrollment-phase-3-abtect-trials
2025-06-02,2025,Abivax,Abivax Presents First Quarter 2025 Financial Results,General_Update,Research and development (R&D) expenses increased by EUR 3.6M to EUR -39.3M in the first quarter of 2025 compared to EUR -35.7M in the same period in 2024.,https://ir.abivax.com/news-releases/news-release-details/abivax-presents-first-quarter-2025-financial-results
2025-07-22,2025,Abivax,Abivax Announces Positive Phase 3 Results from Both ...,Clinical_Milestone,Results from the ABTECT-1 and ABTECT-2 trials demonstrated that obefazimod met its FDA primary endpoint of clinical remission at Week 8 in the 50 mg once-daily ...,https://ir.abivax.com/news-releases/news-release-details/abivax-announces-positive-phase-3-results-both-abtect-8-week
2025-07-23,2025,Abivax,Why did ABVX Surged in Premarket Trading?,Clinical_Milestone,Abivax shares surged over 400% in premarket trading after announcing positive Phase 3 results for its ulcerative colitis drug obefazimod.,https://www.interactivebrokers.com/campus/traders-insight/securities/stocks/why-did-abvx-surge-over-400-in-premarket-trading/
2025-07-23,2025,Abivax,Abivax's obefazimod wows investors; stock climbs 500%+,Clinical_Milestone,"Abivax's obefazimod wows investors; stock climbs 500%+. Stock chart, upward arrow. July 23, 2025 ... In the phase IIb trial there was a seven- to 10-fold increase ...",https://www.bioworld.com/articles/722343-abivaxs-obefazimod-wows-investors-stock-climbs-500
2025-07-23,2025,Abivax,Abivax aces phase 3 colitis trials as end of cash runway ...,Clinical_Milestone,"After a long, cash-strapped journey, French biotech Abivax has presented top-line data from the twin phase 3 trials of its lead ulcerative colitis candidate.",https://www.fiercebiotech.com/biotech/abivax-aces-pair-ph-3-ulcerative-colitis-trials-end-cash-runway-looms
2025-07-23,2025,Abivax,Abivax drug scores major win in ulcerative colitis trials,Clinical_Milestone,"Abivax tested obefazimod in a pair of Phase 3 trials that enrolled 1,275 patients, testing the once-daily oral treatment at 25 milligrams and 50 milligrams ...",https://www.statnews.com/2025/07/23/abivax-obefazimod-ulcerative-colitis-trials/
2025-07-23,2025,Abivax,Obefazimod Meets Primary Endpoint in Phase 3 ABECT ...,Clinical_Milestone,Positive topline results showed obefazimod met its primary endpoint for clinical remission at week 8 in the 50 mg dose cohort in ABECT-1 and ABECT-2.,https://www.hcplive.com/view/obefazimod-meets-primary-endpoint-phase-3-abect-program-ulcerative-colitis
2025-07-23,2025,Abivax,Form 424B5 for Abivax SA filed 07/24/2025,Financial_Performance,"Our ADSs are listed on the Nasdaq Global Market under the symbol “ABVX.” On July 22, 2025, the last reported sale price of the ADSs on the Nasdaq Global Market ...",https://ir.abivax.com/static-files/e3f2335a-ff4e-4170-ab53-9e9e332425a6
2025-07-24,2025,Abivax,Abivax stock surges 580% following dual Phase III success ...,Clinical_Milestone,Abivax's obefazimod resulted in an average 16.4% placebo-adjusted clinical remission rate in UC patients across the two trials.,https://www.clinicaltrialsarena.com/news/abivax-stock-surges-580-following-dual-phase-iii-success-in-uc/
2025-07-24,2025,Abivax,Abivax stock surges 580% following dual Phase III success ...,Clinical_Milestone,Abivax's stock has soared by more than 500% after its first-in-class ulcerative colitis (UC) therapy impressed in a Phase III trial.,https://finance.yahoo.com/news/abivax-stock-surges-580-following-094007484.html
2025-07-25,2025,Abivax,Obefazimod Phase III Success Pushes Abivax Stock to ...,Clinical_Milestone,Abivax's stock rose 586% following obefazimod's promising Phase III results and a successful $250M IPO on Nasdaq.,https://xtalks.com/obefazimod-phase-iii-success-pushes-abivax-stock-to-record-highs-4349/
2025-09-08,2025,Abivax,Abivax Presents First Half 2025 Financial Results,Clinical_Milestone,"A EUR 6.5M, increase related to the Company's Crohn's Disease (CD) clinical program, driven by the progression of Phase 2b clinical trials for obefazimod in CD; ...",https://ir.abivax.com/news-releases/news-release-details/abivax-presents-first-half-2025-financial-results
2025-09-12,2025,Abivax,Abivax to Join CAC Mid 60 and SBF 120 Indices Following ...,General_Update,"This decision will take effect on Friday, September 19, 2025, after market close. The CAC Mid 60 and SBF 120 are key indices on the Euronext Paris exchange, ...",https://ir.abivax.com/news-releases/news-release-details/abivax-join-cac-mid-60-and-sbf-120-indices-following-euronext
2025-10-05,2025,Abivax,Abivax Announces Late-Breaking Presentation of 8-Week ...,Clinical_Milestone,The presentation includes results from Abivax's Phase 3 ABTECT 8-Week Induction Trials investigating obefazimod for the treatment of moderate-to-severely active ...,https://ir.abivax.com/news-releases/news-release-details/abivax-announces-late-breaking-presentation-8-week-abtect-trial
2025-10-06,2025,Abivax,Release Details - Investor Relations | Abivax,Clinical_Milestone,"These data, from the Phase 3 ABTECT 8-Week Induction Trials investigating obefazimod for the treatment of moderate-to-severely active ulcerative colitis ...",https://ir.abivax.com/news-releases/news-release-details/abivax-announces-late-breaking-presentation-8-week-abtect
2025-11-03,2025,Abivax,Release Details - Investor Relations | Abivax,Clinical_Milestone,"Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of ...",https://ir.abivax.com/news-releases/news-release-details/abivax-announces-patient-reported-outcomes-data-phase-3-abtect
2025-12-03,2025,Abivax,Europe's Biotech Standout Faces Crucial Year After ...,General_Update,French biotech company Abivax SA started the year with a market value of less than $500 million and is now worth more than $8 billion after a meteoric rally.,https://www.bloomberg.com/news/articles/2025-12-04/europe-s-biotech-standout-faces-crucial-year-after-1-300-rally
2025-12-03,2025,Abivax,Europe's Biotech Standout Faces Crucial Year After ...,General_Update,"After a meteoric rally, it's now worth more than $8 billion — and some analysts see the potential for even more gains. The optimism began in July when Abivax ...",https://finance.yahoo.com/news/europe-biotech-standout-faces-crucial-050000231.html
2025-12-10,2025,Abivax,Growth or Bubble? Understanding Abivax Surge,Clinical_Milestone,"Live Update At 14:02:11 EST: On Wednesday, December 10, 2025 Abivax SA stock [NASDAQ: ABVX] is trending up by 5.21%! ... Abivax's obefazimod study findings ...",https://stockstotrade.com/news/abivax-sa-abvx-news-2025_12_10-2/
2025-12-10,2025,Abivax,Abivax stock pops on Eli Lilly takeover speculation,Financial_Performance,"Abivax SA (NASDAQ:ABVX, EPA:ABVX), a French biotechnology firm, saw its US-listed shares jump more than 11% on rumors it may be acquired by Eli Lilly and Co ...",https://www.proactiveinvestors.com/companies/news/1084169/abivax-stock-pops-on-eli-lilly-takeover-speculation-1084169.html
2025-12-10,2025,Abivax,French biotech Abivax's shares climb on Eli Lilly bid rumors,Financial_Performance,French biotech company Abivax's shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly could make an offer for the ...,https://www.reuters.com/business/healthcare-pharmaceuticals/french-biotech-abivaxs-shares-climb-eli-lilly-bid-rumors-2025-12-10/
2025-12-10,2025,Abivax,French Biotech Abivax's (ABVX) Shares Climb on Eli Lilly ...,Financial_Performance,"Reuters reported that French biotech company Abivax's (ABVX) shares jumped by 20% on December 10, 2025, on market rumours that U.S. pharma giant Eli Lilly.",https://www.insidearbitrage.com/dealsintheworks/insidearbitrage-potential-deal-alert-french-biotech-abivaxs-abvx-shares-climb-on-eli-lilly-lly-bid-rumors/
2025-12-10,2025,Abivax,Eli Lilly acquisition rumors reportedly fuel Abivax rally,Financial_Performance,Abivax (ABVX) stock rallies as market speculates about a potential takeover bid from Eli Lilly (LLY). Read more here.,https://seekingalpha.com/news/4530037-eli-lilly-acquisition-rumors-fuel-abivax-rally
2025-12-11,2025,Abivax,"Abivax: ""Strong Buy"" On Obefazimod New UC Data And ...",Clinical_Milestone,"According to the 6-K SEC Filing for the 1st half of 2025 financial results, Abivax had $71.63 million as of June 30, 2025. This was not a lot of cash, and ...",https://seekingalpha.com/article/4852659-abivax-strong-buy-on-obefazimod-new-uc-data-and-maintenance-results-q2-2026
2025-12-14,2025,Abivax,Abivax to Be Added to Nasdaq Biotechnology Index,Financial_Performance,"Abivaxto be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ...",https://news.futunn.com/en/post/66392166/abivax-to-be-added-to-nasdaq-biotechnology-index
2025-12-15,2025,Abivax,Abivax Presents Third Quarter 2025 Financial Results,Financial_Performance,"Abivax (NASDAQ:ABVX) reported third-quarter 2025 interim results and operational updates on December 15, 2025. Key financials for the nine months ended ...",https://www.stocktitan.net/news/ABVX/abivax-presents-third-quarter-2025-financial-zvnpeiu7sj3q.html
2025-12-17,2025,Abivax,6 Biotechs That Could Be Big Pharma's Next M&A Target,General_Update,"With M&A back on the table after a dramatic bidding war for Metsera, analysts are searching for clues as to what biotech will be the next Big Pharma target.",https://www.biospace.com/business/6-biotechs-that-could-be-big-pharmas-next-m-a-target
2025-12-18,2025,Abivax,Abivax to be Added to Nasdaq Biotechnology Index,Financial_Performance,"Abivax to be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ...",https://finance.yahoo.com/news/abivax-added-nasdaq-biotechnology-index-210500793.html
2025-12-18,2025,Abivax,EQS-News: ABIVAX: Abivax to be Added to Nasdaq ...,Financial_Performance,"... 2025. Didier Blondel, Chief Financial Officer of Abivax commented: ""Our inclusion in the Nasdaq Biotechnology Index marks a significant milestone for Abivax.",https://www.finanznachrichten.de/nachrichten-2025-12/67271833-eqs-news-abivax-abivax-to-be-added-to-nasdaq-biotechnology-index-023.htm
2025-12-22,2025,Abivax,Why Abivax Stock Was on Fire Today,Financial_Performance,"With that considerable tailwind at its back, Abivax's share price zoomed nearly 21% higher across that day's trading session.",https://www.fool.com/investing/2025/12/22/why-abivax-stock-was-on-fire-today/
2025-12-22,2025,Abivax,Abivax Surges 20.69% on Eli Lilly Takeover Hints and ...,Financial_Performance,"Abivax (ABVX) surged 20.69% on December 22, 2025, with trading volume hitting $0.56 billion, a 105.91% increase from the previous day. The stock ranked 166th in ...",https://www.ainvest.com/news/abivax-surges-20-69-eli-lilly-takeover-hints-nasdaq-index-inclusion-ranks-166th-market-activity-2512/
2025-12-22,2025,Abivax,Abivax Buzz: Stock Surge Analyzed - Timothy Sykes,Financial_Performance,"Abivax's stock has seen some dramatic jumps lately, trading at $137.77 on Dec 22, 2025. The financial report discloses a notable cash flow increase and ...",https://www.timothysykes.com/news/abivax-sa-abvx-news-2025_12_22-2/
2025-12-22,2026,Abivax,Portfolio Armor's Profile,Corporate_Action,"Lilly Executives Flew to Paris to Discuss an Abivax Merger. DEC 22, 2025 - 1:02 AM; 2,743; 5. Portfolio Armor's Photo. Time To Buy Biotech. by Portfolio Armor.",https://www.zerohedge.com/contributors/318661
2025-12-23,2025,Abivax,The Next Big Buyout? Abivax Emerges as a Premier M&A ...,General_Update,"The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave. By: MarketMinute. December 23, 2025 at 14:13 ...",https://markets.financialcontent.com/lightport.lightport3/article/marketminute-2025-12-23-the-next-big-buyout-abivax-emerges-as-a-premier-m-and-a-contender-for-2026-amidst-biotech-consolidation-wave
2025-12-23,2025,Abivax,Abivax is the most likely M&A target in biotech (ABVX: ...,Financial_Performance,"Abivax (ABVX) stock leads biotech M&A prospects for 2026 while Madrigal Pharmaceuticals (MDGL) trails, according to a survey conducted by Truist.",https://seekingalpha.com/news/4534869-abivax-the-most-likely-ma-target-in-biotech
2025-12-24,2025,Abivax,Abivax Shares Surge Amid Acquisition Talks - Timothy Sykes,Financial_Performance,"Reflecting its upward trajectory, Abivax is set to join the Nasdaq Biotechnology Index on December 22, strengthening its position within a competitive sector.",https://www.timothysykes.com/news/abivax-sa-abvx-news-2025_12_24-2/
2025-12-24,2025,Abivax,How Abivax Went From Biotech Nobody To M&A Bullseye ...,General_Update,"Abivax's current market valuation is roughly $11 billion. The company's cash position as of Sept. 2025 is 589.7 million euros, and the company said it has a ...",https://stocktwits.com/news-articles/markets/equity/how-abivax-went-from-biotech-nobody-to-m-and-a-bullseye-after-a-single-blockbuster-readout/cLeso3JREHu
2025-12-24,2026,Abivax,MyTopStock: Stock Market Reviews,Clinical_Milestone,"MLYS, LYEL, NKTR and INSM rise more than 50% in 2025 as clinical wins, FDA approvals and M&A deals revive sector momentum heading into 2026. Dec 24, 2025 ...",https://www.mytopstock.com/
2026-01-01,2026,Abivax,Astera Labs Surge: Analyzing the Boost,Financial_Performance,"Live Update At 10:01:54 EST: On Friday, January 02, 2026 Astera Labs Inc. stock [NASDAQ: ALAB] is trending up by 8.9%! Discover the key drivers behind this ...",https://stockstotrade.com/news/astera-labs-inc-alab-news-2026_01_02/
2026-01-01,2026,Abivax,"Vilkyškių pieninė aktsia hind, uudised ja ajalugu (VLP1L.VS)",Financial_Performance,jaan 2026 0:28. We recently published 10 Market Stars Behind Millionaire-Making in 2025. ABIVAX Societe Anonyme (NASDAQ:ABVX) is last year's top performer.,https://www.baltibors.ee/aktsia/vlp1l.vs
2026-01-01,2026,Abivax,"Abivax (ABVX) Stock Price, News & Analysis",Financial_Performance,"How Abivax went from biotech nobody to M&A bullseye after a single blockbuster readout this year ... Abivax's stock was trading at $134.85 on January 1st, 2026.",https://www.marketbeat.com/stocks/NASDAQ/ABVX/
2026-01-01,2026,Abivax,BioIndustry Association (BIA),Corporate_Action,"Ahead of JPM 2026, join this upcoming webinar exploring the latest trends shaping pharma dealmaking Pharma's deal review: M&A dynamics ahead of JPM 2026 ...",https://uk.linkedin.com/company/bioindustry
2026-01-02,2026,Abivax,Under Armour Shares Surge as Major Investor Increases ...,Financial_Performance,"Weekly Update Dec 29 – Jan 02, 2026: On Friday, January 02, 2026 Under Armour Inc. Class C stock [NYSE: UA] is trending up by 5.62%! Discover the key ...",https://stockstotrade.com/news/underarmourincclassc-ua-news-2026_01_02-2/
2015-01-01,2015,Nanobiotix,A Review of Clinical Translation of Inorganic Nanoparticles,Clinical_Milestone,"by AC Anselmo · 2015 · Cited by 587 — This review will focus on the clinical translation of inorganic nanoparticles, with special emphasis on key clinical trials that are currently recruiting or ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC4540735/
2015-01-01,2015,Nanobiotix,Metals as radio-enhancers in oncology,General_Update,"by A Pottier · 2015 · Cited by 33 — Radio-enhancers, metal-based nanosized agents, could play a key role in oncology. They may unlock the potential of radiotherapy by enhancing the radiation ...","https://nanobiotix.com/wp-content/uploads/docs/2015%20Pottier%20et%20al.,%20Metals%20as%20radio-enhancers%20in%20oncology.pdf"
2015-01-01,2015,Nanobiotix,Metals as radio-enhancers in oncology: The industry ...,General_Update,"by A Pottier · 2015 · Cited by 33 — Radio-enhancers, metal-based nanosized agents, could play a key role in oncology. They may unlock the potential of radiotherapy by enhancing the radiation dose ...",https://pubmed.ncbi.nlm.nih.gov/26362175/
2015-02-19,2015,Nanobiotix,O que é um KOL - Key Opinion Leader?,General_Update,"Os KOLs - Key Opinion Leader (Líder de Opinião) são médicos que influenciam expressivamente a prática médica dos seus pares, incluindo, mas não limitando, ...",https://brazilsfe.blogspot.com/2015/02/terms-KOL-key-opinion-leader.html
2015-03-31,2015,Nanobiotix,Informe - Lista de Laboratórios Farmacêuticos do Brasil,Clinical_Milestone,... Performance (4) indicadores financeiros (3) Indicadores Quantitativos (1) ... NBTXR3 (1) Jobs (3) John Warner (1) john wilson (1) Johnson (2) Johnson ...,https://brazilsfe.blogspot.com/2015/03/informe-lista-de-laboratorios.html
2015-12-10,2015,Nanobiotix,"Pharma, Sales and Marketing Terms - O que é o IQVIA ...",General_Update,O DDD® - Drug Distribution Data (Dados de Distribuição de Medicamentos) - é um estudo com perfil estatístico regionalizado de vendas de produtos ...,https://brazilsfe.blogspot.com/2015/12/terms-ims-ddd-dados-de-distribuicao-de-drogas.html
2016-01-01,2016,Nanobiotix,Nanoparticles in the clinic - PMC,Clinical_Milestone,"by AC Anselmo · 2016 · Cited by 1557 — Hafnium oxide nanoparticles (NBTXR3), developed by Nanobiotix, utilize an external radiation source to enhance cell death at the radiation site via release of ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC5689513/
2016-01-01,2016,Nanobiotix,עד כמה הרכבים האוטונומיים בטוחים? --------- קיבלתי שפע של ...,Clinical_Milestone,"... 2016/09/425 ואת המאמר הקודם - עיר העתיד: רכבים אוטונומיים, רחפנים ורובוטים ב ... חברת Nanobiotix פיתחה ננו-חלקיקים בשם NBTXR3, שמוזרקים ישירות לגידול ...",https://www.facebook.com/Futures.guide/photos/a.439215162845955/872079329559534/?type=3
2016-01-01,2016,Nanobiotix,73.full.pdf,General_Update,by C Ager · 2016 · Cited by 14 — Journal for ImmunoTherapy of Cancer: first published as 10.1186/s40425-016-0173-6 on 16 November 2016. Downloaded from https://jitc.bmj.com on 16 November 2025 ...,https://jitc.bmj.com/content/jitc/4/Suppl_1/73.full.pdf
2016-01-01,2016,Nanobiotix,Nanoparticles in the clinic - Anselmo - 2016,Clinical_Milestone,"by AC Anselmo · 2016 · Cited by 1557 — This review focuses on the clinical translation of intravenously administered nanoparticles, with additional emphasis on the challenges faced by nanoparticles.",https://aiche.onlinelibrary.wiley.com/doi/10.1002/btm2.10003
2016-03-22,2016,Nanobiotix,"Interview: Laurent Levy - CEO, Nanobiotix, France",General_Update,"Therefore, we are striving to improve the efficacy of radiotherapy into the tumor without increasing the damage in surrounding healthy tissue. This is the ...",https://pharmaboardroom.com/interviews/interview-laurent-levy-ceo-nanobiotix-france/
2016-04-15,2016,Nanobiotix,Taiwan - Biotech Companies - Careers Page,General_Update,"Acquired by BMS, Mar 2016, $225 + $375 milestone. Newgen Biopharma, ,, Suspended trading due to scandal. Thyritope Biosciences, ,, Closed Oct 2016. ,, Website ...",https://biopharmguy.com/links/career-by-name-taiwan.php
2016-06-14,2016,Nanobiotix,About Us,General_Update,Learn how Nanobiotix uses physics to push the frontiers of nanomedicine to expand therapeutic possibilities for patients around the world.,https://nanobiotix.com/about-us/
2016-06-14,2016,Nanobiotix,Nanoparticle-Based Medicines: A Review of FDA-Approved ...,Clinical_Milestone,"Developed by Nanobiotix, NBTXR3 is a novel radio enhancer utilizing a high electron density metal oxide (hafnium oxide) nanoparticle to increase ...",https://link.springer.com/article/10.1007/s11095-016-1958-5
2016-06-17,2016,Nanobiotix,"Sacha Pouget : ""Les biotechs représentent de formidables ...",Clinical_Milestone,"Pour Nanobiotix, on attend également d'ici fin juin des résultats de l'étude de phase I/II sur le produit NBTXR3 dans le cancer de la tête et du cou, alors que ...",https://www.tradingsat.com/actualites/interviews/les-biotechs-representent-de-formidables-opportunites-681003.html
2016-08-27,2016,Nanobiotix,A Pirâmide de Maslow,General_Update,"A Pirâmide de Maslow ou a Hierarquia das Necessidades de Maslow é um conceito criado pelo psicólogo norte-americano Abraham H. Maslow, que determina as ...",https://brazilsfe.blogspot.com/2016/08/A-Piramide-de-Maslow.html
2016-09-04,2016,Nanobiotix,A Pirâmide de Kelsen - Teoria pura do direito,General_Update,"Analisando a eficácia e a aplicabilidade das normas, Hans Kelsen embasa uma de suas teorias, empregada na análise do controle de constitucionalidade.",https://brazilsfe.blogspot.com/2016/08/A-Piramide-de-Kelsen.html
2017-01-01,2017,Nanobiotix,Histotype-tailored neoadjuvant chemotherapy versus ...,Clinical_Milestone,by A Gronchi · 2017 · Cited by 546 — A pathological complete response was noted in 14 (16%) of 87 patients in the NBTXR3 group and seven (8%) of 89 in the radiotherapy alone group (p=0·044).,https://www.sciencedirect.com/science/article/abs/pii/S1470204517303340
2017-01-01,2017,Nanobiotix,A Monte Carlo study of I-125 prostate brachytherapy with gold ...,Clinical_Milestone,by D Brivio · 2017 · Cited by 35 — Nanobiotix. NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating and Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and ...,https://pmc.ncbi.nlm.nih.gov/articles/PMC5378384/
2017-01-01,2017,Nanobiotix,A novel approach to low-temperature synthesis of cubic ...,Clinical_Milestone,by N Kumar · 2017 · Cited by 95 — Nanobiotix reports successful results from Phase I/II Trial of NBTXR3 in Head & Neck Cancer. https://globenewswire.com/newsrelease/2016/07/06/854063 ...,https://www.nature.com/articles/s41598-017-07753-0
2017-01-01,2017,Nanobiotix,DNA exonuclease Trex1 regulates radiotherapy-induced ...,General_Update,"by C Vanpouille-Box · 2017 · Cited by 1806 — We show that the DNA exonuclease Trex1 is induced by radiation doses above 12–18 Gy in different cancer cells, and attenuates their immunogenicity.",https://www.nature.com/articles/ncomms15618
2017-01-01,2017,Nanobiotix,First-in-Human Study Testing a New Radioenhancer Using ...,Clinical_Milestone,"by S Bonvalot · 2017 · Cited by 255 — This phase I study aimed to determine the recommended dose (RD), safety profile, and feasibility of a procedure combining intratumoral injection of hafnium ...",https://pubmed.ncbi.nlm.nih.gov/27998887/
2017-01-01,2017,Nanobiotix,Research Metallic nanoparticles for cancer immunotherapy,Clinical_Milestone,"by ER Evans · 2018 · Cited by 257 — Nanobiotix, the company translating the compound, is pursuing Phase ... FDA, “FDA approval brings first gene therapy to the United States,” 30 Aug 2017 2017.",https://www.sciencedirect.com/science/article/pii/S1369702117305187
2017-01-01,2017,Nanobiotix,Part Two | Journal for ImmunoTherapy of Cancer - Springer Link,Clinical_Milestone,by YJ Bang · 2017 · Cited by 1 — 2) Both agents already FDA approved potentially allowing for rapid translation/adoption. 3) Both agents have previously evaluated dosing schedules that are ...,https://link.springer.com/article/10.1186/s40425-017-0288-4
2017-02-02,2017,Nanobiotix,Nanobiotix Stock Price Today | EPA: NANOB Live,Financial_Performance,View today's Nanobiotix stock price and latest NANOB news and analysis. Create real-time notifications to follow any changes in the live stock price.,https://www.investing.com/equities/nanobiotix
2017-02-07,2017,Nanobiotix,"Bayer HealthCare - News, Articles etc.",Clinical_Milestone,"Nanobiotix appoints Oncology industry veteran as Chief Operating Officer. 7 February 2017 ... NBTXR3, which could obtain a CE Mark approval in… article · The ...",https://www.europeanpharmaceuticalreview.com/organisations/bayer-healthcare/
2017-05-01,2017,Nanobiotix,Nanoparticle Technology Enhances Effectiveness of ...,General_Update,"Nanobiotix has been pioneering the development of a technology to address radiotherapy's very real limitations. The technology, NanoXray, uses nanoparticles, ...",https://www.medicaldesignbriefs.com/component/content/article/26890-nanoparticle-technology-enhances-effectiveness-of-radiotherapy
2017-05-21,2017,Nanobiotix,Nano Publications | Nanobiotix,General_Update,2017 – A new opportunity for nanomedicines – Paolini et al. 2015 – Metals as radio-enhancers in oncology – Pottier et al. 2015 – The future of nanosized ...,https://bibliography.nanobiotix.com/fr/
2017-05-31,2017,Nanobiotix,HAFNIUM OXIDE,General_Update,THERAPEUTIC CLAIM. Radioenhancer for treating locally advanced head and neck squamous cell cancer (LA-HNSCC). CHEMICAL NAME.,https://searchlf.ama-assn.org/usan/documentDownload?uri=/unstructured/binary/usan/hafnium-oxide-.pdf
2017-11-16,2017,Nanobiotix,"Parasite Drug May Treat Prostate Cancer, Say Scientists",Financial_Performance,Researchers in Norway have found that a drug used to kill parasites like tapeworms can slow the growth of prostate and colon cancer cells.,https://www.labiotech.eu/trends-news/prostate-cancer-parasite-norway/
2018-01-01,2018,Nanobiotix,"Nanoparticle radio-enhancement: principles, progress and ...",General_Update,"by Z Kuncic · 2018 · Cited by 269 — The underlying principle of NP radio-enhancement is the potential to release copious electrons into a nanoscale volume, thereby amplifying radiation-induced ...",https://iopscience.iop.org/article/10.1088/1361-6560/aa99ce
2018-01-01,2018,Nanobiotix,Combining radiation plus immunotherapy to improve systemic ...,General_Update,by TR Cushman · 2018 · Cited by 64 — The significance of tumor burden for immunotherapy is supported by studies showing that combining RT with immunotherapy even in sequential order is beneficial.,https://pmc.ncbi.nlm.nih.gov/articles/PMC5861265/
2018-01-01,2018,Nanobiotix,Metal-based NanoEnhancers for Future Radiotherapy,Clinical_Milestone,"by Y Liu · 2018 · Cited by 346 — NBTXR3, the functionalized HfO2 NPs developed by Nanobiotix (http://www.nanobiotix.com/_en/), are 50-nm-sized crystalline nanoparticles bearing a negative ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC5858503/
2018-01-01,2018,Nanobiotix,Combining radiation plus immunotherapy to improve systemic ...,General_Update,"by TR Cushman · 2018 · Cited by 64 — Together, radiation and immunotherapy offer potential to eliminate metastatic disease, reduce time to recurrence and improve overall survival.",https://jtd.amegroups.org/article/view/18820/html
2018-01-01,2018,Nanobiotix,Priming the body to receive the therapeutic agent ...,General_Update,by M Germain · 2018 · Cited by 24 — Here we introduce the concept of priming the body to receive the treatment by uncorrelating these functions into two distinct objects sequentially administered.,https://www.nature.com/articles/s41598-018-23140-9
2018-01-01,2018,Nanobiotix,Bone sarcomas: ESMO–PaedCan–EURACAN Clinical ...,Clinical_Milestone,"by PG Casali · 2018 · Cited by 667 — Primary bone tumours are rare, accounting for < 0.2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and ...",https://www.sciencedirect.com/science/article/pii/S0923753419317120
2018-01-01,2018,Nanobiotix,Draft Proposal for PhD Research,General_Update,by TP Letaba · 2018 · Cited by 2 — This research responds to the complexities associated with technology roadmap development in South Africa and other developing countries. It seeks to.,https://repository.up.ac.za/server/api/core/bitstreams/06740d37-e52d-42f9-a6e4-7350ec7956df/content
2018-01-01,2018,Nanobiotix,Clinical Development of Novel Drug-Radiotherapy ...,Clinical_Milestone,"by SS Ahmad · 2018 · Cited by 76 — While no new drug-radiotherapy combinations have passed regulatory approval during this period, the FDA has approved more than 130 novel drug indications in ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC6397668/
2018-01-01,2018,Nanobiotix,33rd Annual Meeting & Pre-Conference Programs of the ...,Clinical_Milestone,"2018. Ethics Approval. The study was approved by IACUC at the hosting institutions ... FDA-approved ICIs including Ipilimumab, Atezolizumab, Nivolumab, and ...",https://link.springer.com/article/10.1186/s40425-018-0423-x
2018-01-01,2018,Nanobiotix,Rational Approaches for Combination Therapy for Solid Tumors,Clinical_Milestone,by AW Tolcher · 2018 · Cited by 115 — This review focuses on ongoing or completed clinical trials with combination targeted therapies for solid tumors and highlights the successes and ongoing ...,https://aacrjournals.org/mct/article/17/1/3/92342/Rational-Approaches-for-Combination-Therapy
2018-02-07,2018,Nanobiotix,放射治疗联合免疫治疗可提高全身免疫反应 - JTD杂志中文版,General_Update,SABR又被称为立体定向全身放射治疗（stereotactic body radiation therapy，SBRT），是作为一种非侵入性的治疗方法，可达到90%以上的局部控制，提高了生存率并且毒性作用和不良 ...,https://jtd-zh.amegroups.cn/article?id=174
2018-02-20,2018,Nanobiotix,Nanoclay - an overview,Clinical_Milestone,"The novel cancer nanotherapeutic product NBTXR3 by Nanobiotix is classified as a medical device in EU and as a drug by FDA. For example, the drug ...",https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/nanoclay
2018-04-04,2018,Nanobiotix,医薬品・医療機器産業の企業ニュース配信サービス,Clinical_Milestone,"... Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway 《米国がん研究会議》 , 非臨床試験データ , 『PEP503 ...",http://www.beagle-hc.com/Joho_ikusei/news_back_201804.html
2018-04-13,2018,Nanobiotix,Sales Revenues at the Potential Expense of Patient Safety,Clinical_Milestone,"MD Anderson, Nanobiotix to collaborate on preclinical research combining NBTXR3, nivolumab · PREVIOUS ISSUE · NEXT ISSUE · Advertisement. YOU MAY BE ...",https://cancerletter.com/trials-and-tribulations/20180413_5/
2018-04-13,2018,Nanobiotix,"Whistleblower suit claims McKesson repackaged, sold ...",Clinical_Milestone,"FDA finalizes guidances to accelerate development of Next Gen sequencing · Karyopharm's Selinexor receive FDA Fast Track designation · MD Anderson, Nanobiotix ...",https://cancerletter.com/the-cancer-letter/20180413_2/
2018-05-11,2018,Nanobiotix,Série: Serialização e a Rastreabilidade de Medicamentos,General_Update,A tendência é claramente a criação de um padrão global com Serialização no nível do artigo para identificar a origem de cada pacote de Medicamentos. Neste ...,https://brazilsfe.blogspot.com/2018/05/Serie-Serializacao-e-a-Rastreabilidade-de-Medicamentos.html
2018-06-22,2018,Nanobiotix,Nanobiotix soars as late-phase cancer trial hits endpoint,Clinical_Milestone,The top-line success against the pathological complete response rate endpoint sent Nanobiotix's stock up by more than 50%. NBTXR3 consists of crystalline ...,https://www.fiercebiotech.com/nanobiotix-soars-as-late-phase-cancer-trial-hits-endpoint
2018-10-15,2018,Nanobiotix,France: Nanobiotix receives EUR 16m of funding through ...,Clinical_Milestone,The proceeds will be used to accelerate the development of the leading innovative product NBTXR3 and preparation of access to the European market.,https://www.eib.org/en/press/all/2018-254-la-bei-soutient-les-activites-rdi-de-la-societe-nanobiotix
2018-11-08,2018,Nanobiotix,Key Technology Trends in Radiation Therapy at ASTRO ...,General_Update,"The system does not yet have any regulatory approvals, but there are several luminary centers already interested in possibly acquiring this technology for use ...",https://www.itnonline.com/content/blogs/dave-fornell-itn-editor-astro/key-technology-trends-radiation-therapy-astro-2018
2019-01-01,2019,Nanobiotix,Phase I/II trial of NBTXR3 activated by SBRT in patients ...,Clinical_Milestone,"by M Pracht · 2019 · Cited by 7 — Conclusions. NBTXR3 was well tolerated and showed preliminary anti-tumor activity, supporting a protocol amendment to evaluate an additional NBTXR3 dose level ...",https://www.annalsofoncology.org/article/S0923-7534(19)58972-4/fulltext
2019-01-01,2019,Nanobiotix,Nanoparticles in the clinic: An update - Anselmo - 2019,Clinical_Milestone,"by AC Anselmo · 2019 · Cited by 1914 — NBTXR3/Hensify is a 50 nm crystalline hafnium oxide nanoparticle with negatively charged phosphate coating, developed and marketed by Nanobiotix.14 NBTXR3/ ...",https://aiche.onlinelibrary.wiley.com/doi/10.1002/btm2.10143
2019-01-01,2019,Nanobiotix,Physical Radiation Enhancement Effects Around Clinically ...,Clinical_Milestone,by B Villagomez-Bernabe · 2019 · Cited by 28 — First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue ...,https://www.nature.com/articles/s41598-019-44482-y
2019-01-01,2019,Nanobiotix,Trabectedin and RAdiotherapy in Soft Tissue Sarcoma ...,Clinical_Milestone,by A Gronchi · 2019 · Cited by 66 — Myxoid liposarcoma (ML) exhibits a special sensitivity to trabectedin (T) and radiation therapy (RT). Preclinical data suggest a synergistic effect.,https://pmc.ncbi.nlm.nih.gov/articles/PMC6510725/
2019-01-01,2019,Nanobiotix,34th Annual Meeting & Pre-Conference Programs of the ...,Clinical_Milestone,"by Z Li · 2019 · Cited by 6 — In this study, we combined radiotherapy with checkpoint inhibitor immunotherapy and a radio-enhancing nanoparticle NBTXR3 ... Intl J Cancer (2019) Epub 2019/06/27 ...",https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0764-0
2019-01-01,2019,Nanobiotix,"NBTXR3, a first-in-class radioenhancer hafnium oxide ...",Clinical_Milestone,by S Bonvalot · 2019 · Cited by 523 — This phase 2-3 trial evaluated the safety and efficacy of the hafnium oxide (HfO 2 ) nanoparticle NBTXR3 activated by radiotherapy versus radiotherapy alone as ...,https://pubmed.ncbi.nlm.nih.gov/31296491/
2019-01-01,2019,Nanobiotix,Trabectedin and RAdiotherapy in Soft Tissue Sarcoma ...,Clinical_Milestone,by A Gronchi · 2019 · Cited by 66 — This is the first-in-human clinical study showing the feasibility of the concurrent administration of T and RT in patients affected by localized myxoid ...,https://www.sciencedirect.com/science/article/pii/S2589537019300434
2019-01-01,2019,Nanobiotix,"Thirty Years of Cancer Nanomedicine: Success, Frustration ...",General_Update,"by L Salvioni · 2019 · Cited by 234 — Starting with the enhanced permeability and retention (EPR) effect discovery, nanomedicine has gained a crucial role in cancer treatment.",https://www.mdpi.com/2072-6694/11/12/1855
2019-01-01,2019,Nanobiotix,Nanoparticles in the clinic: An update - PMC,Clinical_Milestone,by AC Anselmo · 2019 · Cited by 1914 — We provide a 3 year update on the current clinical landscape of nanoparticle drug delivery systems and highlight newly approved nanomedicines.,https://pmc.ncbi.nlm.nih.gov/articles/PMC6764803/
2019-01-01,2019,Nanobiotix,Nanoparticles in the Clinic: An Update,General_Update,"by AC Anselmo · 2019 · Cited by 1821 — Approval of the first RNAi therapeutic was a major milestone in the biotech industry and considering that the delivery vehicle was a nanoparticle, approval of ...",https://aiche.onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10143
2019-01-01,2019,Nanobiotix,Clinical Cancer Advances 2019: Annual Report on ...,Clinical_Milestone,"by SK Pal · 2019 · Cited by 84 — This year, the FDA approved the first treatment for ATCs in almost 50 years, a targeted therapy combination of dabrafenib (Tafinlar; Novartis, East Hanover, NJ) ...",https://ascopubs.org/doi/10.1200/JCO.18.02037
2019-01-01,2019,Nanobiotix,Systemic Treatment Options in Hepatocellular Carcinoma - PMC,Clinical_Milestone,"by L Rimassa · 2019 · Cited by 125 — Based on these data, the US Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab for patients with HCC previously treated with ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC6883446/
2019-01-01,2019,Nanobiotix,Prediction of Drug Approval After Phase I Clinical Trials in ...,Clinical_Milestone,"by G Beinse · 2019 · Cited by 20 — From pharmacologic data and the early clinical trial's PubMed abstracts, RESOLVED2 can predict accurately the time to FDA approval for an antineoplastic agent.",https://ascopubs.org/doi/10.1200/CCI.19.00023
2019-01-01,2019,Nanobiotix,"The great debate at “Immunotherapy Bridge 2018”, Naples ...",General_Update,by PA Ascierto · 2019 · Cited by 5 — This approval is consistent with the concept that tumors with higher mutational burden are more likely to be responsive to immunotherapy. Similar patterns of ...,https://link.springer.com/article/10.1186/s40425-019-0683-0
2019-01-01,2019,Nanobiotix,BRACHYTHERAPY:,General_Update,"Early in 2019, the Commission published a new rule changing the definition to one based on activity, rather than dose. ASTRO continues to support health ...",https://www.astro.org/ASTRO/media/ASTRO/News%20and%20Publications/ASTROnews/PDFs/2019_Spring_ASTROnews.pdf
2019-01-01,2019,Nanobiotix,CXCL14 suppresses human papillomavirus-associated ...,General_Update,by JA Westrich · 2019 · Cited by 58 — Our results suggest that CXCL14 enacts effective tumor suppression through recruitment of CD8 + T cells and restoration of major histocompatibility complex ...,https://www.nature.com/articles/s41388-019-0911-6
2019-04-04,2019,Nanobiotix,NANOBIOTIX ANNOUNCES FIRST EVER ...,General_Update,This innovative product was designed by Nanobiotix to physically destroy tumors and activate the immune system for both local control and systemic disease ...,https://www.massbio.org/news/member-news/nanobiotix-announces-first-ever-radioenhancer-to-receive-european-market-approval/
2019-04-04,2019,Nanobiotix,Nanobiotix Announces First Ever Radioenhancer to Receive,Clinical_Milestone,NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark)...,https://www.globenewswire.com/news-release/2019/04/04/1797273/0/en/Nanobiotix-Announces-First-Ever-Radioenhancer-to-Receive-European-Market-Approval.html
2019-04-05,2019,Nanobiotix,MSK's Kirstein: Robotic mastectomy not demonstrated to ...,Clinical_Milestone,Nanobiotix receives European approval for Hensify therapy for sarcoma · Opdivo shows long-term survival results in NSCLC · Findings from ASCO TAPUR trial ...,https://cancerletter.com/conversation-with-the-cancer-letter/20190405_2/
2019-04-08,2019,Nanobiotix,Nanobiotix scores nod in Europe for the radioenhancer ...,Clinical_Milestone,Nanobiotix has preclinical data indicating NBTXR3 switches the tumor ... Shares in Nanobiotix (Euronext Paris:NANO) closed up 19.53% at €14.14 (US ...,https://www.bioworld.com/articles/411196-nanobiotix-scores-nod-in-europe-for-the-radioenhancer-hensify
2019-04-08,2019,Nanobiotix,PharmaEngine partner gains European approval,Corporate_Action,"The company posted net profit of NT$129.36 million for last year, or NT$0.88 in earnings per share, compared with the year-earlier level of NT$387.06 million, ...",https://www.taipeitimes.com/News/biz/archives/2019/04/08/2003712979
2019-04-11,2019,Nanobiotix,Presenters at the 17th BEF,Clinical_Milestone,Nanobiotix is a late stage clinical company pioneering nanomedicine for more than a decade. We intend to significantly change the outcomes for cancer patients ...,https://www.sachsforum.com/17bef-presenters.html
2019-05-15,2019,Nanobiotix,PATENTS OFFICE JOURNAL,General_Update,"The examinations will consist of the following Final Diploma examinations of the PEB. Tuesday. 15 October, 2019. Paper FD4 (P6). 10.00a.m. – 3.00 p.m..",https://www.ipoi.gov.ie/en/ip-search-tools/search-the-journal/download-journals/journal-2385.pdf
2019-07-08,2019,Nanobiotix,"NBTXR3, a first-in-class radioenhancer hafnium oxide ...",Clinical_Milestone,This study validates the mode of action of NBTXR3 since an increased proportion of patients with a pathological complete response—indicating increased tumour ...,https://www.icm.unicancer.fr/sites/default/files/resources/Publication%202019%20Act%20In%20Sarc.pdf
2019-09-22,2019,Nanobiotix,ESMO 2019 abstract list & presentations - Biotech Radar,Clinical_Milestone,"Stock Dashboard Europe · Stock ... Nanobiotix, 756P, Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis.",https://biotechradar.eu/esmo-2019-abstract-list/
2020-01-01,2020,Nanobiotix,NANORAY-1100: A phase I study of NBTXR3 activated by ...,Clinical_Milestone,by CJ Shen · 2020 · Cited by 3 — Preclinical and early clinical data suggest NBTXR3 activated by RT can increase the anti-tumor response yielding both local and systemic (abscopal) effects.,https://ascopubs.org/doi/abs/10.1200/jco.2020.38.5_suppl.tps86
2020-01-01,2020,Nanobiotix,NANORAY-1100: A phase I study of NBTXR3 activated by ...,Clinical_Milestone,by CJ Shen · 2020 · Cited by 3 — Preclinical and early clinical data suggest NBTXR3 activated by RT can increase the anti-tumor response yielding both local and systemic (abscopal) effects.,https://ascopubs.org/doi/10.1200/JCO.2020.38.5_suppl.TPS86
2020-01-01,2020,Nanobiotix,Radiotherapy-Activated Hafnium Oxide Nanoparticles ...,Clinical_Milestone,"by P Zhang · 2020 · Cited by 76 — We demonstrate that radiotherapy-activated NBTXR3 kill more cancer cells than radiotherapy alone, significantly increase immune cell infiltrates both in treated ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC7280060/
2020-01-01,2020,Nanobiotix,Understanding Nanoparticle Toxicity to Direct a Safe-by- ...,Clinical_Milestone,"by JA Damasco · 2020 · Cited by 125 — Although there are several nanoparticles that have been in clinical trials, as of today, only Hensify® (NBTXR3, Nanobiotix, Paris, France) is currently approved ...",https://www.mdpi.com/2079-4991/10/11/2186
2020-01-01,2020,Nanobiotix,Review of clinical applications of radiation-enhancing ...,Clinical_Milestone,"by N Scher · 2020 · Cited by 40 — Ultimately, two nanoparticles stood out for their use in clinical trials in combination with radiotherapy: Hafnium oxide known as NBTXR3 and gadolinium-based ...",https://www.sciencedirect.com/science/article/pii/S2215017X20306834
2020-01-01,2020,Nanobiotix,Enhancing cancer immunotherapy with nanomedicine - PMC,Clinical_Milestone,"by DJ Irvine · 2020 · Cited by 837 — NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC7536618/
2020-01-01,2020,Nanobiotix,Cancer Immunotherapy and Application of Nanoparticles in ...,General_Update,"by TA Debele · 2020 · Cited by 88 — In this review, we have discussed cancer immunotherapy and the application of NPs in cancer immunotherapy, as a carrier of immunotherapeutic agents and as a ...",https://www.mdpi.com/2072-6694/12/12/3773
2020-01-01,2020,Nanobiotix,Survival of soft tissue sarcoma patients after completing six ...,General_Update,"by AJ Verschoor · 2020 · Cited by 26 — EW reports personal fees from Novartis, Lilly, Nanobiotix, Bayer, PharmaMar, Milestone, Menarini and New Oncology, all outside the submitted work. Footnotes.",https://pmc.ncbi.nlm.nih.gov/articles/PMC7488114/
2020-01-01,2020,Nanobiotix,Nanoscintillator-Mediated X-Ray Induced Photodynamic ...,General_Update,"by W Sun · 2020 · Cited by 214 — This review aims to provide an overview of nanoscintillator-mediated X-ray induced PDT (X-PDT) including the concept, the design considerations of ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC6956812/
2020-01-01,2020,Nanobiotix,Managing cancer patients during the COVID-19 pandemic,Clinical_Milestone,by G Curigliano · 2020 · Cited by 360 — The expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty.,https://www.sciencedirect.com/science/article/pii/S0923753420399488
2020-01-01,2020,Nanobiotix,The Evolution of Antibody-Drug Conjugates: A Positive ...,General_Update,"by AW Tolcher · 2020 · Cited by 52 — In 2019, an important inflection point occurred when the U.S. Food and Drug Administration approved three new antibody-drug conjugates (ADCs) for the ...",https://ascopubs.org/doi/10.1200/EDBK_281103
2020-01-01,2020,Nanobiotix,Green One-Step Synthesis of Medical Nanoagents for ...,General_Update,"by D Salado-Leza · 2020 · Cited by 15 — This work proposes a simple, fast and green strategy to synthesize small, non-toxic and stable NPs in water with a 100% production rate.",https://pmc.ncbi.nlm.nih.gov/articles/PMC7426062/
2020-01-12,2020,Nanobiotix,Industry News,General_Update,"Articles, news, products, blogs and videos covering the Industry News market.",https://www.auntminnie.com/industry-news?page=521
2020-02-11,2020,Nanobiotix,FDA grants fast track designation to NBTXR3 for head and ...,Clinical_Milestone,"The FDA granted fast track designation to NBTXR3, with or without cetuximab, for the treatment of patients with locally advanced head and neck squamous cell ...",https://www.healio.com/news/hematology-oncology/20200211/fda-grants-fast-track-designation-to-nbtxr3-for-head-and-neck-cancer
2020-02-14,2020,Nanobiotix,FDA approves Pemfexy injection for lung cancer,Clinical_Milestone,"FDA has granted approval Pemfexy, a pemetrexed injection ... FDA grants Nanobiotix Fast Track designation for investigation of NBTXR3 in head and neck.",https://cancerletter.com/drugs-and-targets/20200214_8/
2020-06-30,2020,Nanobiotix,Presenting Companies,General_Update,"Ablexis has established license agreements with eight of the top 15 global pharmaceutical companies, and other public and private biotechnology companies.",https://www.bio.org/sites/default/files/2020-06/BIO%20Digital%202020%20Company%20Presentation%20Start-Up%20Stadium%20Public%20Grid%206%2012.xlsx
2020-08-20,2020,Nanobiotix,2024 Legislative Report,General_Update,"The committee also submits annual financial reports to the General Assembly that include the UCRF's economic impacts, detailed budget and expenditure accounts, ...",https://unclineberger.org/wp-content/uploads/sites/867/2020/08/UCRF-Legislative-Report-FY-2024-UNC-Lineberger.pdf
2020-09-30,2020,Nanobiotix,STING Pathway Targeting Therapeutics and Technologies ...,Corporate_Action,"Based on the likely licensing deal structures and agreements that are expected to be signed in the foreseen future, we have provided an informed estimate on ...",https://www.researchandmarkets.com/reports/5201300/sting-pathway-targeting-therapeutics-and?srsltid=AfmBOoqndD72HY8S_dgPISI6NgfJdbjaqh7bT5oqL5BCLTIiwYHfUzD8
2020-11-03,2020,Nanobiotix,NBTXR3 - Page 1,Clinical_Milestone,"Nanobiotix SA has just presented new data from an open-label preclinical study evaluating the action of its nanoparticle-enhanced radiotherapy, NBTXR3.",https://www.bioworld.com/keywords/24749-nbtxr3
2020-12-28,2020,Nanobiotix,logo-nanobiotix-x2 | Nano Publications,Clinical_Milestone,2020 – ASCO-SITC – NBTXR3 with anti-PD-1 therapy · 2020 – ASCO GI – Treatment of liver cancers with NBTXR3 · 2020 – Treatment of hepatocellular carcinoma and ...,https://bibliography.nanobiotix.com/logo-nanobiotix-x2/
2020-12-31,2020,Nanobiotix,Regulatory data of biopharma companies in 2020,General_Update,"Nanobiotix SA, of Paris, NBTXR-3, Designed to destroy tumors through ... contract during first half of 2020, 3/8/20, Infection. Viiv Healthcare Ltd., of ...",https://www.bioworld.com/content/regulatory-data-2020
2021-01-01,2021,Nanobiotix,A phase I trial evaluating NBTXR3 activated by ...,Clinical_Milestone,"by C Shen · 2021 · Cited by 9 — NBTXR3, a novel radioenhancer administered by direct intratumoral injection (ITI), is designed at the nanoscale to increase RT dose deposit within tumor cells.",https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.2590
2021-01-01,2021,Nanobiotix,NBTXR3 Radiotherapy-Activated Functionalized Hafnium ...,Clinical_Milestone,by P Zhang · 2021 · Cited by 59 — NBTXR3 activated by radiotherapy was also more effective in destroying cancer cells and in controlling tumor growth than radiotherapy alone.,https://pmc.ncbi.nlm.nih.gov/articles/PMC8052129/
2021-01-01,2021,Nanobiotix,Phase I dose-escalation study of NBTXR3 activated by ...,Clinical_Milestone,"by C Hoffmann · 2021 · Cited by 69 — This phase I study assessed the safety of first-in-class radioenhancer nanoparticles, NBTXR3, in elderly or frail patients with locally advanced head and neck ...",https://www.sciencedirect.com/science/article/pii/S0959804921000186
2021-01-01,2021,Nanobiotix,Overcoming Resistance to Anti-PD-1 With Tumor Agnostic ...,Clinical_Milestone,"by TY Seiwert · 2021 · Cited by 3 — NBTXR3 increases RT energy deposit inside tumor cells and subsequent tumor cell death, without adding toxicity to healthy tissues. Here we present evidence that ...",https://www.redjournal.org/article/S0360-3016(21)01040-3/fulltext
2021-01-01,2021,Nanobiotix,Long-term evaluation of the novel radioenhancer NBTXR3 ...,Clinical_Milestone,"by S Bonvalot · 2021 · Cited by 4 — NBTXR3, a novel radioenhancer activated by radiotherapy (RT) demonstrated superior efficacy, as preoperative treatment, in patients with locally advanced soft ...",https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.11544
2021-01-01,2021,Nanobiotix,NBTXR3 Radiotherapy-Activated Functionalized Hafnium ...,Clinical_Milestone,by P Zhang · 2021 · Cited by 59 — NBTXR3 activated by radiotherapy was also more effective in destroying cancer cells and in controlling tumor growth than radiotherapy alone. Beyond the effects ...,https://pubmed.ncbi.nlm.nih.gov/33880022/
2021-01-01,2021,Nanobiotix,Phase I dose-escalation study of NBTXR3 activated by ...,Clinical_Milestone,"by C Hoffmann · 2021 · Cited by 69 — This phase I study assessed the safety of first-in-class radioenhancer nanoparticles, NBTXR3, in elderly or frail patients with locally advanced head and neck ...",https://pubmed.ncbi.nlm.nih.gov/33607477/
2021-01-01,2021,Nanobiotix,Phase I dose-escalation study of NBTXR3 activated by ...,Clinical_Milestone,"by C Hoffmann · 2021 · Cited by 69 — This phase I study assessed the safety of first-in-class radioenhancer nanoparticles, NBTXR3, in elderly or frail patients with locally advanced head and neck ...",https://www.ejcancer.com/article/S0959-8049(21)00018-6/fulltext
2021-01-01,2021,Nanobiotix,A phase I trial evaluating NBTXR3 activated by ...,Clinical_Milestone,by C Shen · 2021 · Cited by 9 — Preclinical data suggest NBTXR3/RT can trigger a local and systemic anti-tumor immune response and overcome anti-PD-1 resistance. NBTXR3/RT combined with anti- ...,https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.2590
2021-01-01,2021,Nanobiotix,Final analysis of the randomized trial on imatinib as an ...,Clinical_Milestone,"by PG Casali · 2021 · Cited by 65 — EW received honoraria, research and travel grants from Nanobiotix, Milestone/Menarini, New Oncology, Lilly, Novartis Oncology, Roche and Bayer. J-YB had ...",https://www.annalsofoncology.org/article/S0923-7534(21)00012-0/fulltext
2021-01-01,2021,Nanobiotix,Targeting the Inside of Cells with Biologicals: Chemicals as ...,Clinical_Milestone,"by ALJ Marschall · 2021 · Cited by 17 — Delivering macromolecules into the cytosol or nucleus is possible in vitro for DNA, RNA and proteins, but translation for clinical use has been limited.",https://pmc.ncbi.nlm.nih.gov/articles/PMC8548996/
2021-01-01,2021,Nanobiotix,T cell engagers in solid tumors kick the door down,General_Update,by M de Miguel · 2021 · Cited by 7 — Tebentafusp is the first T cell engager to show a statistically significant overall survival improvement for the treatment of patients with solid tumors.,https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00556-0
2021-01-01,2021,Nanobiotix,Nanotechnology for Cancer Imaging,Clinical_Milestone,by CH Liu · 2021 · Cited by 56 — Only two NIR fluorophores are approved by the FDA and European Medicines Agency for image-guided surgery: indocyanine green (ICG) and methylene blue.,https://pmc.ncbi.nlm.nih.gov/articles/PMC8183257/
2021-01-01,2021,Nanobiotix,Doxorubicin plus lurbinectedin in patients with advanced ...,Clinical_Milestone,"by R Kristeleit · 2021 · Cited by 9 — In June 2020, the United States Food and Drug Administration (FDA) granted accelerated approval to lurbinectedin for adult patients with metastatic small cell ...",https://www.sciencedirect.com/science/article/pii/S1048891X24021352
2021-01-01,2021,Nanobiotix,A Phase II Trial of Prexasertib (LY2606368) in Patients ...,Clinical_Milestone,"by LA Byers · 2021 · Cited by 41 — transcription inhibitor, was recently granted accelerated approval by the FDA for patients with SCLC who progressed on or after platinum chemotherapy based ...",https://www.clinical-lung-cancer.com/article/S1525-7304(21)00089-9/pdf
2021-01-01,2021,Nanobiotix,Predictive modeling of hypoxic head and neck cancers during ...,Clinical_Milestone,by M Huynh · 2021 · Cited by 13 — 19 Nanobiotix. Nanobiotix receives feedback from US FDA to advance phase III head and neck cancer study design and CMC development plan fo NDA. In: Owens B ...,https://aapm.onlinelibrary.wiley.com/doi/abs/10.1002/mp.14872
2021-01-01,2021,Nanobiotix,The effects of releasing early results from ongoing clinical ...,Clinical_Milestone,"by S Ventz · 2021 · Cited by 8 — We investigate the public release of early efficacy and toxicity results, during ongoing clinical studies, to better inform patients about their enrollment ...",https://www.nature.com/articles/s41467-021-21116-4
2021-01-01,2021,Nanobiotix,Advances in Treatment of Recurrent Small Cell Lung Cancer ...,Clinical_Milestone,by M Das · 2021 · Cited by 38 — Jazz pharmaceuticals announces US FDA accelerated approval of Zepzelca™ (lurbinectedin) for the treatment of metastatic small cell lung cancer. https://investor ...,https://link.springer.com/article/10.1007/s12325-021-01909-1
2021-02-12,2021,Nanobiotix,"Laurent Levy and Tanguy Lim-Seiwert, MD, on the ...",Clinical_Milestone,"The agent provided positive results in a number of trials, including data from a phase 3 soft tissue sarcoma trial in Europe, investigating NBTXR3 activated by ...",https://www.cancernetwork.com/view/laurent-levy-and-tanguy-lim-seiwert-md-on-the-potential-of-nbtxr3-to-treat-patients-with-head-and-neck-cancers
2021-03-12,2021,Nanobiotix,ON OUR STRENGTHS - Valneva,General_Update,"... 2021. 9M 2021 Interim Results. November 18, 2021 ...",https://valneva.com/wp-content/uploads/large-agm-files/VAL2020_URD_EN_MeL_val.pdf
2021-04-08,2021,Nanobiotix,Julienne Hearn,Clinical_Milestone,a license agreement with Nanobiotix for a clinical stage radioenhancer for use in multiple oncology indications; a license and development agreement with ...,https://www.cov.com/en/professionals/h/julienne-hearn
2021-05-18,2021,Nanobiotix,Lianbio licenses Landos' LANCL2- and NLRX1-targeted ...,Clinical_Milestone,"The deal with Landos came after Lianbio unveiled on May 12 a $240 million deal with Nanobiotix SA to license radioenhancer NBTXR3 for rights in greater China, ...",https://www.bioworld.com/articles/507216-lianbio-licenses-landos-lancl2--and-nlrx1-targeted-candidates-in-218m-deal-for-uc-and-cd
2021-06-03,2021,Nanobiotix,NANOBIOTIX Reports New Data for Potential First-in-Class ...,Clinical_Milestone,NANOBIOTIX Reports New Data for Potential First-in-Class Radioenhancer NBTXR3 in Combination With Anti-PD-1 Showing Local or Distant Tumor Regression in 76.9% ...,https://www.biospace.com/nanobiotix-reports-new-data-for-potential-first-in-class-radioenhancer-nbtxr3-in-combination-with-anti-pd-1-showing-local-or-distant-tumor-regression-in-76-9-percent-of-evaluable-patients-regardless-of-prior-anti-pd-1-exposure
2021-07-01,2021,Nanobiotix,OrbiMed Partners,Corporate_Action,This presentation is as of the date noted above and may be changed without notice. Annual General Meeting. July 2021. Page 2. © 2021 OrbiMed Advisors ...,https://www.frostrow.com/application/files/7016/3514/4950/BIOG_AGM_Investor_Presentation.pdf
2021-07-11,2021,Nanobiotix,Early and Next-Generation KIT/PDGFRA Kinase Inhibitors ...,Clinical_Milestone,"Ripretinib received FDA approval on May 15, 2020, for the treatment of adult patients with advanced GIST who have received prior treatment with 3 or more ...",https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.672500/full
2021-10-01,2021,Nanobiotix,Form S-1,General_Update,"In May 2021, we entered into a license and collaboration agreement ... As of September 30, 2021, we licensed from Nanobiotix eight families of patent applications ...",https://www.sec.gov/Archives/edgar/data/1831283/000119312521289805/d168979ds1.htm
2021-10-07,2021,Nanobiotix,NANOBIOTIX to Present First Survival Data From Priority ...,Clinical_Milestone,"Given the physical MoA, Nanobiotix believes that NBTXR3 could be scalable across any solid tumor that can be treated with radiotherapy and across any ...",https://www.itnonline.com/content/nanobiotix-present-first-survival-data-priority-head-and-neck-cancer-program-astro21
2021-10-12,2021,Nanobiotix,IASLC World Conference on Lung Cancer Recap,Clinical_Milestone,"Regardless of prior anti-PD1 therapy, the Phase 1 combination of intratumoral delivery of Nanobiotix's NBTXR3+SBRT+nivolumab or pembrolizumab led to tumor ...",https://www.lungcancerresearchfoundation.org/iaslc-world-conference-on-lung-cancer-recap/
2021-12-06,2021,Nanobiotix,Biopharma collaborations in 2021,Corporate_Action,"Rebiotix Inc. Payment unspecified, 2/17/21. Oncology Pharma extended its licensing agreement to use Nanosmart's anti-nuclear antibody nanoparticle drug delivery ...",https://www.bioworld.com/content/biopharmaceutical-collaborations-2021
2021-12-10,2021,Nanobiotix,Study Details | NCT04892173 | JNJ-90301900 (NBTXR3) ...,Clinical_Milestone,"This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 ...",https://clinicaltrials.gov/study/NCT04892173
2021-12-31,2021,Nanobiotix,F-1/A,Clinical_Milestone,"EVT8683 is expected to enter the clinical phase in late 2021 or in 2022. As of June 30, 2021, we have accumulated milestone payments of €43 million since 2016.",https://www.sec.gov/Archives/edgar/data/1412558/000119312521307743/d166695df1a.htm
2022-01-01,2022,Nanobiotix,NANORAY-312: A phase III pivotal study of NBTXR3 ...,Clinical_Milestone,by C Le Tourneau · 2022 · Cited by 8 — NBTXR3 has been shown to prime the adaptive immune response in cancer models. NBTXR3 obtained EU marketing approval in preoperative treatment of locally ...,https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.TPS6110
2022-01-01,2022,Nanobiotix,NANORAY-312: A Phase III Pivotal Study of NBTXR3 ...,Clinical_Milestone,"by SS Yom · 2022 · Cited by 8 — NBTXR3 has been shown to prime the adaptive immune response in cancer models. In a Phase I trial of NBTXR3 + RT alone in elderly LA-HNSCC patients, this ...",https://www.redjournal.org/article/S0360-3016(22)02093-4/fulltext
2022-01-01,2022,Nanobiotix,NBTXR3 improves the efficacy of immunoradiotherapy ...,Clinical_Milestone,"by Y Hu · 2022 · Cited by 16 — We previously demonstrated that NBTXR3, a nanoparticle radioenhancer, significantly improved immune responses in a murine anti-PD1-resistant metastatic lung ...",https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1022011/full
2022-01-01,2022,Nanobiotix,"NBTXR3, a first-in-class radioenhancer for pancreatic ...",Clinical_Milestone,by AF Bagley · 2022 · Cited by 69 — NBTXR3 is a radioenhancer composed of functionalized hafnium oxide nanoparticles. This report describes the first patient with pancreatic cancer treated with ...,https://pmc.ncbi.nlm.nih.gov/articles/PMC8783106/
2022-01-01,2022,Nanobiotix,Imaging Features of Intratumoral Injection of NBTXR3 for ...,Clinical_Milestone,by DT Ginat · 2022 · Cited by 11 — NBTXR3 nanoparticle injection is a relatively novel radioenhancer for treatment of various cancers. CT scans following NBTXR3 injection of metastatic lymph ...,https://www.mdpi.com/2075-4418/12/9/2156
2022-01-01,2022,Nanobiotix,Radiotherapy-activated NBTXR3 nanoparticles modulate ...,Clinical_Milestone,by A Darmon · 2022 · Cited by 14 — We showed that NBTXR3 activated by radiotherapy both increased immunogenic cell death biomarkers and modulated the immunopeptidome profile of CT26.WT cells.,https://pmc.ncbi.nlm.nih.gov/articles/PMC9164428/
2022-01-01,2022,Nanobiotix,NIR-II light-assisted radiotherapy based on ultrasmall HfO 2,General_Update,by Y Chen · 2022 · Cited by 11 — In vitro and in vivo results demonstrated that the prepared nanosensitizer significantly improved RT efficacy at tumor site and reduced side-effect in normal ...,https://www.sciencedirect.com/science/article/abs/pii/S2588842022000815
2022-01-01,2022,Nanobiotix,NBTXR3 improves the efficacy of immunoradiotherapy ...,Clinical_Milestone,"by Y Hu · 2022 · Cited by 16 — We previously demonstrated that NBTXR3, a nanoparticle radioenhancer, significantly improved immune responses in a murine anti-PD1-resistant metastatic lung ...",https://pubmed.ncbi.nlm.nih.gov/36405757/
2022-01-01,2022,Nanobiotix,Imaging Features of Intratumoral Injection of NBTXR3 for ...,Clinical_Milestone,"by DT Ginat · 2022 · Cited by 11 — Intratumoral injection of NBTXR3 followed by radiation therapy has been found to be feasible and safe for a variety of tumors, such as locally advanced squamous ...",https://nanobiotix.com/wp-content/uploads/2023/10/9-Imaging-Features-of-Intratumoral-Injection-of-NBTXR3-for-Head-and-Neck-Squamous-Cell-Carcinoma-Lymph-Node-Metastases.pdf
2022-01-01,2022,Nanobiotix,"NBTXR3, a first-in-class radioenhancer for pancreatic ...",Clinical_Milestone,by AF Bagley · 2022 · Cited by 69 — This report demonstrates initial feasibility of local endoscopic delivery of NBTXR3 activated by radiation therapy for patients with pancreatic cancer who are ...,https://www.sciencedirect.com/science/article/pii/S2405630821001117
2022-01-01,2022,Nanobiotix,Pathological Response and Immune Biomarker Assessment ...,General_Update,by F Rojas · 2022 · Cited by 13 — Received 2022 May 3; Accepted 2022 May 28; Collection date 2022 Jun. © 2022 ... Nanobiotix and receives funding to the MD Anderson Cancer Center from ...,https://pmc.ncbi.nlm.nih.gov/articles/PMC9179283/
2022-01-01,2022,Nanobiotix,Final Safety and Health-Related Quality of LIfe Results ...,Clinical_Milestone,"by S Bonvalot · 2022 · Cited by 38 — Footnotes: This study was funded by Nanobiotix SA (Paris, France) and PharmaEngine, Inc (China). Disclosures: S.B. reports honoraria; research funding; and ...",https://www.redjournal.org/article/S0360-3016(22)00720-9/fulltext
2022-01-01,2022,Nanobiotix,JCO Clinical Cancer Informatics,Clinical_Milestone,by ST Schmidt · 2022 · Cited by 6 — Consulting or Advisory Role: Nanobiotix ... I may personally benefit from milestone and royalty agreements through MDA alliances and out-license agreements.,https://ascopubs.org/doi/abs/10.1200/CCI.22.00040
2022-01-01,2022,Nanobiotix,Current approaches of nanomedicines in the market and ...,Clinical_Milestone,"by X Shan · 2022 · Cited by 340 — This review provides a snapshot of nanomedicines that have been currently launched or in the clinical trials, which manifests a diversified trend in carrier ...",https://www.sciencedirect.com/science/article/pii/S2211383522000818
2022-01-01,2022,Nanobiotix,Current approaches of nanomedicines in the market and ...,Clinical_Milestone,"by X Shan · 2022 · Cited by 340 — In 2006, Opaxio was successfully assigned fast track designation by the FDA for the treatment of women with first-line advanced NSCLC. The enlightenment of ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC9293719/
2022-01-01,2022,Nanobiotix,Recent Advances in Nanoparticle-Based Co-Delivery ...,Clinical_Milestone,"by RD Al Bostami · 2022 · Cited by 95 — Thus, significant preclinical and clinical trials are required before successful translation into clinical use and eventual acquisition of FDA approval [62,63].",https://www.mdpi.com/2079-4991/12/15/2672
2022-01-01,2022,Nanobiotix,Trotabresib (CC-90010) in combination with adjuvant ...,General_Update,"by M Vieito · 2022 · Cited by 22 — For enrollment in the concomitant cohort, patients must have been eligible for treatment with TMZ plus RT and have undergone complete or partial tumor resection ...",https://academic.oup.com/noa/article/4/1/vdac146/6779621
2022-01-03,2022,Nanobiotix,Nanomedicine and Clinical Research List - CD Bioparticles,Clinical_Milestone,CD Bioparticles organizes and provides a list of nano-drugs that have been approved by the FDA and EMA for marketing and clinical research in recent years ...,https://www.cd-bioparticles.net/supports/nanomedicine-and-clinical-research-list?srsltid=AfmBOoopdBUxWaemek2-S1MvnBDfguUmB5aJzKMNzDy6eNLYPsE6MbMt
2022-01-10,2022,Nanobiotix,First Patient Enrolled in NANORAY-312 Global Phase III ...,Clinical_Milestone,"Given the physical MoA, Nanobiotix believes that NBTXR3 could be scalable across any solid tumor that can be treated with radiotherapy and across any ...",https://www.itnonline.com/content/first-patient-enrolled-nanoray-312-global-phase-iii-registrational-study-nbtxr3-head-and
2022-01-31,2022,Nanobiotix,Prospectus,Corporate_Action,"Major M&A transactions, licensing deals and a flood of investor capital has characterised the ... US$300,000 within seven days of 1 January 2022, 1 April 2022, 1 ...",https://radiopharmtheranostics.com/wp-content/uploads/2025/05/619ae23f58666a5a5c9de4f8_Radiopharm-Theranostics-Prospectus.pdf
2022-03-23,2022,Nanobiotix,Standing - Valneva,General_Update,"... 2022. Q1 2022 Interim Results. May 5, 2022. AGM - Record date. June 20, 2022 ...",https://valneva.com/wp-content/uploads/2022/03/VAL2021_URD_EN_MeL_220322_Final.pdf
2022-03-30,2022,Nanobiotix,NANOBIOTIX Provides Business Update,Clinical_Milestone,Reporting of recommended Phase II dose for each cohort is expected in 2022 along with the initiation of a new expansion Phase of Study 1100 evaluating NBTXR3 in ...,https://www.citybiz.co/article/238990/nanobiotix-provides-business-update-2/
2022-06-24,2022,Nanobiotix,Nanobiotix's cancer nanomedicine secures good Phase II/ ...,Clinical_Milestone,A nanomedicine designed to help amplify and focus radiation treatment on hard to treat soft tissue sarcoma cells has achieved positive Phase II/III trial ...,https://www.labiotech.eu/trends-news/nanobiotix-cancer-nanomedicine-results/
2022-09-06,2022,Nanobiotix,The 2022 PharmaVoice 100,General_Update,"In July, Novavax's COVID-19 shot became the fourth approved vaccine in the U.S. — a major milestone ... The company he co-founded, Nanobiotix, is putting ...",https://www.pharmavoice.com/news/pv100-pharma-industry-leaders-next-era/629818/
2022-10-25,2022,Nanobiotix,Daniela Sanchez Lawyer / Attorney,General_Update,Nanobiotix in its co-development and commercialization agreement with Janssen for a potential first-in-class radioenhancer; upfront value of up to $60 ...,https://www.goodwinlaw.com/en/people/s/sanchez-daniela
2022-12-28,2022,Nanobiotix,Nanobiotix randomises first patient in head/neck cancer trial,Clinical_Milestone,Nanobiotix randomises first patient in head and neck cancer therapy trial. The trial will assess the safety and efficacy of NBTXR3 alone or in combination with ...,https://www.clinicaltrialsarena.com/news/nanobiotix-head-neck-cancer-trial/
2023-01-01,2023,Nanobiotix,Efficacy from the ongoing phase I trial Study 1100 with ...,Clinical_Milestone,"by C Shen · 2023 · Cited by 6 — In preclinical models, NBTXR3/RT has been shown to enhance tumor cell death and tumor antigen release and to effectively expand T-cell repertoire, thus ...",https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.6038
2023-01-01,2023,Nanobiotix,887P Antitumor activity of the radioenhancer NBTXR3 on ...,Clinical_Milestone,"by C Le Tourneau · 2023 · Cited by 3 — NBTXR3 is a first-in-class radioenhancer, composed of hafnium oxide nanoparticles, injected once intratumorally (IT) and activated by radiotherapy (RT) ...",https://www.annalsofoncology.org/article/S0923-7534(23)02869-7/fulltext
2023-01-01,2023,Nanobiotix,Understanding the Role of Radio-Sensitizing ...,Clinical_Milestone,by A Stergioula · 2023 · Cited by 7 — Additionally NBTXR3 has been granted regulatory Fast Track designation by the FDA for its investigation in the management of locally advanced HNSCC [54].,https://pmc.ncbi.nlm.nih.gov/articles/PMC10705175/
2023-01-01,2023,Nanobiotix,In the literature: September 2023 - PMC,General_Update,"by A Lamarca · 2023 · Cited by 3 — Based on these data, futibatinib was approved (accelerated approval pending confirmatory data for full approval) by regulatory agencies in this indication (the ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC10590842/
2023-01-01,2023,Nanobiotix,The evolving landscape of antibody-drug conjugates in ...,Clinical_Milestone,by A Tolcher · 2023 · Cited by 48 — There have been several important recent developments in gyneco- logic malignancies with 2 ADCs having received accelerated approval by the FDA in gynecologic ...,https://www.mersana.com/wp-content/uploads/2023/04/Evolving-Landscape-of-ADCs-in-GYN-Cancers.pdf
2023-01-01,2023,Nanobiotix,A multi-stakeholder view,Corporate_Action,"by C Le Tourneau · 2023 · Cited by 6 — Conditional approval, which allows for expedited drug access while further data are generated, is an important strategy by which regulatory bodies deal with ...",https://www.ejcancer.com/article/S0959-8049(23)00380-5/pdf
2023-04-24,2023,Nanobiotix,"Press release - xx.XXXX, 2023",Clinical_Milestone,"Given the physical. MoA, Nanobiotix believes that NBTXR3 could be scalable across any solid tumor that can be treated with radiotherapy and across any ...",https://ir.nanobiotix.com/static-files/5bb4abd5-b17c-4fd9-8d3c-ccc67fd4b5cc
2023-05-10,2023,Nanobiotix,Soft Tissue Sarcoma Pipeline Space Brims With Novel ...,Clinical_Milestone,"In September 2022, TRACON Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted fast-track designation for the ...",https://www.prnewswire.com/news-releases/soft-tissue-sarcoma-pipeline-space-brims-with-novel-emerging-therapies-with-over-125-key-companies-working-in-the-domain--delveinsight-301820474.html
2023-06-06,2023,Nanobiotix,Nanobiotix: A Promising Cancer Treatment But A Risky ...,Financial_Performance,Nanobiotix has only sufficient funds to carry on to Q3 of 2023. Click here to see why NBTX stock is a Hold.,https://seekingalpha.com/article/4609612-nanobiotix-promising-cancer-treatment-but-risky-investment-now
2023-06-14,2023,Nanobiotix,Soft Tissue Sarcoma Pipeline Insight,Clinical_Milestone,"In September 2022, TRACON Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted fast-track designation for the ...",https://paulatakacsfoundation.org/soft-tissue-sarcoma-pipeline-insight/
2023-07-10,2023,Nanobiotix,Release Details,Clinical_Milestone,NANOBIOTIX announces license agreement for worldwide co-development and commercialization of potential first-in-class radioenhancer NBTXR3.,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-license-agreement-worldwide-co-development
2023-07-10,2023,Nanobiotix,Nanobiotix ADRs Jump Over 50% After Agreement With ...,Clinical_Milestone,"... Nanobiotix jumped over 50% in early trading on Monday following the news. Nanobiotix said it will co-develop and commercialize the NBTXR3 ... 2023, compared ...",https://www.investopedia.com/nanobiotix-adrs-jump-after-agreement-with-janssen-pharmaceutical-7558419
2023-07-10,2023,Nanobiotix,NANOBIOTIX Announces License Agreement for Worldwide,Clinical_Milestone,NANOBIOTIX announces license agreement for worldwide co-development and commercialization of potential first-in-class radioenhancer NBTXR3.,https://www.globenewswire.com/news-release/2023/07/10/2701468/0/en/NANOBIOTIX-Announces-License-Agreement-for-Worldwide-Co-development-and-Commercialization-of-Potential-First-In-Class-Radioenhancer-NBTXR3.html
2023-07-10,2023,Nanobiotix,"Nanobiotix licenses cancer treatment to J&J, extending ...",General_Update,The pharma company will pay $30 million upfront to gain rights to an experimental therapy meant to enhance the anti-tumor effect of radiation.,https://www.biopharmadive.com/news/nanobiotix-johnson-johnson-licensing-head-neck-cancer-radioenhancer/685982/
2023-07-10,2023,Nanobiotix,"Nanobiotix License Agreement with Janssen*, for Co- ...",General_Update,"*Total success-based payments: $1.8 billion excluding upfront, in-kind support, equity, royalties and additional milestones for new potential indications ...",https://ir.nanobiotix.com/static-files/c159b943-19b2-4376-92c9-7907a2fa5369
2023-07-10,2023,Nanobiotix,J&J seizes on cash crunch to bag late-phase cancer ...,Clinical_Milestone,Johnson & Johnson has seized on the cash crunch at Nanobiotix to pick up a phase 3 cancer prospect for $30 million upfront.,https://www.fiercebiotech.com/biotech/jj-capitalizes-cash-crunch-capture-late-phase-cancer-candidate-30m-upfront
2023-07-10,2023,Nanobiotix,J&J Extends Lifeline to Nanobiotix in Potential $1.8B ...,Clinical_Milestone,"The deal brings an upfront payment of $30 million for the NBTXR3 radioenhancer to Nanobiotix, including milestone payments of up to $1.8 billion and an ...",https://www.biospace.com/nanobiotix-finds-lifeline-in-johnson-and-johnson-deal-receives-30-million-upfront-payment
2023-07-10,2023,Nanobiotix,J&J snaps up Nanobiotix cancer radiotherapy in $2.5bn+ ...,General_Update,"J&J is providing up to $30 million to complete NANORAY-132 as part of its upfront support and has also pledged up to $1.8 billion in development, regulatory, ...",https://pharmaphorum.com/news/jj-snaps-nanobiotix-cancer-radiotherapy-25bn-deal
2023-07-10,2023,Nanobiotix,Why Janssen signed a $2B+ deal with Boston-Paris ...,Corporate_Action,"Under the terms of the agreement, Nanobiotix will get a $30 million upfront payment, another $30 million in regulatory and development support, and up to $1.8 ...",https://www.bizjournals.com/boston/news/2023/07/10/nanobiotix-johnson-johnson-collaboration-deal.html
2023-07-10,2023,Nanobiotix,Nanobiotix SA licences NBTXR3 to J&J,Clinical_Milestone,"Potential milestones sum up to US$1.8bn. Moreover, the agreement includes a framework for additional success-based potential development and regulatory ...",https://european-biotechnology.com/latest-news/nanobiotix-sa-licences-nbtxr3-to-jj/
2023-07-17,2023,Nanobiotix,Nanobiotix partners with Janssen | C&EN Global Enterprise,Corporate_Action,"Nanobiotix will get $60 million, split evenly between up-front cash and in-kind support. The agreement also provides for up to $1.8 billion in milestone ...",https://pubs.acs.org/doi/10.1021/cen-10123-buscon15
2023-07-18,2023,Nanobiotix,LianBio Partner NANOBIOTIX Enters into License ...,Clinical_Milestone,"Nanobiotix will grant Janssen a worldwide license for the co-development and commercialization of NBTXR3. The license is exclusive, excepting territories ...",https://firstwordpharma.com/story/5762268
2023-09-26,2023,Nanobiotix,Nanobiotix (Nasdaq:NBTX) - Stock Analysis,Clinical_Milestone,"... Nbtxr3 for Patients with Pancreatic Ductal Adenocarcinoma. Sep 30. Nanobiotix S.A. to Report First Half, 2023 Results on Sep 26, 2023. Sep 20. NANOBIOTIX ...",https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbtx/nanobiotix
2023-09-26,2023,Nanobiotix,Nanobiotix Future Growth,Financial_Performance,Nanobiotix is forecast to grow earnings and revenue by 33% and 22.5% per annum respectively while EPS is expected to grow by 29% per annum.,https://simplywall.st/stocks/gb/pharmaceuticals-biotech/bats-chixe-nanop/nanobiotix-shares/future
2023-10-04,2023,Nanobiotix,Release Details,Clinical_Milestone,Nanobiotix Announces the Presentation of the Final Efficacy Analysis From Phase 1 Cohort Expansion Evaluating NBTXR3 in Locally Advanced Head and Neck Cancer ...,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-presentation-final-efficacy-analysis-phase
2023-10-19,2023,Nanobiotix,Institut Curie at the 2023 ESMO annual meeting,Clinical_Milestone,"For over 10 years Institut Curie has been working on this extremely original therapy with the company Nanobiotix, which developed these NBTXR3 nanoparticles.",https://institut-curie.org/ESMO2023
2023-10-22,2023,Nanobiotix,NANOBIOTIX Announces Updated Preliminary Results ...,Clinical_Milestone,NANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial and New Exploratory Analysis From Completed Phase 1 Head and Neck Cancer ...,https://finance.yahoo.com/news/nanobiotix-announces-updated-preliminary-results-060000423.html
2023-12-06,2023,Nanobiotix,Nanobiotix Announces Closing of the Remaining $4.8 ...,General_Update,"Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc. 13 December 2023 | East North America.",https://jnjinnovation.com/news/press-releases/nanobiotix-announces-closing-of-the-remaining-48-million-investment-from-johnson--johnson-innovation--jjdc-inc
2023-12-26,2023,Nanobiotix,LianBio Enters into Agreement Assigning its Rights for ...,General_Update,"In July 2023, Nanobiotix granted Janssen a worldwide exclusive license, excepting territories previously licensed to LianBio, for the co-development and ...",https://www.biospace.com/lianbio-enters-into-agreement-assigning-its-rights-for-nbtxr3-in-china-and-other-asian-markets
2024-01-01,2024,Nanobiotix,Early signs of efficacy in patients with anti-PD-1 naïve and ...,Clinical_Milestone,by C Shen · 2024 · Cited by 4 — NBTXR3/RT/anti-PD-1 combination was feasible and well tolerated. Early data suggest the addition of NBTXR3/RT to ICI showed evidence of efficacy.,https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.6035
2024-01-01,2024,Nanobiotix,Superior antitumor immune response achieved with proton ...,Clinical_Milestone,by Y Hu · 2024 · Cited by 7 — Proton IRT combined with NBTXR3 offers enhanced tumor control and survival rates over photon-based treatments in managing αPD1-resistant lung cancer.,https://pubmed.ncbi.nlm.nih.gov/39354474/
2024-01-01,2024,Nanobiotix,Enhancing tumor radiotherapy sensitivity through metal ...,General_Update,by S Xiao · 2024 · Cited by 6 — Nanomaterials have shown potential in improving the efficacy and safety of tumor radiotherapy. This paper briefly overviews the radiation enhancement ...,https://onlinelibrary.wiley.com/doi/full/10.1002/msp2.52
2024-01-01,2024,Nanobiotix,Nanomaterials for refining tumor microenvironment and...,General_Update,"by K Zheng · 2024 · Cited by 33 — It is mainly used in radiotherapy for soft tissue sarcoma and head-neck, oral and pharyngeal, prostate, liver, colorectal, and other cancers.",https://journals.lww.com/otm/fulltext/2024/08000/nanomaterials_for_refining_tumor_microenvironment.1.aspx
2024-01-01,2024,Nanobiotix,Application of High-Z Nanoparticles to Enhance Current ...,General_Update,"by N Jackson · 2024 · Cited by 28 — It is suggested that approximately 50% of cancer patients benefit from receiving radiotherapy, either as an independent treatment option or used in conjunction ...",https://www.mdpi.com/1420-3049/29/11/2438
2024-01-01,2024,Nanobiotix,Nivolumab plus ipilimumab versus sunitinib for first-line ...,General_Update,by NM Tannir · 2024 · Cited by 149 — Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety,https://www.annalsofoncology.org/article/S0923-7534(24)01516-3/fulltext
2024-01-01,2024,Nanobiotix,Novel Therapies Beyond PD-L1 Immunotherapy,Clinical_Milestone,"by AJ Rosenberg · 2024 · Cited by 16 — Because of the promising phase II results from VERSATILE 002, the US Food and Drug Administration (FDA) granted PDS0101 fast-track designation in June 2022.",https://ascopubs.org/doi/pdf/10.1200/EDBK_433330
2024-01-01,2024,Nanobiotix,Targeting the organelle for radiosensitization in cancer ...,Clinical_Milestone,"by X Sun · 2024 · Cited by 16 — In February 2020, the NBTXR3 was granted fast-track designation by the FDA for the treatment of patients with locally advanced head and neck squamous cell ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC10999375/
2024-01-23,2024,Nanobiotix,JNJ.N - Q4 2023 Johnson & Johnson Earnings Call EVENT ...,Financial_Performance,"We project MedTech operational sales growth to be relatively consistent throughout the year, expecting procedures in 2024 to remain above pre-COVID levels. The ...",https://s203.q4cdn.com/636242992/files/doc_financials/2023/q4/final-jnj-usq_transcript_2024-01-23.pdf
2024-03-05,2024,Nanobiotix,Biotechnology Licensing Deals Analysis Reveals Key Trends,Corporate_Action,"The biotechnology sector has observed a consistent flow of licensing deals from 2019 through 2024, marking a significant phase in the industry's development and ...",https://www.globenewswire.com/news-release/2024/03/05/2840742/28124/en/Biotechnology-Licensing-Deals-Analysis-Reveals-Key-Trends-and-Major-Agreements-from-2019-2024.html
2024-03-06,2024,Nanobiotix,Liem-2024-Head-Neck-NBTXR3-Injection-Guidelines- ...,Clinical_Milestone,DNA damage enhance- ment by radiotherapy-activated hafnium oxide nanoparticles improves cGAS-STING pathway activation in human colorectal cancer cells.,https://nanobiotix.com/wp-content/uploads/2024/08/Liem-2024-Head-Neck-NBTXR3-Injection-Guidelines-HN.pdf
2024-03-08,2024,Nanobiotix,A Case for Radiation Enhancement in Head and Neck ...,General_Update,Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents ...,https://www.medscape.com/viewarticle/case-radiation-enhancement-head-and-neck-cancer-2024a10004gf
2024-04-13,2024,Nanobiotix,11 Best Nanotechnology Stocks To Invest In,Financial_Performance,"... share price target of $11.98. In fact, April 2024 is turning out to be a crucial month for Nanobiotix S.A. (NASDAQ:NBTX) as the firm completed the dose ...",https://finance.yahoo.com/news/11-best-nanotechnology-stocks-invest-140232952.html
2024-04-24,2024,Nanobiotix,Annual Report 2023 - English,Corporate_Action,milestone and license payments dependent on present and future net income or on third-party sub-licensing fees. REPORT ON ECONOMIC POSITION. 45. Page 47 ...,https://www.evotec.com/uploads/download-files/IR-ESG/2023/Evotec_AnnualReport2023-English.pdf
2024-05-14,2024,Nanobiotix,Release Details,Clinical_Milestone,NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer. May 14 2024 at 4: ...,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-us-fda-protocol-acceptance-new-randomized
2024-05-21,2024,Nanobiotix,Nanobiotix Announces Progress in Global NBTXR3 ...,Clinical_Milestone,Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth · Lead: MD Anderson · Status ...,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-progress-global-nbtxr3-development
2024-05-22,2024,Nanobiotix,Pipeline overview- Nanobiotix NBTXR3 in the clinic,Clinical_Milestone,Discover how Nanobiotix is transforming radiation oncology and helping vulnerable patients with head and neck cancer and other solid tumors.,https://nanobiotix.com/pipeline/
2024-06-02,2024,Nanobiotix,Release Details,Clinical_Milestone,"In 2023, Nanobiotix announced a license agreement for the global co-development and commercialization of NBTXR3 with Janssen Pharmaceutica NV. About NANOBIOTIX.",https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-new-data-showing-disease-control-and-tumor
2024-06-10,2024,Nanobiotix,ASCO 2024: The latest advances in oncology clinical trials,Clinical_Milestone,The drug had bagged accelerated approval in 2021. Oncology clinical trials ... Nanobiotix' NBTXR3 clinical trial reveals promising data at ASCO 2024.,https://www.labiotech.eu/in-depth/asco-2024-latest-advances-in-oncology-clinical-trials/
2024-06-28,2024,Nanobiotix,NANOBIOTIX Gets FDA Nod for Phase 2 Study of NBTXR3 ...,Clinical_Milestone,"In February 2020, the US FDA granted Fast Track designation for NBTXR3 activated by radiation therapy, with or without cetuximab, for patients with locally ...",https://synapse.patsnap.com/article/nanobiotix-gets-fda-nod-for-phase-2-study-of-nbtxr3-in-stage-3-lung-cancer
2024-07-31,2024,Nanobiotix,Development pipeline - investor.jnj.com,Clinical_Milestone,Stock chart · Historical stock quote · Investment calculator · Dividend history · Stock ... NBTXR3: Nanobiotix; A2a Receptor Antagonist: AdoRx Therapeutics ...,https://www.investor.jnj.com/pipeline/development-pipeline/default.aspx?a=Oncology%3BCardiovascular+and+Metabolism
2024-09-18,2024,Nanobiotix,NANOBIOTIX Provides Business Update and Reports Half ...,Clinical_Milestone,"Nanobiotix reports promising H1 2024 results: Favorable tumor response in cancer trials, revenue surge to €9.3M, and extended cash runway.",https://www.stocktitan.net/news/NBTX/nanobiotix-provides-business-update-and-reports-half-year-2024-hfyshlwokd41.html
2024-09-24,2024,Nanobiotix,Renal Cancer Clinical Trial Pipeline Appears Robust With ...,Clinical_Milestone,"In July 2024, The US Food and Drug Administration (FDA) granted Fast Track designation to the novel drug ADI-270 for the treatment of patients with metastatic ...",https://finance.yahoo.com/news/renal-cancer-clinical-trial-pipeline-170000663.html
2024-10-22,2024,Nanobiotix,Eight nanotechnology companies to watch out for,General_Update,It has been designed to heighten the energy deposited by radiotherapy in cancer cells to aid in tumor cell death while not affecting healthy cells.,https://www.labiotech.eu/best-biotech/eight-nanotechnology-companies-to-watch-out-for/
2024-11-19,2024,Nanobiotix,India's MedTech industry: The renaissance of a sector,Corporate_Action,"▻ Most deals during 2023 and 2024 focused on surgical devices and consumables, followed by IVD and cardiovascular devices. Top five deals in 2024 (till Aug'24).",https://www.ey.com/content/dam/ey-unified-site/ey-com/en-in/insights/health/documents/2024/11/ey-india-s-medtech-industry-the-renaissance-of-a-sector.pdf
2024-12-09,2024,Nanobiotix,NANOBIOTIX Announces Completion of Phase 1 Study ...,Clinical_Milestone,NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer. Dec 09 2024 at 4:15 PM EST. PDF Version.,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-completion-phase-1-study-nbtxr3-jnj-1900
2024-12-09,2024,Nanobiotix,NANOBIOTIX Announces Completion of Phase 1 Study ...,Clinical_Milestone,"This Phase 1 study was designed to evaluate the safety, feasibility, and early signs of efficacy of RT-activated NBTXR3 for patients with LAPC or BRPC.",https://live.euronext.com/en/products/equities/company-news/2024-12-09-nanobiotix-announces-completion-phase-1-study-nbtxr3-jnj
2024-12-31,2024,Nanobiotix,Annual Report 2024,Corporate_Action,"Our Company's position has been strengthened in 2024 and early 2025 with our licensing agreements and increased financial flexibility. ... Nanobiotix, France; ...",https://www.newron.com/sites/newron-pharma-corp/files/news-and-media/regulatory-news/2025/1%20april/AR24_web%20final.pdf
2025-01-01,2025,Nanobiotix,Historic Price Lookup,General_Update,"Date Requested, Open Price, Day High, Day Low, Closing Price, Volume, Split Adjustment Factor. December 29, 2025, 19.74, 19.90, 19.04, 19.28, 117,943, 1:1.",https://ir.nanobiotix.com/share-information/historic-price-lookup
2025-01-01,2025,Nanobiotix,Nanoray-312: phase III study of NBTXR3 + radiotherapy ...,Clinical_Milestone,by C Le Tourneau · 2025 · Cited by 8 — NBTXR3 is a new type of treatment that helps improve how radiation therapy works. It is a special kind of nanoparticle that is injected into cancer cells.,https://pubmed.ncbi.nlm.nih.gov/40323213/
2025-01-01,2025,Nanobiotix,The radioenhancer NBTXR3: bridging physics and biology to ...,Clinical_Milestone,"by C Bienassis · 2025 — Overall, this study indicates that NBTXR3 has the potential to improve the effectiveness of standard chemoradiation therapy in cancer treatment. While ...",https://link.springer.com/article/10.1186/s13046-025-03579-1
2025-01-21,2025,Nanobiotix,Release Details,Clinical_Milestone,Radiotherapy-activated NBTXR3 is being evaluated across multiple solid tumor indications as a single agent or in combination with anti-PD-1 immune checkpoint ...,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-first-patient-dosed-new-randomized-phase-2
2025-01-21,2025,Nanobiotix,NANOBIOTIX Announces First Patient Dosed in a New ...,Clinical_Milestone,"In February 2020, the United States Food and Drug Administration granted regulatory Fast Track ... FDA Policy Tracker: 2025 Was a Year of Change. December ...",https://www.biospace.com/press-releases/nanobiotix-announces-first-patient-dosed-in-a-new-randomized-phase-2-study-evaluating-jnj-1900-nbtxr3-for-patients-with-stage-3-unresectable-non-small-cell-lung-cancer
2025-01-21,2025,Nanobiotix,Nanobiotix Stock Gains as Dosing Begins in Mid-Stage ...,Clinical_Milestone,"JNJ-1900 enjoys the FDA's Fast Track designation for the same indication in the United States. Last month, the company announced the completion of the dose ...",https://www.nasdaq.com/articles/nanobiotix-stock-gains-dosing-begins-mid-stage-nsclc-study
2025-03-17,2025,Nanobiotix,Release Details,Corporate_Action,"The global licensing agreement, now valued up to approximately $2.6B, includes Nanobiotix eligibility for potential success-based payments that include: $1.77B, ...",https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-strengthens-financial-position-through-amendment
2025-03-28,2025,Nanobiotix,NBTXR3 (JNJ-1900) Could Offer a New Therapeutic ...,Clinical_Milestone,"In February 2020, the United States Food and Drug Administration (FDA) granted regulatory Fast Track designation for the investigation of NBTXR3 activated by ...",https://www.oncozine.com/nbtxr3-jnj-1900-could-offer-a-new-therapeutic-option-for-some-lung-cancer-patients/
2025-04-02,2025,Nanobiotix,NANOBIOTIX Provides Business Update and Reports Full ...,Clinical_Milestone,"In February 2020, the United States Food and Drug Administration granted regulatory Fast Track designation for the investigation of NBTXR3 (JNJ-1900) ...",https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-provides-business-update-and-reports-full-year-2024
2025-04-04,2025,Nanobiotix,"Nanobiotix S.A. (NBTX) Stock Price, News, Quote & History",Financial_Performance,Profit Margin. 0.00% · Return on Assets (ttm). -41.64% · Return on Equity (ttm). -- · Revenue (ttm). 10.16M · Net Income Avi to Common (ttm). -51.64M · Diluted EPS ( ...,https://ca.finance.yahoo.com/quote/NBTX/
2025-04-15,2025,Nanobiotix,Novel Radioenhancer JNJ-1900 Shows Potential Across ...,General_Update,"Jared Weiss, MD, discussed the mechanism of action of JNJ-1900 and the preliminary data presented at the 2025 European Lung Cancer Congress.",https://www.targetedonc.com/view/novel-radioenhancer-jnj-1900-shows-potential-across-cancers
2025-05-21,2025,Nanobiotix,Nanobiotix Provides First Quarter 2025 Operational and ...,General_Update,"Nanobiotix anticipates that the cash and cash equivalents of €39.8 million as of March 31, 2025, will fund its operations into mid-2026.",https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-provides-first-quarter-2025-operational-and-financial
2025-07-07,2025,Nanobiotix,Release Details,General_Update,"The product candidate's mechanism of action (MoA) is designed to induce significant tumor cell death in the injected tumor when activated by radiotherapy, ...",https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-regulatory-harmonization-and-new
2025-09-18,2025,Nanobiotix,Nanobiotix: Today's Data Readout For Radiation Therapy ...,Clinical_Milestone,"Nanobiotix S.A. stock has surged after strong Phase 1 data for NBTXR3 in anti-PD-1 resistant melanoma, showing high response and disease control rates.",https://seekingalpha.com/article/4824121-nanobiotix-today-data-readout-for-radiation-therapy-enhances-bull-case
2025-09-18,2025,Nanobiotix,NANOBIOTIX Announces New Results From a Phase 1 ...,Clinical_Milestone,"As of the August 21, 2025, data cutoff, 21 patients had been injected with JNJ-1900 and 19 were evaluable for tumor response (2 patients were not evaluable due ...",https://www.biospace.com/press-releases/nanobiotix-announces-new-results-from-a-phase-1-study-evaluating-jnj-1900-nbtxr3-in-combination-with-immune-checkpoint-inhibitors-as-a-2l-therapy-for-patients-with-primary-cutaneous-melanoma-resistant-to-anti-pd-1
2025-09-30,2025,Nanobiotix,NANOBIOTIX Provides Business Update and Reports Half ...,Clinical_Milestone,Strengthened financial position through amendment of the JNJ-1900 (NBTXR3) global licensing agreement extending cash visibility to mid-2026; In active ...,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-provides-business-update-and-reports-half-year-2025
2025-10-01,2025,Nanobiotix,NANOBIOTIX Announces First Data From Phase 1 Study ...,Clinical_Milestone,NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer. Oct 01 2025 at 4:15 PM EDT. PDF Version.,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-first-data-phase-1-study-evaluating-jnj
2025-10-01,2025,Nanobiotix,NANOBIOTIX Announces First Data From Phase 1 Study,Clinical_Milestone,"NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer. October 01, 2025 16:15 ET | Source: ...",https://www.globenewswire.com/news-release/2025/10/01/3159946/0/en/NANOBIOTIX-Announces-First-Data-From-Phase-1-Study-Evaluating-JNJ-1900-NBTXR3-for-Patients-With-Esophageal-Cancer.html
2025-10-02,2025,Nanobiotix,"Nanobiotix S.A. (NBTX) Stock Price, Quote, News & Analysis",Financial_Performance,What is Nanobiotix S.A.'s 2026 earnings estimate? ... Nanobiotix S.A.'s 2026 earnings estimate is $-0.54 and Nanobiotix S.A.'s revenue estimate is $53.52M. Learn ...,https://seekingalpha.com/symbol/NBTX
2025-10-03,2025,Nanobiotix,Nanobiotix's HNSCC hopeful wins in Phase I oesophageal ...,Corporate_Action,"This deal set the New Jersey-based big pharma back approximately $2.6bn after a $100m agreement tweak in March 2025. Through this updated deal, J&J will cover ...",https://www.clinicaltrialsarena.com/news/nanobiotix-johnson-johnson-jnj-1900-oesophageal-cancer-phase-i/
2025-10-03,2025,Nanobiotix,JNJ-190 Plus Anti–PD-1 Immune Checkpoint Inhibitors ...,Clinical_Milestone,"In February 2020, the FDA granted JNJ-1900 fast track designation for the treatment of patients with advanced HNSCC who are ineligible for platinum-based ...",https://www.onclive.com/view/jnj-190-plus-anti-pd-1-immune-checkpoint-inhibitors-generate-early-antitumor-activity-in-hnscc
2025-10-10,2025,Nanobiotix,"NBTXR3 Well Tolerated in R/M HNSCC, With Early Efficacy ...",Clinical_Milestone,"Innovative NBTXR3 shows promise in enhancing radiotherapy for recurrent head and neck cancer, potentially transforming treatment options for patients.",https://www.targetedonc.com/view/nbtxr3-well-tolerated-in-r-m-hnscc-with-early-efficacy-signals
2025-10-24,2025,Nanobiotix,Nanobiotix Transfers Phase 3 Trial to J&J - NBTX,Clinical_Milestone,"In February 2020, the United States Food and Drug Administration granted regulatory Fast Track designation for the investigation of JNJ-1900 (NBTXR3) ...",https://www.stocktitan.net/news/NBTX/nanobiotix-announces-updates-to-jnj-1900-nbtxr3-clinical-program-2iel2jqv4pun.html
2025-10-31,2025,Nanobiotix,NANOBIOTIX Announces Strategic Royalty Monetization ...,Financial_Performance,NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth.,https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-strategic-royalty-monetization-agreement
2025-10-31,2025,Nanobiotix,Nanobiotix finds new way to source cash from J&J ...,General_Update,Nanobiotix said the money from HCRx will fund the biotech into early 2028. With milestone payments for JNJ-1900's development in both head and neck cancer and ...,https://www.fiercebiotech.com/biotech/cash-strapped-nanobiotix-finds-fresh-way-source-cash-jj-partnered-cancer-drug
2025-10-31,2025,Nanobiotix,NANOBIOTIX Announces Strategic Royalty Monetization,Financial_Performance,NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth.,https://www.globenewswire.com/news-release/2025/10/31/3178112/0/en/NANOBIOTIX-Announces-Strategic-Royalty-Monetization-Agreement-With-Healthcare-Royalty-for-up-to-71-Million-and-Extends-Cash-Runway-Toward-Long-Term-Growth.html
2025-10-31,2025,Nanobiotix,Nanobiotix Secures $71 Million Royalty Agreement ...,General_Update,"At closing, Nanobiotix receives $50 million upfront, with an additional $21 million available one year later, subject to milestone achievement. Repayment to ...",https://marketchameleon.com/articles/b/2025/10/31/nanobiotix-71-million-royalty-agreement-extends-cash-runway-advances-cancer-pipeline
2025-11-01,2025,Nanobiotix,Nanobiotix Secures $71 Million Royalty Agreement with ...,General_Update,"This agreement is expected to extend the company's cash runway into early 2028, supporting the development of its nanotherapeutic platforms and advancing key ...",https://www.theglobeandmail.com/investing/markets/stocks/NBTX-Q/pressreleases/35843340/nanobiotix-secures-71-million-royalty-agreement-with-healthcare-royalty/
2025-11-11,2025,Nanobiotix,Nanobiotix Stock Price Today | NASDAQ: NBTX Live,Financial_Performance,"Mar 27, 2025. Guggenheim cuts Nanobiotix stock target to $8, maintains buy. On Friday, Guggenheim revised its price target for Nanobiotix (EPA:NANOB) S.A ...",https://www.investing.com/equities/nanobiotix-n
2025-11-13,2025,Nanobiotix,Why Nanobiotix (ENXTPA:NANO) Is Up 5.9% After ...,General_Update,"Why Nanobiotix (ENXTPA:NANO) Is Up 5.9% After Securing $71M in Non-Dilutive Financing and What's Next. Simply Wall St. November 13, 2025 3 min read.",https://finance.yahoo.com/news/why-nanobiotix-enxtpa-nano-5-091449892.html
2025-11-24,2025,Nanobiotix,Nanobiotix Provides Third Quarter 2025 Operational and ...,Clinical_Milestone,"Given the physical MoA, Nanobiotix believes that JNJ-1900 (NBTXR3) could be scalable across any solid tumor that can be treated with radiotherapy and across any ...",https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-provides-third-quarter-2025-operational-and-financial
2025-11-24,2025,Nanobiotix,Nanobiotix Provides Third Quarter 2025 Operational and ...,Clinical_Milestone,"Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook. Nanobiotix S.A.. November 24, 2025 7 MINUTES_READ.",https://finance.yahoo.com/news/nanobiotix-provides-third-quarter-2025-211500646.html
2025-12-17,2025,Nanobiotix,NBTX - Nanobiotix S.A. Latest Stock News & Market Updates,Clinical_Milestone,Nanobiotix (NASDAQ: NBTX) reported a third-quarter 2025 operational and financial update and a 2026 clinical outlook. Key items include a $50 million upfront ...,https://www.stocktitan.net/news/NBTX/
2026-01-01,2026,Nanobiotix,"Nanobiotix (NBTX) Stock Price, News & Analysis",Financial_Performance,"Nanobiotix's stock was trading at $23.12 on January 1st, 2026. Since then, NBTX stock has decreased by 4.3% and is now trading at $22.13. When did Nanobiotix ...",https://www.marketbeat.com/stocks/NASDAQ/NBTX/
2026-01-01,2026,Nanobiotix,"Forum NANOBIOTIX : bourse, conseils, ...",Clinical_Milestone,"Performance 2025, nouveaux sommets pour 2026, juste un avis ....... Par ... Nouvel article scientifique NBTXR3. Par Qwest35 •20 déc. 2025 • 07:59. 20 déc ...",https://www.boursorama.com/bourse/forum/1rPNANO/
2015-02-15,2015,Palvella_Therapeutics,LÄÄKKEIDEN TURVALLINEN KÄYTTÖKUNTOON ... - HELDA,General_Update,Satakunnan sairaanhoitopiirin lääkehuollon listauksessa vuodelta 2014 kalleimmista yksittäisistä lääkeannoksista useat olivat osastoilla käyttökuntoon.,https://helda.helsinki.fi/bitstreams/bda4f9a6-2e6d-4fbc-8b39-4edf95ff9eed/download
2015-03-23,2015,Palvella_Therapeutics,Cellectis S.A. Stock Price - CLLS,Financial_Performance,"The company's business model is driven by R&D and is supported by strategic collaborations, licensing agreements, and research funding ... Palvella Therapeutics, ...",https://www.perplexity.ai/finance/CLLS/holders
2015-04-01,2015,Palvella_Therapeutics,Alger Small Cap Focus Composite - Institutional Investors,Financial_Performance,"Palvella Therapeutics, Inc. 0.75%, 0.03%, 0.71%. Forte Biosciences Inc. 0.69 ... Growth stocks may be more volatile than other stocks as their prices tend ...",https://www.alger.com/Pages/Products.aspx?productCode=SmlCapFRep
2015-06-12,2015,Palvella_Therapeutics,BioAdvance Portfolio Companies Attract $85 Million of ...,General_Update,"BioAdvance Portfolio Companies Attract $85 Million of Capital in 12 Months. By WebmasterJune 12, 2015November 1st, 2024No Comments ... Palvella Therapeutics ...",https://bioadvance.com/bioadvance-portfolio-companies-attract-85-million-of-capital-in-12-months/
2015-09-15,2015,Palvella_Therapeutics,6 Luova laskentatoimi - Trepo,General_Update,Artikkelin tarkoituksena on avata meillä Suomessa suhteellisen vähän käytetyn luovan laskentatoimen käsitettä ja tuoda esille.,https://trepo.tuni.fi/bitstream/handle/10024/101444/luova_laskentatoimi.pdf?sequence=1&isAllowed=y
2015-12-11,2015,Palvella_Therapeutics,VALO PIETARIN LUONNON NAHKURIN,General_Update,Pure water is elemental to the success of your experiments. But finding the right water system for your research goes deeper than water quality alone.,https://www.kemiamedia.fi/wp-content/uploads/2013/04/kem715_kevyt.pdf
2017-01-01,2017,Palvella_Therapeutics,Kenen nuorisotyö?,General_Update,by T HOIKKALA · Cited by 1 — Vuonna 2017 tilanne on tässä suhteessa vakiintuneempi. Tutkinnolla ja sen eväin työelämässä toimivilla on ollut oma paikkansa. Nuorisokielellä: normihommaa ...,https://www.humak.fi/wp-content/uploads/2017/12/hoikkala-kuivakangas-kenen-nuorisotyo.pdf
2017-05-01,2017,Palvella_Therapeutics,Alger Dynamic Return Composite - Institutional Investors,General_Update,"Palvella Therapeutics, Inc. 0.50%, 0.00% ; Danaher Corporation, 0.50%, 0.24% ; Cameco Corporation, 0.49%, 0.00% ; Abivax SA Sponsored ADR, 0.49%, 0.00% ...",https://www.alger.com/Pages/Products.aspx?productCode=DynRetRep
2017-05-11,2017,Palvella_Therapeutics,40 Under 40: Get up close & personal with the honorees ...,General_Update,"Grew membership by more than 40 percent, corporate membership by more than 300 percent, and more than doubled fundraising in less than two years. Wes Kaupinen.",https://www.bizjournals.com/philadelphia/news/2017/05/11/40-under-40-get-up-close-personal-with-the.html
2017-05-12,2017,Palvella_Therapeutics,We asked the 40 Under 40s: What else do you plan to ...,General_Update,Wes Kaupinen: Adding another novel product to Palvella's pipeline of therapies for rare skin diseases. Monica Jindia: Receive the National Sales Achiever ...,https://www.bizjournals.com/philadelphia/news/2017/05/12/we-asked-the-40-under-40s-what-else-do-you-plan-to.html
2017-05-16,2017,Palvella_Therapeutics,Retiring Trustees George Jenkins '74 and Bruce Maggin '65 ...,General_Update,This page is no longer being updated and remains online for informational and historical purposes only. The information is accurate as of the last page ...,https://news.lafayette.edu/2017/05/16/retiring-trustees-george-jenkins-74-and-bruce-maggin-65-elected-to-emeritus-status/
2017-08-10,2017,Palvella_Therapeutics,News on William C. McGowan - MarketScreener,Corporate_Action,"News on William C. McGowan. Palvella Therapeutics, Inc. completed the acquisition of Pieris Pharmaceuticals, Inc. in a reverse merger transaction.",https://www.marketscreener.com/insider/WILLIAM-C-MCGOWAN-A0ETAP/news/
2017-10-19,2017,Palvella_Therapeutics,Team,Financial_Performance,He currently serves on the boards of Palvella Therapeutics Inc. (Nasdaq: PVLA) and ViroCell Biologics. He is a former board member of the Harvard Business ...,https://www.ligand.com/aboutus/team/
2017-10-26,2017,Palvella_Therapeutics,VASTUULLISUUS & KIERTOTALOUS,General_Update,"TILAUSHINTA 2017. Kestotilaus 63 €/vsk määräaikaistilaus 68 €/vsk kestotilaus oppilaitokset. 50 €/vsk irtonumero 9,50 € + postituskulut vähintään 10 kpl ...",https://kehittyvaelintarvike.fi/wp-content/uploads/5-2017-pdf-5.pdf
2017-11-07,2017,Palvella_Therapeutics,standards of care v7 – - hyvän hoidon suositus,General_Update,"Etä- eli verkkoterapia on osoittautunut erittäin tehokkaaksi henkilöille, joilla on vaikeuksia päästä pätevään henkilökohtaiseen psykoterapeuttiseen hoitoon ja ...",https://seta.fi/wp-content/uploads/2017/11/Standars_of_care_V7_hyvan_hoidon_suositus.pdf
2017-11-15,2017,Palvella_Therapeutics,Nuorten urheilijoiden keskivartalon ja lantiorenkaan ...,General_Update,"Kasvaurheilijaksi.fi -sivusto toimii lisäksi yhteenvetoraporttien tuojana, joilla voidaan palvella esimerkiksi lajiliittoja ja sinettiseuroja. ... 2017 – 2018.",https://www.theseus.fi/bitstream/handle/10024/139021/Viinikainen_Otteliina.pdf?sequence=1&isAllowed=y
2018-01-01,2018,Palvella_Therapeutics,Nuoret palveluiden pauloissa,General_Update,by M Gissler · 2018 · Cited by 13 — PunaMusta Oy Helsinki 2018 Nuoret palveluiden pauloissa – Nuorten elinolot -vuosikirja 2018 on 12. osa vuodesta 2001 lähtien julkaistussa Nuorten elinolot - ...,https://www.julkari.fi/bitstream/handle/10024/137198/THL_TEE030_2018.pdf
2018-01-01,2018,Palvella_Therapeutics,OLKAPÄÄN LIIKKUVUUS- JA HALLINTAHARJOITTELU,General_Update,"by J Leivonen · 2018 — Laji on kasvattanut suosiotaan kovaa vauhtia, sillä 10 vuoden ai- kana saleja on avattu Suomeen jo 63 (CrossFit Suomi 2018). CrossFit on kovan intensiteetin ...",https://www.theseus.fi/bitstream/10024/144905/1/Leivonen_Jenny_Lindstrom_Irene_Raasu_Suvi.pdf
2018-05-22,2018,Palvella_Therapeutics,Lymphangiomatosis & Gorham's Disease Alliance,General_Update,"Palvella Therapeutics is seeking individuals or parents of children, aged 6 and older, living with cutaneous microcystic lymphatic malformations (mLM) to take ...",https://www.facebook.com/LGDAlliance/photos/lgdawareness-lgd-alliance-europe-lymphangiomatosis-en-gorhams-disease-alfie-miln/10156362074091064/
2018-06-18,2018,Palvella_Therapeutics,CMTRF Board of Directors,General_Update,"Dr. Motley also serves as a member of the Medical and Scientific Advisory Board of Palvella Therapeutics, a company focused on bringing therapies to patients ...",https://cmtrf.org/board-of-directors/
2018-06-19,2018,Palvella_Therapeutics,David Osborne Email & Phone Number | Asian ...,General_Update,"Palvella Therapeutics Employee David Osborne's profile photo. David Osborne. Chief Innovation Officer at Palvella Therapeutics. Fort Collins, CO, US. View. 2.",https://rocketreach.co/david-osborne-email_66202703
2018-09-03,2018,Palvella_Therapeutics,searchcoverage.txt,Financial_Performance,... THERAPEUTICS INC|| 10817748|FDMT|4D Molecular Therapeutics|10007680|080906 ... GROWTH TRUST PLC|| 333398||ABERFORTH SMALLER COMPANIES TRUST PLC ...,https://publicresearch.barclays.com/misc/searchcoverage.txt?ts=1536002944025
2018-11-19,2018,Palvella_Therapeutics,US9034881B2 - Treatment for vitiligo,General_Update,"Vitiligo is a condition that causes depigmentation of skin, typically in sections or patches, and affects about 1-2% of the world population.",https://patents.google.com/patent/US9034881B2/en
2018-12-17,2018,Palvella_Therapeutics,Ligand Acquires Milestone and Royalty Rights to PTX-022 ...,General_Update,Ligand will pay $10 million to Palvella Therapeutics and in return will receive a tiered royalty on net sales in the mid-to-upper single digits.,https://investor.ligand.com/news-and-events/press-releases/news-details/2018/Ligand-Acquires-Milestone-and-Royalty-Rights-to-PTX-022-from-Palvella-Therapeutics-12-17-2018/default.aspx
2019-01-01,2019,Palvella_Therapeutics,Severe skin reactions associated with Cladribine treatment ...,General_Update,by M Mateo-Casas · 2019 — Objective: To describe two cases of severe skin reactions in patients receiving Cladribine to control their multiple sclerosis (MS).,https://www.neurology.org/doi/10.1212/WNL.92.15_supplement.P4.2-022
2019-01-01,2019,Palvella_Therapeutics,Prevalence of Diagnosed/Highly Symptomatic ...,Clinical_Milestone,"by JR Gallagher · 2019 · Cited by 1 — The study and publication development were supported by Palvella. Therapeutics, Inc, Wayne, PA, USA. ... Pachonychia Congenita (PC) Project (2019) IPCRR Growth ...",https://www.hilarispublisher.com/open-access/prevalence-of-diagnosedhighly-symptomatic-pachyonychia-congenita-pc-patients-managed-annually-by-us-dermatologistsnation.pdf
2019-03-21,2019,Palvella_Therapeutics,Aallon Group Oyj,General_Update,"Aallon Group Oyj (”Aallon Group” tai ”Yhtiö”) tarjoaa alustavasti enintään 800 000 uutta osaketta. (”Tarjottavat Osakkeet”) merkittäväksi 6,60 euron ...",https://aallon.fi/wp-content/uploads/2019/03/Aallon_yhtioesite_21032019.pdf
2019-04-02,2019,Palvella_Therapeutics,Aallon Group Oyj:n listautumisanti 2019,Financial_Performance,Kaupankäynti Aallon Groupin osakkeilla alkoi Nasdaq First North Finland -markkinapaikalla 8.4.2019. Osakkeiden kaupankäyntitunnus on AALLON ja ISIN-tunnus on ...,https://aallon.fi/ipo/
2019-04-10,2019,Palvella_Therapeutics,Pocket Guide,Clinical_Milestone,"Sunday, April 28. Location. Time. Registration/Badge Printing. Main Lobby. 7am–6pm. ARVO Central. Exhibit Hall. 7am–6pm. Basic Clinical Lecture.",https://www.arvo.org/uploads/files/general/Annual-Meeting/Pocket-Guides/ARVO-2019-Pocket-Guide.pdf
2019-05-15,2019,Palvella_Therapeutics,Best Performing Stock May2019,Financial_Performance,Palvella Therapeutics (PVLA). 801.55%. Cidara Therapeutics (CDTX). 714.79 ... DeFi Development (DFDV). 650.48%. Nanobiotix (NBTX). 643.41%. AXT (AXTI). 636.49 ...,https://www.statmuse.com/money/ask/best-performing-stock-may2019
2019-05-22,2019,Palvella_Therapeutics,DNLI | Denali Therapeutics Inc. Stock Overview (U.S.,Financial_Performance,Peers. NameChg %Market Cap. Palvella Therapeutics Inc. -4.19. $1.24B. Plandai Biotechnology Inc. -99.00. $4.49M. Overview. news. BARRON'S. OTHER DOW JONES ...,https://www.barrons.com/market-data/stocks/dnli?gaa_at=eafs&gaa_n=AWEtsqfzVyUk6K3XYpC-p9D93lyAW24QGwTgFTeu-YP1qnIpEqsn1ldSglWH&gaa_ts=6959dc7a&gaa_sig=NK6zvHEXlcbOM4AshI8c0PYnLoAxo3FMGAI7qKlteC4SkhvRYb6Y4ZcIRqAi5g0We4EK7MkI1xkHdCnOUV8zMQ%3D%3D
2019-06-06,2019,Palvella_Therapeutics,InflaRx N.V. Stock Quote (U.S.: Nasdaq) - IFRX,Financial_Performance,"6, 2019 at 10:04 a.m. ET by Tomi Kilgore. InflaRx stock price target cut ... Palvella Therapeutics Inc. -4.19%, $1.24B. Plandai Biotechnology Inc. -99.00 ...",https://www.marketwatch.com/investing/stock/ifrx?gaa_at=eafs&gaa_n=AWEtsqfps8ZrqoGSb7AZCLG-9yMor4TlgrQ9v3ZkkoSTpMokeN28PiJmdSTy&gaa_ts=6959dc7a&gaa_sig=twAWM_9FAyc8FvDgojO1ZrTicj8Vc_v9sJySIxvCtpryrnb8Xt1fBfs2DX6IA8fuBgtDUcF65AWE2HgmfiiCIQ%3D%3D
2019-06-06,2019,Palvella_Therapeutics,InflaRx N.V. Stock Quote (U.S.: Nasdaq) - IFRX,Financial_Performance,"Palvella Therapeutics Inc. -4.19%, $1.24B. Plandai Biotechnology Inc. -99.00%, $4.49M ...",https://www.marketwatch.com/investing/stock/ifrx?gaa_at=eafs&gaa_n=AWEtsqcPbvBTQARNWHmk0RQRm0YiZwdeFJPwvFoH3crTA8-ONzTSl7x5kvxf&gaa_ts=6959dc7c&gaa_sig=tO-Y0ttXl5QvE_WjUiEIxKWeJ1CgNv0hjJwGmr7ODaTIQac3rRtBRO9XObfevyFfa9UKzETd1UcBTkEWP6XaRg%3D%3D
2020-01-01,2020,Palvella_Therapeutics,"Efficacy and safety of ixekizumab in a phase III, randomized ...",General_Update,"by AS Paller · 2020 · Cited by 140 — Ixekizumab resulted in rapid and statistically significant improvements over placebo in skin involvement, itch and health‐related quality of life, which ...",https://pmc.ncbi.nlm.nih.gov/articles/PMC7496501/
2020-01-15,2020,Palvella_Therapeutics,Team,General_Update,"Aditya Asokan, PhD. Aditya joined Samsara as a Senior Analyst in 2020 and he currently serves on the Board of Palvella Therapeutics and is a Board Observer for ...",https://orsobio.com/team/
2020-01-15,2020,Palvella_Therapeutics,1. Correct fonts won't load until you open this in PowerPoint ...,Clinical_Milestone,"EXPERIMENTAL TREATMENT: PC Project partnered with Palvella Therapeutics on their randomized, placebo-controlled, Phase 2/3 VALO Study of PTX-022. (QTORIN™ ...",https://palvellatx.com/wp-content/uploads/2020/10/PC-Project-PeDRA2020-PC_Demographics_and_Awareness-Poster-1014-final.pdf
2020-01-17,2020,Palvella_Therapeutics,Syros Pharmaceuticals Inc. Stock Quote (U.S.: OTC),Financial_Performance,"Name, Chg %, Market Cap. Palvella Therapeutics Inc. -4.19%, $1.24B. Plandai Biotechnology Inc. -99.00%, $4.49M. Advertisement. Advertisement. Back to Top. Go to ...",https://www.marketwatch.com/investing/stock/syrs?gaa_at=eafs&gaa_n=AWEtsqfwp4R_X1DHUm6Uop4Tn5No3PBd9UNiF86DgMUnx9kdPg_UOo0f_ONU&gaa_ts=6959dc88&gaa_sig=FmgZZQ17vsqMBHVf6_QVnhnVomOWoG6ZR3iRGU7MVw5OV4xK3ojArYcTdmqJ8q-3_eq8I53bWMIjPFmAvcsysA%3D%3D
2020-01-17,2020,Palvella_Therapeutics,Syros Pharmaceuticals Inc. Stock Quote (U.S.: OTC),Financial_Performance,Flagship Pioneering Seeks $500 Million for New Life Sciences Fund.,https://www.marketwatch.com/investing/stock/syrs?gaa_at=eafs&gaa_n=AWEtsqfhDiIg0r-ZzKS8T7wyIxgBcUGa6Ds50qIgHaKLBoKS51gYRovyI1iC&gaa_ts=6959dc8a&gaa_sig=mRUGE_eQTjtcVK1_IXdPTB1E93cD16o4AIPTjxEHqPmc5TDCyiv9fl37WWa04VpjoK1Z00Olhf9DYfKntR2cDQ%3D%3D
2020-02-21,2020,Palvella_Therapeutics,Dovre Group - Lumitöitä ja turskaa - Sivu 8 - Osakkeet,General_Update,"Liittymällä osaksi Dovrea voimme palvella asiakkaitamme entistä paremmin ja kasvattaa toimintaamme kansainvälisesti”, toteaa eSiten johtaja Miko Olkkonen. “Olen ...",https://forum.inderes.com/t/dovre-group-lumitoita-ja-turskaa/3631?page=8
2020-05-28,2020,Palvella_Therapeutics,Palvella Therapeutics raises $45M to advance product ...,General_Update,"The Series C financing round brings five-year-old Palvella Therapeutics Inc.'s total funding to nearly $67 million, according to Pitchbook.",https://www.bizjournals.com/philadelphia/news/2020/05/28/palvella-therapeutics-wayne-rare-genetic-diseases.html
2020-06-05,2020,Palvella_Therapeutics,镁客网每周硬科技领域投融资汇总（5.30-6.5）,General_Update,Palvella Therapeutics. 罕见疾病疗法及药物开发商Palvella Therapeutics完成4500万美元的C轮融资。 Palvella Therapeutics主要从事先天性厚甲症（PC）和戈林综合征 ...,https://picture.iczhiku.com/weixin/message1591425948251.html
2020-07-03,2020,Palvella_Therapeutics,Jessica X.Y. Rothenberg,Corporate_Action,Troutman Pepper Locke Advises Havpak in Sale to Mapaex Health and Personalcare · Palvella Therapeutics Completes Reverse Merger with Pieris Pharmaceuticals and ...,https://www.troutman.com/professionals/jessica-xy-rothenberg/
2020-07-14,2020,Palvella_Therapeutics,Privacy Policy,General_Update,"... Microcystic Lymphatic Malformations. ✕. Skip to main content. Hit enter to ... Last Updated: July 14, 2020. Palvella Therapeutics, Inc. respects your ...",https://palvellatx.com/privacy/
2020-08-24,2020,Palvella_Therapeutics,https://www.alphavantage.co/query?function=LISTING...,Financial_Performance,"... Stock,1999-11-18,null,Active AA,Alcoa Corp,NYSE,Stock,2016-10-18,null,Active AAA,ALTERNATIVE ACCESS FIRST PRIORITY CLO BOND ETF ,NYSE ARCA,ETF,2020 ... Growth ...",https://www.alphavantage.co/query?function=LISTING_STATUS&apikey=demo
2020-10-19,2020,Palvella_Therapeutics,Ethan Rigel Discusses Gore Range's Skin Health Fund ...,Financial_Performance,"Overall, it saw investments in 14 companies, with six successful exits, including a $60 million IPO ... Palvella Therapeutics Awarded Up to $2.6 million Grant ...",https://www.gorerangecapital.com/post/vc-firm-eyes-skin-health-startups-with-new-nine-figure-fund
2020-10-31,2020,Palvella_Therapeutics,Home health visits Telemedicine Patient daily diaries,Clinical_Milestone,"The study sponsor, Palvella Therapeutics, Inc. incorporated into the. VALO Study protocol the use of: 1. Telemedicine. - Clinical assessments including foot ...",https://palvellatx.com/wp-content/uploads/2020/10/PC-Project-PeDRA2020-Bringing_Clinical_Studies_to_the_Home-Poster-1014-final.pdf
2020-12-03,2020,Palvella_Therapeutics,vocab.txt,Financial_Performance,... ipo ##ipul ##järjestöt jollakin FC Yhden paikkaansa itsetun puhumaan Trumpin lentä asiakkaat metr seurannut Hit 1994 Hollan vienti ##eron Kalle ##yksikön ...,https://huggingface.co/TurkuNLP/bert-base-finnish-cased-v1/resolve/main/vocab.txt?download=true
2021-01-01,2021,Palvella_Therapeutics,Impact of novel systemic therapies on the first‐year costs of ...,General_Update,by KC Gogebakan · 2021 · Cited by 12 — The total direct cost of treatment for persons with melanoma older than 65 years increased by $16.03 million (4.93%) from $324.68 million in 2010 to $340.71 ...,https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.33515
2021-01-01,2021,Palvella_Therapeutics,Setipiprant for Androgenetic Alopecia in Males,Financial_Performance,by J DuBois · 2021 · Cited by 15 — Setipiprant 1000 mg BID was safe and well tolerated but did not demonstrate efficacy versus placebo for scalp hair growth in men with AGA.,https://pmc.ncbi.nlm.nih.gov/articles/PMC8526366/
2021-01-01,2021,Palvella_Therapeutics,Atkins et al 1 The State of Melanoma - AACR Journals,Financial_Performance,"by MB Atkins · 2021 · Cited by 113 — Leachman: Advisory Boards: Palvella Therapeutics, DermDetect, Inc., Merck, & ... Adjuvant therapy may alter the kinetics of growth of any residual cells ...",https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-20-4092/2126584/1078-0432_ccr-20-4092v1.pdf
2021-01-01,2021,Palvella_Therapeutics,Genotype‒Structurotype‒Phenotype Correlations in ...,Clinical_Milestone,"by TT Wu · 2021 · Cited by 20 — Understanding the pathologic alterations in keratin structure improves our knowledge of how PC genotype correlates with clinical phenotype, advancing insight ...",https://www.sciencedirect.com/science/article/pii/S0022202X21013154
2021-01-23,2021,Palvella_Therapeutics,The Complete List of Biotech Stocks Trading on NASDAQ,Financial_Performance,"Palvella Therapeutics Inc. PVLA, United States. 535, Pasithea Therapeutics Corp. KTTA, United States. 536, Passage Bio Inc. PASG, United States. 537, PDS ...",https://topforeignstocks.com/stock-lists/the-complete-list-of-biotech-stocks-trading-on-nasdaq/
2021-02-09,2021,Palvella_Therapeutics,Royce Smaller-Companies Growth Fund,Financial_Performance,"Palvella Therapeutics. 1.6. Top 20 as % of Net Assets. 39.3. Show More. Monthly as of 11/30/25. SECTORS, RVPHX (%), RUSSELL 2000 GROWTH (%). Health Care. 22.4.",https://www.royceinvest.com/funds/royce-smaller-companies-growth-fund/rvphx
2021-02-15,2021,Palvella_Therapeutics,Sirolimus in the Treatment of Microcystic Lymphatic ...,General_Update,"Introduction. Lymphatic malformations (LMs) are nonmalignant, congenital, abnormal lymphatic vessels that result in enlarged fluid-filled lymphatic spaces.",https://liebertpub.com/doi/full/10.1089/lrb.2021.0103?doi=10.1089/lrb.2021.0103
2021-02-26,2021,Palvella_Therapeutics,EHOS Stock Price | Ehouse Global Inc. Stock Quote (U.S.,Financial_Performance,"Name, Chg %, Market Cap. Palvella Therapeutics Inc. -4.19%, $1.19B. Plandai Biotechnology Inc. -99.00%, $44.89K. Advertisement. Advertisement. Back to Top. Go ...",https://www.marketwatch.com/investing/stock/ehos?gaa_at=eafs&gaa_n=AWEtsqeIt0lhwQ7O4zW3kuEVdTR1jK1sioQAFl4C3zyYVYOoJEecyQZRVlfy&gaa_ts=6959dc95&gaa_sig=EJoN0B4lqOVgQtEwk6MekVPFRjq0V7I4qDOHDJpdWJzymbgz34oUpOom3M-txrVc30-9MxBBcgq-4LSnTpb-Mg%3D%3D
2021-02-26,2021,Palvella_Therapeutics,EHOS Stock Price | Ehouse Global Inc. Stock Quote (U.S.,Financial_Performance,"Palvella Therapeutics Inc. -4.19%, $1.19B. Plandai Biotechnology Inc. -99.00%, $44.89K ...",https://www.marketwatch.com/investing/stock/ehos?gaa_at=eafs&gaa_n=AWEtsqceYzk71NGdCJdu2R2o39chBOuj5IaYh7MJHT3L3uNINvQ5_g2_mi1P&gaa_ts=6959dc97&gaa_sig=QkhaTQVVLX92ce7yhfmMjrUDKA94WOYrvyVoThbmnC8fRFM-VaGntVK87lh09gwlaRwwn9N0umWV0TNKQ9J3qA%3D%3D
2021-03-09,2021,Palvella_Therapeutics,"Eirion Therapeutics, Inc. Closes $40 Million Series A ...",Clinical_Milestone,Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development.,https://www.gorerangecapital.com/post/eirion-therapeutics-inc-closes-40-million-series-a-investment-and-licensing-deal-with-shanghai-ha
2021-03-09,2021,Palvella_Therapeutics,Portfolio News,Financial_Performance,"Palvella Therapeutics Awarded Up to $2.6 million Grant. Apr 17, 2024. Avive Solutions Raises $56.5M. Avive Solutions Raises $56.5M in Growth Funding To Build ...",https://www.gorerangecapital.com/newsandperspectives/categories/portfolio-news
2021-04-14,2021,Palvella_Therapeutics,VFSIX Vanguard Short-Term Investment-Grade Fund ...,Financial_Performance,"Palvella Therapeutics, Inc. -4.39%. QQDN. $25.84. ProShares UltraShort QQQ Mega ETF. +0.32%. SPAVE:IND. $186.71. S&P Aave Reference Price Index (USD). +14.66%.",https://seekingalpha.com/symbol/VFSIX
2021-04-15,2021,Palvella_Therapeutics,PC News Brief,Clinical_Milestone,"Wes Kaupinen, CEO of Palvella and Braham Shroot, CSO of Palvella, joined the meeting to present data about the VALO clinical trial to the MSAB.",https://www.pachyonychia.org/wp-content/uploads/2021/04/2021PCNewsBriefWEB.pdf
2021-04-16,2021,Palvella_Therapeutics,"Inderes Oyj - ""Yhtiö kuuluu kaikille"" - Osakkeet",Financial_Performance,näppituntumalla yhtiön ipo 15 milj € arvoinen. Taaleri Oyj -ketju Osakkeet. Tätä parin viikon takaista ei kukaan mehustellutkaan Taaleri-ketjussa. [ ...,https://forum.inderes.com/t/inderes-oyj-yhtio-kuuluu-kaikille/17104?tl=en
2021-05-27,2021,Palvella_Therapeutics,查看可卖空股票,General_Update,您的损失可能会大于您的初始投资。有关保证金借贷利率的详细信息，请参见保证金贷款利率页面。证券期货具有高风险，并非适合所有投资者。您的损失可能会大于您的初始投资。,https://www.interactivebrokers.com.au/cn/index.php?f=46982&cntry=usa&tag=United%20States&ib_entity=hk&ln=&asset=&b=PTR&e=QCC
2021-06-10,2021,Palvella_Therapeutics,Puuilo Oyj Noin 30 miljoonan euron Osakeanti Alustavasti ...,General_Update,"Yhtiö tulee jättämään listalleottohakemuksen Helsingin Pörssille koskien Osakkeiden listaamista Helsingin Pörssin pörssilistalle kaupankäyntitunnuksella ""PUUILO ...",https://magdoc.s3.eu-north-1.amazonaws.com/data/SECURED+-+Puuilo+Oyj+-+Listalleottoesite+-+10.6.2021.pdf
2021-06-10,2021,Palvella_Therapeutics,"Adicet Bio (ACET) Stock Forecast, Price Targets and ...",Financial_Performance,"In the current month, ACET has received 10 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ACET average Analyst price target in the past 3 months is 7.00.",https://www.tipranks.com/stocks/acet/forecast
2021-08-30,2021,Palvella_Therapeutics,Global Startups - Funding & Investors Data [2020 Updated],General_Update,Find the 2021 updated list of Startup Funding News Globally. Get the recently top-funded and seed-funded startups and the investors' data.,https://startuptalky.com/global-startups-funding-investors-data-2020/
2021-09-24,2021,Palvella_Therapeutics,Implementointiopas,General_Update,Opas tarjoaa tukea psykososiaalisten menetelmien implementointiin eli suunnitelmalliseen käyttöönottoon lasten ja nuorten palveluissa.,https://itla.fi/implementointiopas/
2021-10-14,2021,Palvella_Therapeutics,Amunix Presents Preclinical Data on Its XPAT T Cell ...,Clinical_Milestone,Amunix expects to file a CTA for AMX-818 by the end of 2021. “These data show the promise of our Pro-XTEN protease-cleavable masking technology and showcase ...,https://trialstat.com/2021/10/amunix-presents-preclinical-data-on-its-xpat-t-cell-engager-platform-at-the-aacr-nci-eortc-conference-on-molecular-targets-and-cancer-therapeutics/
2021-10-26,2021,Palvella_Therapeutics,Christopher S. Miller,Financial_Performance,"The combined company operates under the name Palvella Therapeutics, Inc. and its shares trade on the Nasdaq Capital Market.",https://www.troutman.com/professionals/christopher-s-miller/
2022-01-01,2022,Palvella_Therapeutics,Annual prevalence estimation of lymphatic malformation ...,General_Update,"by JR Gallagher · 2022 · Cited by 10 — Palvella Therapeutics Inc., Our survey results indicated the estimated number of unique annually managed LMC patients by target specialists is 79,920 (CI 66, ...",https://pubmed.ncbi.nlm.nih.gov/35550604/
2022-01-01,2022,Palvella_Therapeutics,Drug Repurposing Reveals mTOR Inhibition as a ...,Clinical_Milestone,"by H Ragot · 2022 · Cited by 3 — The phase 2/3 clinical trial (VALO) by Palvella Therapeutics, which uses QTORIN 3.9% rapamycin gel, achieved statistically significant improvement in the phase ...",https://www.sciencedirect.com/science/article/pii/S0022202X21025215
2022-01-01,2022,Palvella_Therapeutics,Multispecialty Approach to a Very Large Congenital Head ...,Clinical_Milestone,"by G Sibrecht · 2022 · Cited by 4 — The topical use of sirolimus has also been studied in randomized controlled trials in older children to treat microcystic lymphatic malformations [21,22].",https://www.mdpi.com/2227-9059/10/10/2422
2022-02-07,2022,Palvella_Therapeutics,Team,Clinical_Milestone,"now merged with NASDAQ-listed Palvella Therapeutics, to lead IND-enabling studies and clinical trials planning $250 million in 2022).",https://www.asgardthx.com/team/
2022-02-17,2022,Palvella_Therapeutics,Jakautumissuunnitelma,General_Update,Jakautumisen täytäntöönpanon rekisteröintipäivän (Täytäntöönpanopäivä) suunnitellaan olevan Jakautumissuunnitelman kohdan 18 mukaisesti arviolta. 30.6.2022.,https://investors.f-secure.com/files/documents/F-Secure%20Oyj%20-%20Jakautumissuunnitelma%20liitteineen.pdf
2022-03-02,2022,Palvella_Therapeutics,ADAG Stock Price | Adagene Inc. ADR Stock Quote (U.S.,Financial_Performance,Sanofi to pay up to $2.5 billion in deal with Adagene. Shares of Adagene Inc. jumped 11.2% in premarket trading on Wednesday after it announced a licensing ...,https://www.marketwatch.com/investing/stock/adag?gaa_at=eafs&gaa_n=AWEtsqdfR2_r5WuiixDkziGfaKLmHuHjq1XZmQ6tpDNmLtxG1_DVaiHLM4T4&gaa_ts=6959dca5&gaa_sig=C3nPuy_9OnMXqBAzFNNvyb7pvzmHODBh8NQAZeQ5p2YeKVvTKjk18KzzMkURam00wYzIMpPnKroThDQDqSsFZg%3D%3D
2022-03-04,2022,Palvella_Therapeutics,"TYRA Stock | Tyra Bioscience Price, Quote, News & Analysis",Financial_Performance,"Track TYRA Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. Get Tyra Bioscience news, earnings, ...",https://www.tipranks.com/stocks/tyra
2022-03-22,2022,Palvella_Therapeutics,Voyager Therapeutics Inc. Stock Quote (U.S. - VYGR,Financial_Performance,Voyager Therapeutics shares soar 32% on news of deal with Novartis that includes up to $1.2 billion in milestone payments.,https://www.marketwatch.com/investing/stock/vygr?gaa_at=eafs&gaa_n=AWEtsqcKBDX4-C1EZFUA8t3Mulf0EaVscUD7DYKWOjZBJgbglx3YbN7DJZsk&gaa_ts=6959dca3&gaa_sig=SMkn8XLjrRdzke_QdRZDPFdodqhQmLyQByO7fVIxL4jf2-gnVb_gjE3iiov-H9rcipirV66ZbY4dB0AUjaSoyQ%3D%3D
2022-03-22,2022,Palvella_Therapeutics,Voyager Therapeutics Inc. Stock Quote (U.S. - VYGR,Financial_Performance,Voyager Therapeutics shares soar 32% on news of deal with Novartis that includes up to $1.2 billion in milestone payments.,https://www.marketwatch.com/investing/stock/vygr?gaa_at=eafs&gaa_n=AWEtsqeB4-R9181PUjWLJLUsAWnzFCI5pmnSiC1LdtQJpjDKyQhrrHeJvYOH&gaa_ts=6959dca5&gaa_sig=_CeRscMqhDXMMDWnHdZnhESxqgLCncBcFPw3L6MjF9fqhFnCWLI7SbmZ1Ft9-3WKLS4r3VBSpG3raewJIHec7g%3D%3D
2022-04-11,2022,Palvella_Therapeutics,Bridging the gap between innovation and later-stage ...,Corporate_Action,e Palvella Therapeutics Raises USD9.7 Million in Venture late-stage biotech venture deals in the USA extracted from GlobalData for 2022.,https://media.nature.com/original/magazine-assets/d41573-023-00074-0/25975132
2022-06-01,2022,Palvella_Therapeutics,Institutional Investors - Alger Life Sciences Innovation,Financial_Performance,"Sales Growth (Next 12 Months) -3.60% 12.69% EPS Growth (3-5 YR) Palvella Therapeutics, Inc. 4.95% 0.00% Palvella Therapeutics, Inc. Growth stocks may be more ...",https://www.alger.com/pages/Products.aspx?productCode=LfScInnRep
2022-06-13,2022,Palvella_Therapeutics,"Tiziana Life Sciences Ltd (TLSA) stock price, news, quote ...",Financial_Performance,"Find the latest Tiziana Life Sciences Ltd (TLSA) Volume 314,679 Market cap (intra-day) Palvella Therapeutics, Inc. 100.38 -4.10% Mkt cap 1.188B",https://sg.finance.yahoo.com/quote/TLSA/
2022-06-23,2022,Palvella_Therapeutics,NEXT 15 GROUP PLC | F-6EF：自動有效登記聲明,General_Update,在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者 ...,https://www.moomoo.com/hant/news/notice/304593992/next-15-group-plc-f-6ef-auto-effective-registration-statement
2022-06-27,2022,Palvella_Therapeutics,"PTX-022 Palvella Therapeutics, Inc. Protocol PALV-06 ...",General_Update,"TREATMENT OF MICROCYSTIC LYMPHATIC MALFORMATIONS. Protocol Number: PALV-06. Compound Number PTX-022. Sponsor Name: Palvella Therapeutics, Inc. Legal Registered ...",https://cdn.clinicaltrials.gov/large-docs/49/NCT05050149/Prot_SAP_000.pdf
2022-07-28,2022,Palvella_Therapeutics,"Federated Hermes, Inc. Portfolio Holdings",General_Update,"Federated Hermes, Inc. has disclosed 2,113 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 56,636,803,707 USD.",https://fintel.io/i/federated-investors-inc-pa-
2022-09-27,2022,Palvella_Therapeutics,Palvella Therapeutics: Homepage,General_Update,Palvella Therapeutics is a biotechnology company specializing in developing and commercializing medicines for patients with rare dermatological diseases.,https://palvellatx.com/
2022-10-10,2022,Palvella_Therapeutics,Fund Skybox Security stock options,Financial_Performance,Skybox Security has raised a total of $284.8 million over 11 funding rounds; the company's latest funding was a $150 million private equity round raised in ...,https://equitybee.com/companies/company?company=skybox%20security
2022-11-18,2022,Palvella_Therapeutics,Koskisen Oyj - Listalleottoesite 18.11.2022,Financial_Performance,"Tämän Listalleottoesitteen voimassaolo päättyy, kun Tarjottavat osakkeet on otettu kaupankäynnin kohteeksi Nasdaq Helsingin pörssilistalla. Kaupankäynnin ...",https://koskisen.fi/wp-content/uploads/2022/11/Koskisen-Oyj-Listalleottoesite-18.11.2022.pdf
2022-11-29,2022,Palvella_Therapeutics,Board of Directors | Lifecore Biomedical,Financial_Performance,"Palvella Therapeutics, Inc.'s (Nasdaq: PVLA) Chief Financial Officer since October 2024.",https://ir.lifecore.com/corporate-governance/board-of-directors
2022-12-09,2022,Palvella_Therapeutics,NCT05643872 | A Study Evaluating the Safety and ...,Clinical_Milestone,A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita. ClinicalTrials ...,https://www.clinicaltrials.gov/study/NCT05643872
2022-12-12,2022,Palvella_Therapeutics,Adicet Bio Inc. Stock Quote (U.S.: Nasdaq) - ACET,Clinical_Milestone,"Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It ...",https://www.marketwatch.com/investing/stock/acet?gaa_at=eafs&gaa_n=AWEtsqfhFWDjiWY5R3VsYmu9ezVFTcAFCNwue2LZCZlWGm9SFQs3kkmqBH-C&gaa_ts=6959dca5&gaa_sig=Q-smJkNqxRXQeRrWWZnRkFy2jQUUfwB3PcryNgXrdoYKclWygIl_bFIdbI8Xp8vn4D0bE27YVK6Y48AoM2ul3A%3D%3D
2023-01-05,2023,Palvella_Therapeutics,Palvella Therapeutics Announces Series D Financing ...,General_Update,Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late Stage Development and Support Commercialization of Novel Therapies ...,https://palvellatx.com/2023/01/05/palvella-therapeutics-announces-series-d-financing-of-up-to-37-7-million/
2023-01-05,2023,Palvella_Therapeutics,Palvella Therapeutics Announces Series D Financing ...,General_Update,Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support Commercialization of Novel Therapies ...,https://finance.yahoo.com/news/palvella-therapeutics-announces-series-d-213000244.html
2023-01-05,2023,Palvella_Therapeutics,Palvella Therapeutics raises $9.7M to advance drug ...,Financial_Performance,"The private stock sale, which could raise up to $37.7 million when complete, was disclosed in documents Palvella Therapeutics filed with the Securities and ...",https://www.bizjournals.com/philadelphia/news/2023/01/05/palvella-therapeutics-wayne-rare-genetic-diseases.html
2023-01-31,2023,Palvella_Therapeutics,Calithera Biosciences Inc. Stock Quote (U.S. - CALA,Financial_Performance,CALA | Complete Calithera Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.,https://www.marketwatch.com/investing/stock/cala?gaa_at=eafs&gaa_n=AWEtsqedfOX89kf6ivhbOV3Pf_Q4UZxjLRB625MR98FYG92EURglbw-e4v5g&gaa_ts=6959dcb2&gaa_sig=nXHdg5I4-3O2qa69P231yh2CvoOimcwaHByP8vNiyVclgcr5IBpfzSwZs18S_CZPqkcqqx2YV6wYMFE8yh3ANw%3D%3D
2023-02-21,2023,Palvella_Therapeutics,Press Release on the Development of QTORIN Rapamycin ...,Clinical_Milestone,"Founded and led by rare disease veterans, Palvella Therapeutics is a late clinical-stage biopharmaceutical company whose vision is to become the leading rare ...",https://www.pachyonychia.org/press-release-on-the-development-of-qtorin-rapamycin-for-pachyonychia-congenita/
2023-03-09,2023,Palvella_Therapeutics,Palvella Therapeutics Announces Positive Topline Results ...,Clinical_Milestone,"Pending additional interactions with FDA, Palvella anticipates potentially initiating a pivotal Phase 3 study of QTORIN™ rapamycin in the second half of 2023.",https://palvellatx.com/2023/03/09/palvella-therapeutics-announces-positive-topline-results-from-phase-2-study-for-the-treatment-of-microcystic-lymphatic-malformations/
2023-03-13,2023,Palvella_Therapeutics,QTORIN Rapamycin Gets Positive Topline Results for Rare ...,Clinical_Milestone,"QTORIN 3.9% anhydrous rapamycin gel (QTORIN rapamycin) produced positive results in treating microcystic lymphatic malformations (microcystic LMs), according ...",https://www.dermatologytimes.com/view/qtorin-rapamycin-gets-positive-topline-results-for-rare-skin-disease-treatment
2023-06-06,2023,Palvella_Therapeutics,Hyödynnä uusi tutkimus- ja kehittämistoiminnan ...,General_Update,Vuoden 2023 alussa voimaan tullut tutkimus- ja kehittämistoiminnan yhdistelmävähennys verotuksessa on uusi yrityksille suunnattu yleinen verotuki.,https://www.ey.com/fi_fi/insights/tax/hyodynna-uusi-tutkimus-ja-kehittamistoiminnan-yhdistelmavahennys
2023-06-15,2023,Palvella_Therapeutics,LAKIMIES 2/2023,General_Update,"Oikeuden mahdollisuudet maailmassa vaikuttavat tällä hetkellä liian rajallisilta, mutta samalla oikeus ja sen tavoittelu luovat toivoa paremmasta huomisesta.",https://journal.fi/lakimies/issue/download/8930/1819
2023-07-20,2023,Palvella_Therapeutics,Palvella Therapeutics Reports Topline Results from Pivotal ...,Clinical_Milestone,"We are developing a broad pipeline of product candidates based on our patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, ...",https://palvellatx.com/2023/07/20/palvella-therapeutics-reports-topline-results-from-pivotal-phase-3-vapaus-study-of-qtorin-rapamycin-pachyonychia-congenita/
2023-07-20,2023,Palvella_Therapeutics,Palvella Therapeutics Announces Planned Pivotal Phase 3 ...,Clinical_Milestone,"We are developing a broad pipeline of product candidates based on our patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, ...",https://palvellatx.com/2023/07/20/palvella-therapeutics-announces-planned-pivotal-phase-3-study-design-of-qtorin-rapamycin-microcystic-lymphatic-malformations/
2023-07-20,2023,Palvella_Therapeutics,Investigational Topical Rapamycin Misses in Pachyonychia ...,Clinical_Milestone,"Publish Date July 20, 2023. Topline results were announced from the phase 3 VAPAUS study evaluating the investigational QTORIN™ 3.9% rapamycin anhydrous gel ...",https://www.empr.com/home/news/drugs-in-the-pipeline/investigational-topical-rapamycin-misses-in-pachyonychia-congenita-trial/
2023-11-14,2023,Palvella_Therapeutics,Concord Biotech - Not-so-Hidden Gems - ValuePickr Forum,General_Update,Financial impact: Revenue down 20% in Q2 and 14% in H1 YoY. PAT down 34% in Q2 and 31% in H1 YoY. EBITDA ...,https://forum.valuepickr.com/t/concord-biotech/123381
2023-11-16,2023,Palvella_Therapeutics,Palvella Therapeutics Announces U.S. FDA Breakthrough ...,Clinical_Milestone,"Based on the positive Phase 2 results and a productive end-of-Phase 2 meeting with FDA, Palvella previously announced plans to conduct a pivotal Phase 3 study ...",https://palvellatx.com/2023/11/16/fda-breakthrough-therapy-designation-qtorin-rapamycin-microcystic-lymphatic-malformations/
2023-11-16,2023,Palvella_Therapeutics,FDA Grants Breakthrough Therapy Designation to QTORIN ...,Clinical_Milestone,The US Food and Drug Administration (FDA) has granted Palvella Therapeutics' 3.9% rapamycin anhydrous gel (QTORIN rapamycin) a Breakthrough Therapy Designation.,https://www.dermatologytimes.com/view/fda-grants-breakthrough-therapy-designation-to-qtorin-rapamycin-for-microcystic-lymphatic-malformations
2023-12-01,2023,Palvella_Therapeutics,Palvella Therapeutics and Ligand Pharmaceuticals ...,Clinical_Milestone,"Palvella Therapeutics, Inc. today announced the expansion of their strategic partnership to accelerate Phase 3 development of QTORIN™ rapamycin for the ...",https://www.biospace.com/palvella-therapeutics-and-ligand-pharmaceuticals-expand-strategic-partnership-to-accelerate-phase-3-development-of-qtorin-rapamycin-for-microcystic-lymphatic-malformations-and-additional-high-unmet-need-clinical-indications
2023-12-04,2023,Palvella_Therapeutics,Palvella and Ligand Expand Strategic Partnership,Clinical_Milestone,"December 4, 2023​​ Palvella Therapeutics said it has expanded its strategic partnership with Ligand Pharmaceuticals to accelerate phase 3 development of Qtorin ...",https://globalgenes.org/raredaily/palvella-and-ligand-expand-strategic-partnership/
2023-12-04,2023,Palvella_Therapeutics,Palvella and Ligand partner for Phase III rare lymphatic ...,Clinical_Milestone,"Palvella will receive $5m as an upfront payment, with Ligand getting 8%-9.8% in tiered royalties on worldwide sales of Qtorin rapamycin.",https://www.clinicaltrialsarena.com/news/palvella-and-ligand-partner-for-phase-iii-rare-lymphatic-tumour-trial/
2024-01-01,2024,Palvella_Therapeutics,Phase 2 study of the safety and efficacy of QTORIN...,Clinical_Milestone,by J Treat · 2024 · Cited by 1 — QTORIN rapamycin was generally safe and well-tolerated with very low detectable systemic exposure throughout the 12-week treatment period.,https://journals.lww.com/jova/fulltext/2024/12000/phase_2_study_of_the_safety_and_efficacy_of_qtorin.8.aspx
2024-01-01,2024,Palvella_Therapeutics,Lymphatic malformations: mechanistic insights and ...,Financial_Performance,"by M Petkova · 2024 · Cited by 26 — We discuss lymphatic malformations (LMs), which are localized lesions that manifest as fluid-filled cysts or extensive infiltrative lymphatic vessel overgrowth.",https://www.jci.org/articles/view/172844
2024-01-29,2024,Palvella_Therapeutics,Update on Drugs & Devices: January - February 2024,General_Update,The primary efficacy endpoint was Investigator Global Assessment (IGA) success (IGA of clear or almost clear + a ≥2-grade improvement from baseline) at week 8.,https://www.skintherapyletter.com/drug-updates/jan-feb-2024/
2024-07-24,2024,Palvella_Therapeutics,Palvella Therapeutics and Pieris Pharmaceuticals ...,Clinical_Milestone,"Proposed merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments.",https://palvellatx.com/2024/07/24/palvella-therapeutics-and-pieris-pharmaceuticals-announce-definitive-merger-agreement/
2024-09-01,2024,Palvella_Therapeutics,Clinical Studies,Clinical_Milestone,Microcystic Lymphatic Malformations: Phase 3 Study. Baseline-Controlled Study Evaluating Safety and Efficacy of QTORIN ... Estimated Study Dates: July 2024-Q1 ...,https://palvellatx.com/clinical-studies/
2024-09-10,2024,Palvella_Therapeutics,Palvella Therapeutics (PVLA) Income Statement & Earnings,General_Update,"Provides income statements of Palvella Therapeutics (PVLA), including historical and latest financial data and analysis. You can search by quarterly report, ...",https://www.moomoo.com/stock/PVLA-US/financials-income-statement
2024-10-01,2024,Palvella_Therapeutics,Orphan Products Grants Awarded,Clinical_Milestone,"Palvella Therapeutics, Inc. (Wayne, Pennsylvania), Jeff Martini, Phase 3 study of PTX-022 (Sirolimus) for the treatment of microcystic lymphatic malformations ...",https://www.fda.gov/industry/orphan-products-grants-program/orphan-products-grants-awarded
2024-10-03,2024,Palvella_Therapeutics,Palvella Therapeutics Awarded Up to $2.6 million Grant ...,Clinical_Milestone,The US Food and Drug Administration (FDA) Office of Orphan Products Development has awarded the company a grant of up to $2.6 million to support the ongoing ...,https://palvellatx.com/2024/10/03/palvella-therapeutics-awarded-up-to-2-6-million-grant/
2024-10-04,2024,Palvella_Therapeutics,Palvella secures FDA grant for microcystic LMs treatment trial,Clinical_Milestone,Palvella has received an FDA grant to support the Phase III SELVA trial of QTORIN 3.9% rapamycin anhydrous gel for microcystic LMs.,https://www.clinicaltrialsarena.com/news/palvella-microcystic-lms-trial/
2024-11-11,2024,Palvella_Therapeutics,Investors,General_Update,"Maximizing opportunities to serve. Find press releases, upcoming events, and sign up for email alerts to stay informed on the latest news and updates.",https://palvellatx.com/investors/
2024-12-12,2024,Palvella_Therapeutics,Pieris Pharmaceuticals Announces Merger and Share ...,Corporate_Action,"... 2024 Equity Incentive Plan. Additionally, the company finalized plans for a merger with Palvella Therapeutics, which will result in a name change to Palvella ...",https://www.nasdaq.com/articles/pieris-pharmaceuticals-announces-merger-and-share-increase
2024-12-12,2024,Palvella_Therapeutics,Concord Biotech's Investment in Palvella Therapeutics,General_Update,"Concord Biotech invests $1M in Palvella Therapeutics for rare genetic skin disease treatments, strengthening biopharma collaborations.",https://www.angelone.in/news/share-market/concord-biotech-investment-in-palvella-therapeutics-share-price-in-focus
2024-12-13,2024,Palvella_Therapeutics,Palvella Therapeutics Announces Closing of Merger with ...,Corporate_Action,"Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million - Fri, 12/13/2024 - 14:55.",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-announces-closing-merger-pieris
2024-12-13,2024,Palvella_Therapeutics,pirs20241210_8k.htm,Financial_Performance,"On December 12, 2024, the Company implemented an increase in the number of authorized shares of the Company's common stock from 3,750,000 to 200,000,000 (the “ ...",https://www.sec.gov/Archives/edgar/data/1583648/000143774924037515/pirs20241210_8k.htm
2024-12-13,2024,Palvella_Therapeutics,Palvella Therapeutics 2025 Company Profile,Financial_Performance,Its current market cap is $861M with 11.8M shares. (As of Friday Closing). Stock Price $77.83. Previous Close $78.63.,https://pitchbook.com/profiles/company/184764-61
2024-12-13,2024,Palvella_Therapeutics,Palvella Therapeutics Announces Closing of Merger with ...,Corporate_Action,Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million. Palvella Therapeutics Inc.,https://finance.yahoo.com/news/palvella-therapeutics-announces-closing-merger-195500710.html
2024-12-13,2024,Palvella_Therapeutics,Palvella Therapeutics Announces Closing of Merger with,Corporate_Action,Palvella Therapeutics announces closing of merger with Pieris Pharmaceuticals and concurrent private placement of $78.9 million.,https://www.globenewswire.com/news-release/2024/12/13/2997010/0/en/Palvella-Therapeutics-Announces-Closing-of-Merger-with-Pieris-Pharmaceuticals-and-Concurrent-Private-Placement-of-78-9-Million.html
2024-12-13,2024,Palvella_Therapeutics,Equity Corporate Actions Alert #2024 - 610 (UPDATED,General_Update,"(UPDATED: Closed) Information Regarding the Business Combination and Change of Control of Pieris Pharmaceuticals, Inc. (PIRS) & Palvella Therapeutics, Inc.",https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2024-610
2024-12-16,2024,Palvella_Therapeutics,Palvella Therapeutics (PVLA) Market Cap & Net Worth,Financial_Performance,"Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.24B, an increase of 760.55%. That is a compound annual growth ...",https://stockanalysis.com/stocks/pvla/market-cap/
2024-12-16,2024,Palvella_Therapeutics,Palvella Therapeutics Announces Closing of Merger With ...,Clinical_Milestone,"In the third quarter of 2024, Palvella initiated SELVA, a 24-week, Phase 3, single-arm, baseline-controlled clinical trial of QTORIN rapamycin",https://drug-dev.com/palvella-therapeutics-announces-closing-of-merger-with-pieris-pharmaceuticals-concurrent-private-placement-of-78-9-million/
2024-12-17,2024,Palvella_Therapeutics,Palvella Therapeutics Completes Reverse Merger with ...,Clinical_Milestone,"Palvella's lead product candidate, QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently in the Phase 3 SELVA clinical trial in microcystic ...",https://www.troutman.com/experience/palvella-therapeutics-completes-reverse-merger-with-pieris-pharmaceuticals-and-concurrent-private-placement/
2024-12-20,2024,Palvella_Therapeutics,Palvella Therapeutics Inc (PVLA),Financial_Performance,"See the latest Palvella Therapeutics Inc stock price (PVLA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.",https://www.morningstar.com/stocks/xnas/pvla/quote
2024-12-31,2024,Palvella_Therapeutics,2024 TECHNOLOGY AND LIFE SCIENCES PIPE AND ...,General_Update,This report examines PIPEs and RDOs by operating companies and sets forth quantitative and qualitative results concerning proceeds and security types; ...,https://www.wsgr.com/a/web/wS8TDWKeqJqncQJEQzqbWd/ye24-technology-and-life-sciences-pipe-rdo-report.pdf
2025-01-01,2025,Palvella_Therapeutics,"Why Palvella Therapeutics, Inc.'s (PVLA) Stock Is Up 6.13%",Financial_Performance,"As of December 31, 2025, Palvella Therapeutics, Inc.'s stock price is $104.910, which is up 5.04% from its previous closing price. AAII advises against making ...",https://www.aaii.com/investingideas/article/395158-why-palvella-therapeutics-inc8217s-pvla-stock-is-up-613
2025-01-10,2025,Palvella_Therapeutics,Release Details,Clinical_Milestone,"""The Phase 2 results highlight QTORIN™ rapamycin's potential to be the first targeted therapy for children and adults living with microcystic lymphatic ...",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-announces-publication-results-phase-2
2025-02-10,2025,Palvella_Therapeutics,Palvella Therapeutics to Expand Phase 3 SELVA Clinical ...,Clinical_Milestone,"Palvella is currently enrolling approximately 40 patients in SELVA, a 24-week, Phase 3, single-arm, baseline-controlled trial of QTORIN™ rapamycin for the ...",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-expand-phase-3-selva-clinical-trial
2025-04-11,2025,Palvella_Therapeutics,Palvella Therapeutics' QTORIN Rapamycin 3.9% ...,Clinical_Milestone,"QTORIN rapamycin 3.9% anhydrous gel is showing promise in the treatment of microcystic lymphatic malformations, according to a presentation.",https://thedermdigest.com/palvella-therapeutics-qtorin-rapamycin-3-9-anhydrous-gel-shows-promise-for-microcystic-lms/
2025-04-22,2025,Palvella_Therapeutics,Palvella Secures New US Patent for Qtorin Rapamycin in ...,Clinical_Milestone,"Palvella has secured its 5th US patent for Qtorin rapamycin, extending intellectual property coverage to 2038 and advancing treatment for microcystic lymphatic ...",https://www.dermatologytimes.com/view/palvella-secures-new-us-patent-for-qtorin-rapamycin-in-microcystic-lymphatic-malformations
2025-04-23,2025,Palvella_Therapeutics,Release Details,General_Update,Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted ...,https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-announces-abstract-highlighting-estimated
2025-04-30,2025,Palvella_Therapeutics,"Why Palvella Therapeutics, Inc. (PVLA) is Surging in 2025",Clinical_Milestone,"The stock is up significantly so far in 2025 due to the February 2025 announcement that Palvella Therapeutics, Inc. (NASDAQ:PVLA) expanded its Phase 3 SELVA ...",https://finance.yahoo.com/news/why-palvella-therapeutics-inc-pvla-094458871.html
2025-05-12,2025,Palvella_Therapeutics,Palvella Therapeutics to Ring the Nasdaq Opening Bell on ...,Financial_Performance,"The Company will ring the opening bell at the Nasdaq Stock Market (Nasdaq) on Monday, May 12, 2025 in New York City.",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-ring-nasdaq-opening-bell-may-12-2025
2025-05-15,2025,Palvella_Therapeutics,Palvella Therapeutics Reports First Quarter 2025 Financial ...,Financial_Performance,"Shares outstanding were 13,697,114 as of March 31, 2025, including 11,021,389 shares of common stock and 2,675,725 common share equivalents assuming conversion ...",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-reports-first-quarter-2025-financial
2025-06-09,2025,Palvella_Therapeutics,Palvella Therapeutics Receives Initial Proceeds from FDA ...,Clinical_Milestone,Palvella Therapeutics Receives Initial Proceeds from FDA Orphan Products Grant to Support Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic ...,https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-receives-initial-proceeds-fda-orphan
2025-06-20,2025,Palvella_Therapeutics,Palvella Therapeutics (PVLA) Stock Forecast & Price Targets,Financial_Performance,"The 16 analysts that cover Palvella Therapeutics stock have a consensus rating of ""Strong Buy"" and an average price target of $141.5, which forecasts a 35.19% ...",https://stockanalysis.com/stocks/pvla/forecast/
2025-06-23,2025,Palvella_Therapeutics,Palvella Therapeutics Completes Enrollment in Phase 3 ...,Clinical_Milestone,"... Phase 3 trial of QTORIN™ rapamycin. Top-line results from SELVA are expected in the first quarter of 2026, with a New Drug Application submission planned ...",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-completes-enrollment-phase-3-selva-trial
2025-08-14,2025,Palvella_Therapeutics,Palvella Therapeutics Reports Second Quarter 2025 ...,Financial_Performance,"Palvella Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update ; Net loss attributable to common stockholders, $, (9,471, ) ...",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-reports-second-quarter-2025-financial
2025-08-14,2025,Palvella_Therapeutics,Palvella Therapeutics Reports Second Quarter 2025 ...,Clinical_Milestone,"“We remain on track for two near-term data readouts for QTORIN™ rapamycin, including our Phase 3 SELVA study in microcystic LMs which we believe will ...",https://ir.palvellatx.com/node/10841/pdf
2025-08-14,2025,Palvella_Therapeutics,Palvella Therapeutics Reports Second Quarter 2025 ...,Financial_Performance,"With strong momentum and a solid financial foundation, Palvella is well-positioned for continued growth and execution on our vision.”",https://finance.yahoo.com/news/palvella-therapeutics-reports-second-quarter-113000138.html
2025-09-17,2025,Palvella_Therapeutics,Release Details,Clinical_Milestone,"... 2025. ""This publication highlights the ... microcystic lymphatic malformations and the Phase 2 TOIVA clinical trial in cutaneous venous malformations.",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-announces-scientific-publication-lymphatic
2025-09-24,2025,Palvella_Therapeutics,Release Details,Clinical_Milestone,Angiokeratomas were recently classified as an isolated lymphatic malformation in 2025 by the International Society for the Study of Vascular Anomalies (ISSVA).,https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-announces-expansion-qtorintm-rapamycins
2025-10-13,2025,Palvella_Therapeutics,Palvella Therapeutics Secures Second Year of FDA ...,Clinical_Milestone,"Palvella Therapeutics secures $2.6 million grant for Phase 3 SELVA trial, with top-line results expected in early 2026.",https://www.moomoo.com/news/post/59653064/palvella-therapeutics-secures-second-year-of-fda-funding-for-phase
2025-10-13,2025,Palvella_Therapeutics,Palvella Receives Second Year of FDA Grant Funding for ...,Clinical_Milestone,Palvella Therapeutics (PVLA) said Monday it has received the second year of funding under its US Food and Drug Administration Office of Orphan Products ...,https://www.moomoo.com/news/post/59633853/palvella-receives-second-year-of-fda-grant-funding-for-phase
2025-11-04,2025,Palvella_Therapeutics,Palvella Therapeutics to Host Third Quarter 2025 Financial ...,General_Update,"Palvella Therapeutics to Host Third Quarter 2025 Financial Results and Corporate Update Conference Call on November 11, 2025 - Tue, 11/04/2025 - 07:30.",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-host-third-quarter-2025-financial-results
2025-11-05,2025,Palvella_Therapeutics,Palvella Therapeutics Announces New QTORIN™ Product ...,Clinical_Milestone,Palvella plans to meet with the FDA in the first half of 2026 to discuss the proposed design of a Phase 2 clinical trial evaluating QTORIN™ pitavastatin in ...,https://www.fidelity.com/news/article/default/202511050600PRIMZONEFULLFEED9568972
2025-11-11,2025,Palvella_Therapeutics,Palvella Therapeutics Reports Third Quarter 2025 ...,Financial_Performance,"Shares outstanding were 13,768,036 as of November 7, 2025, including 11,836,490 shares of common stock and 1,931,546 common share equivalents assuming ...",https://ir.palvellatx.com/news-releases/news-release-details/palvella-therapeutics-reports-third-quarter-2025-financial
2025-11-11,2025,Palvella_Therapeutics,Palvella Therapeutics Reports Third Quarter 2025 ...,General_Update,Palvella will host a conference call and live audiovisual webcast to discuss the Company's third quarter 2025 financial results and provide a corporate update ...,https://finance.yahoo.com/news/palvella-therapeutics-reports-third-quarter-123000878.html
2025-11-11,2025,Palvella_Therapeutics,Palvella Therapeutics Q3 2025 slides: Pipeline expansion ...,General_Update,"The company reported a solid financial position with $63.6 million in cash as of September 30, 2025, following quarterly R&D and G&A expenditures of $10.2 ...",https://www.investing.com/news/company-news/palvella-therapeutics-q3-2025-slides-pipeline-expansion-and-strong-cash-position-93CH-4349437
2025-12-06,2025,Palvella_Therapeutics,Palvella Therapeutics (PVLA) Price Target Increased by ...,General_Update,"This is an increase of 15.61% from the prior estimate of $115.65 dated November 14, 2025. The price target is an average of many targets provided by analysts.",https://www.nasdaq.com/articles/palvella-therapeutics-pvla-price-target-increased-1561-13370
2025-12-14,2025,Palvella_Therapeutics,Frazier Life Sciences Management L.P. Has $16.28 Million ...,Financial_Performance,"Finally, New York State Common Retirement Fund acquired a new stake in shares of Palvella Therapeutics during the second quarter worth approximately $110,000.",https://www.marketbeat.com/instant-alerts/filing-frazier-life-sciences-management-lp-has-1628-million-stock-position-in-palvella-therapeutics-inc-pvla-2025-12-13/
2025-12-15,2025,Palvella_Therapeutics,Palvella Therapeutics Announces Positive Topline Results ...,Clinical_Milestone,73% of trial participants (11/15 participants) improved on the Overall Cutaneous Venous Malformations Investigator Global Assessment (Overall cVM-IGA) at ...,https://www.biospace.com/press-releases/palvella-therapeutics-announces-positive-topline-results-from-phase-2-toiva-clinical-trial-of-qtorin-3-9-rapamycin-anhydrous-gel-qtorin-rapamycin-for-the-treatment-of-cutaneous-venous-malformations-a-serious-rare-genetic-disease-with-no-fda-approved-therapies
2025-12-16,2025,Palvella_Therapeutics,Palvella Therapeutics stock price target raised to $133 from ...,Financial_Performance,"Palvella Therapeutics stock price target raised to $133 from $97 at TD Cowen. Analyst Ratings. Published 12/16/2025, 07:01 AM. Palvella Therapeutics stock ...",https://www.investing.com/news/analyst-ratings/palvella-therapeutics-stock-price-target-raised-to-133-from-97-at-td-cowen-93CH-4410313
2025-12-21,2025,Palvella_Therapeutics,Palvella Therapeutics (PVLA) Price Target Increased by ...,General_Update,"This is an increase of 33.50% from the prior estimate of $133.70 dated December 3, 2025. The price target is an average of many targets provided by analysts.",https://www.nasdaq.com/articles/palvella-therapeutics-pvla-price-target-increased-3350-17850
2025-12-23,2025,Palvella_Therapeutics,Palvella Therapeutics: Phase 2 Success De-Risks 2026 ...,Clinical_Milestone,"Palvella completed patient enrollment in the Phase 3 SELVA trial in June 2025 with 51 patients and is conducting a single arm, baseline controlled study. The ...",https://seekingalpha.com/article/4855391-palvella-therapeutics-phase-2-success-de-risks-2026-catalyst
2026-01-01,2026,Palvella_Therapeutics,"Why Palvella Therapeutics, Inc.'s (PVLA) Stock Is Up 6.25%",Financial_Performance,"As of January 02, 2026, Palvella Therapeutics, Inc. has a weighted four-quarter relative price strength of 70.80%, which translates to a Momentum Score of 99 ...",https://www.aaii.com/investingideas/article/399816-why-palvella-therapeutics-inc8217s-pvla-stock-is-up-625
2026-01-01,2026,Palvella_Therapeutics,"Palvella Therapeutics (PVLA) Stock Price, News & Analysis",Financial_Performance,"Palvella Therapeutics' stock was trading at $104.67 at the beginning of 2026. Since then, PVLA stock has decreased by 4.2% and is now trading at $100.28.",https://www.marketbeat.com/stocks/NASDAQ/PVLA/
2026-01-01,2026,Palvella_Therapeutics,2025's 10 Best-Performing Stocks | Investing - US News Money,Financial_Performance,"Palvella Therapeutics Inc. (PVLA), 772%. 4. Almonty Industries Inc. (ALM), 840 ... 10 Best Growth Stocks to Buy for 2026. If global growth slows, high ...",https://money.usnews.com/investing/articles/best-performing-stocks-of-the-year
2026-01-01,2026,Palvella_Therapeutics,"Biotech Investing News, Stocks, Forecasts and Analysis | INN",Financial_Performance,"What's the outlook for biotech in 2026? Learn about the sector's key growth drivers, and find out which technologies and catalysts are set to disrupt the ...",https://investingnews.com/category/daily/life-science-investing/biotech-investing/
2026-01-01,2026,Palvella_Therapeutics,PI6 - Palvella Therapeutics Inc Earnings Call Transcripts,Clinical_Milestone,"Our Phase 3 SELVA trial remains on track, and we expect to report top-line data in the first quarter of 2026.",https://www.morningstar.com/stocks/xfra/pi6/earnings-transcripts
2026-01-01,2026,Palvella_Therapeutics,"Form S-3 PALVELLA THERAPEUTICS,",Clinical_Milestone,"Study initiation is anticipated in the second half of 2026. In November 2025, we announced a new product candidate, QTORIN™ pitavastatin, for the treatment of ...",https://www.streetinsider.com/SEC+Filings/Form+S-3+PALVELLA+THERAPEUTICS%2C/25796200.html
2026-01-01,2026,Palvella_Therapeutics,FDA Sets 2026 Decision Clock for INOVIO's Rare Disease ...,Clinical_Milestone,"In the Phase 1/2 trial, 72 percent of patients experienced a 50 to 100 percent reduction in surgeries after one year of treatment.",https://www.mychesco.com/a/news/regional/fda-sets-2026-decision-clock-for-inovios-rare-disease-therapy/
2026-01-01,2026,Palvella_Therapeutics,Clinical Trial Calendar,Clinical_Milestone,"Q1 2026. Palvella Therapeutics, Inc. PVLA. Top-line results from Phase 3 trial of QTORIN 3.9% rapamycin anhydrous gel (SELVA). Microcystic lymphatic ...",https://www.rttnews.com/corpinfo/clinicaltrialcalendar.aspx
2026-01-01,2026,Palvella_Therapeutics,100 Top Companies in Pennsylvania · January 2026,General_Update,"Detailed info and reviews on 100 top companies and startups in Pennsylvania in 2026. Get the latest updates on their products, jobs, funding, investors,",https://www.f6s.com/companies/united-states/pennsylvania/so
2026-01-01,2026,Palvella_Therapeutics,"Palvella Therapeutics Aktie (A40RA6,PVLA,US6979471090)",General_Update,Die Marktkapitalisierung basiert auf dem am 01.01.2026 ermittelten Gesamtwert des börsennotierten Unternehmens. Die Daten werden von FactSet zur Verfügung ...,https://www.finanzen.net/aktien/palvella_therapeutics-aktie
2015-01-01,2015,Resolute_Holdings,2012 - Bank Hapoalim,General_Update,"... 2015. The new three-year plan is based on a thorough analysis of the economic, regulatory and business environment and incorporates a sound vision of the ...",https://www.bankhapoalim.com/sites/bnhpcom/files/media/com/FinancialInformation/12001124e.pdf
2015-01-01,2015,Resolute_Holdings,The Rescue of Fannie Mae and Freddie Mac,General_Update,by WS Frame · 2015 · Cited by 156 — Fannie Mae and Freddie Mac released their second quarter earnings in early August 2008.,https://www.newyorkfed.org/medialibrary/media/research/staff_reports/sr719.pdf
2015-01-15,2015,Resolute_Holdings,Annual Report 2016,Financial_Performance,"the two successful buyback programmes conducted in 2015. The repurchase of registered shares A, which lasts from 7. June 2016 to at latest 31 May 2017, is ...",https://www.vpbank.com/sites/default/files/50_Geschaeftsbericht_2016_en.pdf
2015-01-25,2015,Resolute_Holdings,The Global arms IndusTry In 2030 (and beyond),Financial_Performance,"The company also plans to buy back another quarter of its shares by the end of 2015 at a cost of US$4 billion. To do this, it will use cash, free cash flow ...",https://rsis.edu.sg/wp-content/uploads/2015/01/ER150123_Global_Arms_Industry.pdf
2015-02-16,2015,Resolute_Holdings,FISCA LL F L POLICY PAP FY 2015/16 PER,General_Update,FY. 2015/16 marks the inaugural simultaneous tabling of the Estimates of Revenue and Expenditure. This profound change in the budget preparation and approval ...,https://www.mof.gov.jm/wp-content/uploads/Fiscal_Policy_Paper2015-16_revised.pdf
2015-02-26,2015,Resolute_Holdings,Oil and Gas ExplOratiOn & prOductiOn (E&p) incEntivE ...,Financial_Performance,"Stock options / SARs have declined in popularity due to a change in the accounting treatment for these awards, the overall market shift toward performance- ...",https://www.alvarezandmarsal.com/sites/default/files/am_tax_oilandgas_e-preport.pdf
2015-02-27,2015,Resolute_Holdings,Form 10-K,General_Update,"The following table summarizes the services provided by, and information regarding, our US facilities as of February 11, 2015.",https://www.sec.gov/Archives/edgar/data/1520697/000119312515069793/d854534d10k.htm
2015-03-05,2015,Resolute_Holdings,Resolute Announces Permanent Closure of Machine #9 at ...,General_Update,"Resolute's decision to reduce specialty papers production capacity is driven by market weakness, exacerbated by fiber cost issues in Quebec, as well as ongoing ...",https://www.newswire.ca/news-releases/resolute-announces-permanent-closure-of-machine-9-at-the-alma-paper-mill-517339131.html
2015-03-11,2015,Resolute_Holdings,Ukraine,General_Update,• The US$10.6 billion underlying BOP gap in 2015 is split roughly 4:1 between the financial and current account of the BOP. This projection reflects ...,https://www.imf.org/external/pubs/ft/scr/2015/cr1569.pdf
2015-03-17,2015,Resolute_Holdings,International Investment Agreement,General_Update,"Gramercy Funds Management LLC and Gramercy Peru Holdings LLC v. Republic of Peru, ICSID Case No. UNCT/18/2. View case details. Strategic Infrasol Foodstuff ...",https://www.italaw.com/case-types/international-investment-agreement
2015-03-30,2015,Resolute_Holdings,"Contracts for March 30, 2015",Corporate_Action,"Estimated value cited is based on demand quantities for the life of the contract. This contract was a competitive acquisition, and four offers were received.",https://www.war.gov/Newsroom/Contracts/Contract/Article/606816
2015-03-31,2015,Resolute_Holdings,A Year of Transformation and Growth,Financial_Performance,CVBI Holdings (Barbados) Inc. and Clearwater Holdings (Barbados) Limited as of 31 March 2015. The loan receivable of US$56 million relates to the two year ...,https://www.cwc.com/live/annual-report/downloads/Cable%20%26%20Wireless%20Annual%20Report.pdf
2015-04-08,2015,Resolute_Holdings,Form 20-F,General_Update,"Other than these adjustments, there has been no material change in our capitalization from debt or equity issuances, re-capitalization or special dividends ...",https://www.sec.gov/Archives/edgar/data/1166663/000119312515122947/d901152d20f.htm
2015-04-17,2015,Resolute_Holdings,united states,Financial_Performance,"The Board of Directors set April 6, 2015 as the record date for the Annual Meeting, or the Record Date. All stockholders who owned common stock of the Company ...",https://www.sec.gov/Archives/edgar/data/1588216/000110465915028418/a15-8720_2def14a.htm
2015-04-29,2015,Resolute_Holdings,EPC Contracting Issues in the Oil & Gas Industry,General_Update,"ruling from the IRS prior to May 6, 2015 holding that a certain activity generates qualifying income will have 10 years until they can no longer rely on ...",https://files.klgates.com/files/upload/epc_contracting_issues_in_the_oil_and_gas_industry.pdf
2015-05-11,2015,Resolute_Holdings,Invest. Innovate. Inspire. For a new India.,Financial_Performance,"India is at the threshold of a new era of growth and opportunity. This is driven by increasing economic activity, ongoing 'Make in India' initiatives and a ...",https://www.ril.com/sites/default/files/2022-12/RIL-AR-2014-15.pdf
2015-05-12,2015,Resolute_Holdings,CompoSecure | LLR Portfolio Companies,Corporate_Action,CompoSecure to Become a Publicly Traded Company Through Merger With Roman DBDR Tech Acquisition Corp. Resolute Holdings Completes Acquisition of Majority ...,https://www.llrpartners.com/portfolio-company/composecure/
2015-05-13,2015,Resolute_Holdings,Dustin to acquire Finnish supplier of network solutions,General_Update,"Dustin has signed an agreement to acquire Resolute ISMS Oy, one of Finland's leading suppliers of network solutions to private and public sectors.",https://www.dustingroup.com/en/press/dustin-acquire-finnish-supplier-network-solutions-1356291
2015-05-31,2015,Resolute_Holdings,RY 2014 Pre-Populated Names,General_Update,"... MANAGEMENT CO. 1626, 49022HRBRM800SF, ATERIAN ... HOLDINGS INC. 22752, 48174WDBRD15573, WOODBRIDGE HOLDINGS INC. 22753, 64150WDBRD555NW, WOODBRIDGE HOLDINGS INC.",https://19january2017snapshot.epa.gov/sites/production/files/2015-05/ry_2014_parent_companies_list.xlsx
2015-06-30,2015,Resolute_Holdings,"THE GOLDMAN SACHS GROUP, INC. GLOBAL ...",General_Update,"This strategy and the financial projections in our resolution plan (“Resolution Plan”) have been prepared using assumptions about funding, liquidity, market.",https://www.federalreserve.gov/bankinforeg/resolution-plans/goldman-sachs-1g-20150701.pdf
2015-07-01,2015,Resolute_Holdings,Annual Sales,General_Update,"Annual Report 2015 primarily covers results for the year ended. March 2015 (April 1, 2014 to March 31, 2015; January 1, 2014 to December 31, 2014 for ...",https://corp.shiseido.com/en/ir/library/annual/pdf/2015/anu00001.pdf
2015-07-15,2015,Resolute_Holdings,"Stock Spinoffs: What they are, Examples, Pros & Cons",Financial_Performance,A stock spinoff is a type of corporate action where a parent company separates (spins off) a section of itself into an independent entity.,https://thunderclapresearch.com/stock-spinoffs/
2015-08-06,2015,Resolute_Holdings,Europe Economic Outlook,Financial_Performance,"The worse than expected first half on balance warrants a downward revision for growth for 2015 as a whole, which could amount to 2.5%, or some 0.4pp below the ...",https://www.bbvaresearch.com/wp-content/uploads/2015/08/Europe_Economic_Outlook_Aug15.pdf
2015-08-18,2015,Resolute_Holdings,Indiana Public Retirement System,Clinical_Milestone,"During fiscal year 2015, Verus performed an asset-liability study that resulted in an adjustment to the. Plan's target asset allocation. The Portfolio's new ...",https://www.in.gov/inprs/files/2015INPRSInvestmentSection.pdf
2015-08-25,2015,Resolute_Holdings,significantly higher consolidated net income of CHF 40.9 ...,General_Update,"In the first half of 2015, VP Bank Group earned a consolidated net income of CHF 40.9 million. Net operating income rose by 56.1 per cent.",https://www.vpbank.com/en/news/2015/2015-semi-annual-results-vp-bank-group-significantly-higher-consolidated-net-income-chf
2015-09-28,2015,Resolute_Holdings,Canadian Timber Firm Buys Family-Owned Anthony Forest ...,General_Update,Canadian timberland company Canfor Corp. on Monday (Sept. 28) announced it has agreed to buy family-owned Anthony Forest Products Co. (AFP) of El Dorado for ...,https://talkbusiness.net/2015/09/canadian-timber-firm-buys-family-owned-anthony-forest-of-el-dorado-for-93-5-million/
2015-09-30,2015,Resolute_Holdings,Annual Report of Activities Pursuant to Act 44 of 2010,General_Update,"Accordingly, we have prepared this report on the activities our funds have undertaken to comply with the requirements of Act 44 during the period July 1, 2014 ...",https://www.patreasury.gov/pdf/divestment/2015-Annual-Divestment-Report.pdf
2015-09-30,2015,Resolute_Holdings,Resolute Digital is One of the First Digital Marketing ...,Corporate_Action,"A leading digital agency based in NYC, Resolute Digital is now one of the first agencies to become a Google Tag Manager Partner. As soon as the opportunity was ...",https://www.prweb.com/releases/resolute_digital_is_one_of_the_first_digital_marketing_agencies_to_become_a_google_tag_manager_partner/prweb12939165.htm
2015-10-15,2015,Resolute_Holdings,Epic Resolute Billing Audit Audit and Management ...,General_Update,"To conduct our audit we reviewed management reports and system documentation; assessed applicable policies, procedures and business practices; and, interviewed ...",https://auditreports.ucop.edu/?action=public_ar_display&id=ec1a0b2003913b76
2015-11-16,2015,Resolute_Holdings,Resolute Grows Into Tissue with Acquisition of Atlas Paper,Corporate_Action,"Resolute Forest Products Inc. (NYSE: RFP) (TSX: RFP) today announced the acquisition of Atlas Paper Holdings, Inc., a leading manufacturer of at-home and away- ...",https://resolutefp.mediaroom.com/2015-11-16-Resolute-Grows-Into-Tissue-With-Acquisition-of-Atlas
2015-11-19,2015,Resolute_Holdings,Resolute Forest acquires Atlas Paper for $156M,General_Update,"Montreal-based paper firm Resolute Forest Products Inc. has acquired Atlas Paper Holdings, which operates a paper recycling facility in Tampa, ...",https://www.wastedive.com/news/resolute-forest-acquires-atlas-paper-for-156m/409515/
2015-11-25,2015,Resolute_Holdings,Resolute acquires Atlas Paper for $156M,Corporate_Action,"Resolute Forest Products Inc., Montreal, has announced its acquisition of Atlas Paper Holdings Inc., a manufacturer of tissue products based in Miami, for $156 ...",https://www.recyclingtoday.com/news/resolute-acquires-atlas-paper/
2015-12-15,2015,Resolute_Holdings,FY2015 - FINAL ASSET LISTING REPORT,Financial_Performance,"INTERNATIONAL SHORT‐TERM: 99WB618. CASH COLLATERAL (AUD) AT SSB. 1,272,033. 99WB629. CASH COLLATERAL (CAD) AT SSB. 978,013. 99WB630.",https://www.pa.gov/content/dam/copapwp-pagov/en/psers/documents/transparency/financial-reports/year-end-listing/fy2015%20-%20final%20asset%20listing%20report.pdf
2015-12-17,2015,Resolute_Holdings,Annual Report 2015,General_Update,"In response to a string of corporate financial reporting scandals at the turn of the century, IOSCO became a founding member of the Monitoring Group (MG) of ...",https://www.iosco.org/annual_reports/2015/pdf/CompleteAnnualReport2015.pdf
2015-12-31,2015,Resolute_Holdings,2015 Citizens Bank IDI Resolution Plan,General_Update,"A third public offering was held in August 2015, reducing RBS Group ownership to. 20.9%, and in November 2015, in connection with a fourth public offering, RBS ...",https://fdic.gov/system/files/2024-07/cfg-idi-1512.pdf
2015-12-31,2015,Resolute_Holdings,FINANCIAL SERVICES SUPERVISION REPORT 2015,General_Update,CBS' strategic plan recognises the importance of consumer protection to financial soundness and. CBS is resolute to enhance this area in the financial sector.,https://www.cbs.sc/Downloads/publications/FSSD%20Report%202015%20-%20CBS.pdf
2016-01-01,2016,Resolute_Holdings,Novartis Annual Report 2015,General_Update,Our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most.,https://www.novartis.com/sites/novartiscom/files/novartis-annual-report-2015-en.pdf
2016-01-08,2016,Resolute_Holdings,"Adlerstein, Jacob A.",Corporate_Action,"A partner in the Restructuring Department, Jake Adlerstein has broad experience advising a variety of clients in bankruptcy cases and corporate restructurings.",https://www.paulweiss.com/professionals/partners-and-counsel/jacob-a-adlerstein
2016-02-03,2016,Resolute_Holdings,Cases,General_Update,"The PCA is currently acting as registry in seven inter-state arbitrations, one other inter-state proceeding, 98 arbitrations arising under bilateral or ...",https://pca-cpa.org/cases/
2016-02-04,2016,Resolute_Holdings,USDOT SMART CITIES CHALLENGE,General_Update,"Reduce traffic congestion. • Improve traveler safety, especially for pedestrians. • Protect the environment and conserve energy. • Connect underserved ...",https://www.transportation.gov/sites/dot.gov/files/docs/GA%20Brookhaven.pdf
2016-02-21,2016,Resolute_Holdings,Money manager's mea culpa cost him nearly $1 million,General_Update,Francis Chou is feeling the pain of his U.S. investors after his Opportunity Fund suffered its worst annual performance ever in 2015.,https://www.investmentnews.com/mutual-funds/money-managers-mea-culpa-cost-him-nearly-1-million/66518
2016-02-25,2016,Resolute_Holdings,20-F,General_Update,"Detailed reporting of our financial performance, at Group level as well as within our matrix structure. It also includes our full risk report and reporting on ...",https://www.sec.gov/Archives/edgar/data/1089113/000119312516478487/d117963d20f.htm
2016-02-26,2016,Resolute_Holdings,10-K,Financial_Performance,Unit case volume growth is a metric used by management to ... We currently expect to repurchase $2.0 billion to $2.5 billion of our stock during 2016 ...,https://www.sec.gov/Archives/edgar/data/21344/000002134416000050/a2015123110-k.htm
2016-03-01,2016,Resolute_Holdings,Medtronic Reports Third Quarter Financial Results,General_Update,"The company expects fiscal year 2016 diluted non-GAAP EPS in the range of $4.36 to $4.40, which continues to include an expected $0.45 to $0.50 negative foreign ...",https://news.medtronic.com/2016-03-01-Medtronic-Reports-Third-Quarter-Financial-Results
2016-03-08,2016,Resolute_Holdings,Annual Report 2015,General_Update,"... 2016. Media and analyst conference, 2015 annual results. Friday, 29 April 2016. 53rd ordinary annual general meeting. Friday, 6 Mai 2016. Dividend payment.",https://www.vpbank.com/sites/default/files/50_Geschaeftsbericht_2015_en.pdf
2016-03-11,2016,Resolute_Holdings,Jarrow fuels terminals acquired by Prax Terminals,Corporate_Action,"State Oil has announced that its subsidiary, Prax Terminals, has successfully completed the acquisition of the Jarrow fuels terminal from Shell; ...",https://www.hydrocarbonengineering.com/tanks-terminals/11032016/Prax-Terminals-acquires-Shells-Jarrow-fuels-terminal-2739/
2016-03-31,2016,Resolute_Holdings,annual report,General_Update,"our resolute performance which continued in FY 2016. While the market conditions remained challenging, we continued to report healthy financial performance ...",https://www.hzlindia.com/wp-content/uploads/HZ_Final_Annual_Report-15-16-3.pdf
2016-04-01,2016,Resolute_Holdings,Annual Report,General_Update,"The Company split off Energy Systems & Solutions Company and Nuclear Systems. & Solutions Division, which were succeeded by Toshiba Energy Systems & Solutions.",https://www.global.toshiba/content/dam/toshiba/migration/corp/irAssets/about/ir/en/finance/ar/ar2018/tar2018e_or.pdf
2016-04-08,2016,Resolute_Holdings,BP Annual Report and Form 20-F 2017,Financial_Performance,"The energy we produce serves to power economic growth and lift people out of poverty. The way heat, light and mobility are delivered is changing. We aim.",https://www.bp.com/content/dam/bp/business-sites/en/global/corporate/pdfs/investors/bp-annual-report-and-form-20f-2017.pdf
2016-04-14,2016,Resolute_Holdings,FISCAL POLICY PA FY 2016/17 FISCAL ...,General_Update,"The FY 2016/17 Estimates of Revenue and Expenditure, as well as the FPP, were due to be tabled in. February 2016 to allow for the approval of the budget by both ...",https://www.mof.gov.jm/wp-content/uploads/Fiscal_Policy_Paper2016-17_revised-03-05-2016.pdf
2016-05-02,2016,Resolute_Holdings,REPORT ON EXAMINATION OF UNITED STATES FIRE ...,Financial_Performance,stocks. The Company's common stock holdings consisted of unaffiliated common stock holdings in publicly traded companies totaling $402.2 million and ...,https://insurance.delaware.gov/wp-content/uploads/sites/15/2016/12/UnitedStatesFireInsuranceCompany2014web.pdf
2016-05-12,2016,Resolute_Holdings,Buying Great Businesses at a Fair Price,Financial_Performance,"have any basic advice for investors as they look at 2016? Mr. Hanson: In terms of trends in 2016, clearly, there is a lot of angst around slowing global growth.",https://haas.berkeley.edu/wp-content/uploads/Hanson_Great_Businesses.pdf
2016-05-15,2016,Resolute_Holdings,Annual Report,General_Update,Reconciliations from the financial performance measures as defined by the. Group to these measures are provided in the Financial review on pages 24 to 30.,https://annualreport.baesystems.com/dam/jcr:ed912521-92cf-420b-b4b1-a91ec128eb78/BAESystemsAnnualReport2016.pdf
2016-05-27,2016,Resolute_Holdings,Resolute Performance Fund calls for a sale of Wesdome ...,General_Update,Resolute has come to the conclusion that a sale of Wesdome is the best alternative now available to maximize shareholder value.,https://www.newswire.ca/news-releases/resolute-performance-fund-calls-for-a-sale-of-wesdome-gold-mines-581170791.html
2016-06-06,2016,Resolute_Holdings,https://data.cityofchicago.org/api/views/dmeb-2zra...,General_Update,"... 2016,Y 2020,4047833126,MAKTUB DEVELOPMENT LLC,4554 S LAKE PARK AVE,,CHICAGO,IL,60653,UNITED STATES,773-339-4956,,10/31/2018,Y 2020,1159084318,MILLENNIUM ...",https://data.cityofchicago.org/api/views/dmeb-2zra/rows.csv?accessType=DOWNLOAD
2016-06-30,2016,Resolute_Holdings,16019238.pdf,General_Update,"The undersigned and applicant represent that the information and statements contained herein, including exhibits, schedules, or other documents attached hereto, ...",https://www.sec.gov/Archives/edgar/vprr/1601/16019238.pdf
2016-08-08,2016,Resolute_Holdings,Item 7a,General_Update,Section I: Total Fund. Total Fund Summary & Total Fund Plus Terminated Agency (TAP) Summary. Section II: Public Equity. Public Equity Summary.,https://www.calpers.ca.gov/documents/201608-invest-item07a-05/download
2016-09-09,2016,Resolute_Holdings,Homeloans Limited,General_Update,"As announced on Wednesday 20 July 2016, Homeloans has entered into a Scheme. Implementation Agreement with RESIMAC Limited (RESIMAC) to implement a proposal ...",https://www.asx.com.au/asxpdf/20160909/pdf/43b2syt57jplyc.pdf
2016-09-13,2016,Resolute_Holdings,Monthly Archives: September 2016,Financial_Performance,Through most of 2015 and into the first couple of month of 2016 the movements of small company stocks just didn't feel right. Every move up was pressured. Every ...,https://reminiscencesofastockblogger.com/2016/09/
2016-09-13,2016,Resolute_Holdings,Weber Shandwick acquires U.K. mobile and digital firm ...,Corporate_Action,"NEW YORK: Weber Shandwick has acquired U.K.-based mobile and digital agency Flipside. The deal, which closed at the end of August, combines Flipside's ...",https://www.prweek.com/article/1408635/weber-shandwick-acquires-uk-mobile-digital-firm-flipside
2016-09-21,2016,Resolute_Holdings,AA The Last Microcap in the Delaware Basin,Financial_Performance,That is why Resolute's shares— priced for bankruptcy at $3 for so long —skyrocketed to $23 in two months. The management team of my Delaware Basin Gem locked ...,https://oilandgas-investments.com/last-microcap-in-the-delaware-basin/
2016-09-22,2016,Resolute_Holdings,Corporate Name Change & Merger Index Current As Of,Corporate_Action,Chevron U.S.A. Holdings Inc. (Oil and Gas Leases Only). Chevron U.S.A. Holdings ... 07/19/2016. 08/04/2016. CO. WY. WR Company. LR Company. 04/23/1980. WY. WRB ...,https://eplanning.blm.gov/public_projects/nepa/75541/102244/250019733/Master_NC_Index_03-12-2020.pdf
2016-10-01,2016,Resolute_Holdings,Wells Fargo & Company 2016 Resolution Plan Submission ...,General_Update,"This document contains forward-looking statements about the Company's future plans, objectives, and resolution strategies, including the Company's ...",https://www.federalreserve.gov/bankinforeg/resolution-plans/wells-fargo-2g-20161001.pdf
2016-10-11,2016,Resolute_Holdings,Press Releases | Risk Strategies Acquires TSG Financial,General_Update,"Risk Strategies today announced it had acquired TSG Financial, bolstering expertise in its employee benefits practice.",https://www.risk-strategies.com/press-releases-risk-strategies-company-acquires-long-island-based-tsg-financial-bolstering-expertise-in-employee-benefits-practice
2016-10-14,2016,Resolute_Holdings,North Carolina,General_Update,"... SERVICES,% CHRIS BRADY,200 COMMONWEALTH CT,CARY,NC,27511-2431,0000,03,3,1700 ... FINANCIAL FLCA,% EUGENE K CHARVILLE,4000 POOLE RD,RALEIGH,NC,27610 ...",https://www.irs.gov/pub/irs-soi/eo_nc.csv
2016-11-01,2016,Resolute_Holdings,Monthly Archives: November 2016,Financial_Performance,"It is The Zombie Bull Market, animated by unholy practices: low interest rates make borrowing free, executives use borrowed money to underwrite stock buybacks ...",https://www.mutualfundobserver.com/2016/11/
2016-11-11,2016,Resolute_Holdings,IMF Executive Board Approves US$12 billion Extended ...,General_Update,"On November 11, 2016, the Executive Board of the International Monetary Fund (IMF) approved a three-year extended arrangement under the Extended Fund Facility ( ...",https://www.imf.org/en/news/articles/2016/11/11/pr16501-egypt-executive-board-approves-12-billion-extended-arrangement
2016-11-15,2016,Resolute_Holdings,Financial Stability Review November 2016,General_Update,"The Financial Stability Review (FSR) assesses developments relevant for financial stability, including identifying and prioritising the main sources of ...",https://www.ecb.europa.eu/pub/pdf/other/financialstabilityreview201611.en.pdf
2016-12-23,2016,Resolute_Holdings,Wisconsin (WIOA) Unified and Combined State Plan ...,General_Update,"Wisconsin's economy is strong and continuing to grow. The Wisconsin workforce, raised with strong. Midwest values of hard work and dedication, ...",https://dwd.wisconsin.gov/wioa/pdf/wi-wioa-state-plan-201612.pdf
2016-12-29,2016,Resolute_Holdings,Diversifying into tissue,General_Update,Montreal-based Resolute Forest Products acquired Atlas Paper Mills in 2015 to diversify into tissue production and to expand its sustainability practices.,https://www.recyclingtoday.com/article/diversifying-into-tissue/
2017-01-01,2017,Resolute_Holdings,Greece and the Euro: From Crisis to Recovery,General_Update,"by G Alogoskoufis · 2021 · Cited by 10 — While the Greek economy appeared to be on a path to an admittedly weak recovery after 2017, in. 2020 it was hit by another major negative shock, that of Covid- ...",https://www.dept.aueb.gr/sites/default/files/imop/attachments/Greece-and-the-Euro.pdf
2017-01-17,2017,Resolute_Holdings,STRATEGIC SABOTAGE - à www.publications.gc.ca,General_Update,"The views expressed in this publication are entirely those of the authors and do not necessarily reflect the views, policy, or positions of the Government ...",https://publications.gc.ca/collections/collection_2022/mdn-dnd/D2-440-2021-eng.pdf
2017-02-07,2017,Resolute_Holdings,MCM exits Cole Information Services - PE Hub,Corporate_Action,"Brook Venture Partners, Resolute Capital Partners and Eagle Private Capital have acquired Cole Information Services, a provider of customer acquisition ...",https://www.pehub.com/mcm-exits-cole-information-services/
2017-02-11,2017,Resolute_Holdings,"Growth Stock Scan: Feb. 11, 2017",Financial_Performance,"The Growth Stock Report strategy, money management, discipline. Growth Stock Scan: Feb. 11, 2017. Posted on February 11, 2017.",https://gsrtrades.com/growthstocks/growth-stock-scan-feb-11-2017/
2017-02-19,2017,Resolute_Holdings,DoD ACQUISITION PROGRAM CODES,Corporate_Action,DoD ACQUISITION PROGRAM CODES. C-17A C-17A GLOBEMASTER III. GALAXY INTER-THEATER AIRLIFT AIRCRAFT 10/1/03. DEFENSE METEOROLOGICAL SATELLITE PROGRAM. MANNED ...,https://www.fpds.gov/downloads/DoD_Acquisition_Codes.xls
2017-02-22,2017,Resolute_Holdings,Budget Review,General_Update,"The 2017 Budget reflects a balance between maintaining our spending commitments, particularly in higher education, health and social protection, and ensuring ...",https://www.treasury.gov.za/documents/national%20budget/2017/review/fullbr.pdf
2017-02-24,2017,Resolute_Holdings,DRAFT LETTER OF OFFER THIS DOCUMENT IS ...,Financial_Performance,"The Board of Directors at their meeting on Thursday, 5th January, 2017 passed a resolution approving buyback of. Equity Shares of the Company and sought ...",https://www.sebi.gov.in/sebi_data/attachdocs/1488193133377.pdf
2017-02-28,2017,Resolute_Holdings,American Beacon Large Cap Value Fund (AALRX),Financial_Performance,A multi-manager Fund seeking long-term capital appreciation and current income primarily through investments in large market capitalization U.S. stocks. Share ...,https://americanbeaconfunds.com/products/mutual-funds/american-beacon-large-cap-value-fund/aalrx/
2017-03-13,2017,Resolute_Holdings,Defense Intelligence Agency (DIA) Style Manual for ...,General_Update,"Requester Service Center, as well as our FOIA Public Liaison at 301-394-5587. Additionally, you may contact the Office of Government Information Services (OGIS ...",https://www.governmentattic.org/23docs/DIAstyleManualIntelProd_2016.pdf
2017-03-29,2017,Resolute_Holdings,Resolute Announces Start-up of New Tissue Machine at ...,General_Update,Tissue parent rolls are now being produced at Resolute's new Calhoun (Tennessee) tissue facility. (CNW Group/Resolute Forest Products Inc.).,https://www.newswire.ca/news-releases/resolute-announces-start-up-of-new-tissue-machine-at-calhoun-617424603.html
2017-03-31,2017,Resolute_Holdings,FY2017AnnualRepL&T Annual Report 2016-17.pdf,General_Update,"The. Order Book of the Company stands at a robust level of ` 261,241 crore, providing good revenue visibility for. 2017-18. The Company recorded.",https://investors.larsentoubro.com/upload/AnnualRep/FY2017AnnualRepL&T%20Annual%20Report%202016-17.pdf
2017-04-04,2017,Resolute_Holdings,Resolute Ventures seals up its third fund with $65 million ...,General_Update,"Resolute Ventures just closed its third fund with $65 million. It's a sizable step up from its first two funds, which closed with $47 million and $45.",https://techcrunch.com/2017/04/04/resolute-ventures-seals-up-its-third-fund-with-65-million-from-investors/
2017-04-22,2017,Resolute_Holdings,Sheet1,General_Update,"Resolute Forest Products Inc ... NL Industries Inc. 42849. 3017, NLY, Annaly Capital Management, 42849. 3018, NM, Navios Maritime Holdings Inc, 42849. 3019, NM ...",https://www.nyse.com/publicdocs/nyse/markets/nyse/Roll_Out_Schedule_Limit_Order_Protection_3_22_17.xlsx
2017-04-25,2017,Resolute_Holdings,SEC FORM D/A,General_Update,"Name of Issuer. Resolute Investment Holdings, LLC. Street Address 1, Street Address 2. KELSO & COMPANY, 320 PARK AVENUE. City, State/Province/Country ...",https://www.sec.gov/Archives/edgar/data/1641904/000164190417000003/xslFormDX01/primary_doc.xml
2017-04-26,2017,Resolute_Holdings,Candescent Partners Invests in the Southeastern Spine ...,Corporate_Action,"Candescent Partners, a Boston-based private equity firm, announced that it has invested in the Southeastern Spine Institute (SSI).",https://www.eagleprivatecapital.com/04-13-17-spine.html
2017-05-05,2017,Resolute_Holdings,Nicholas J. Sutton,General_Update,Nicholas J. Sutton has been Executive Chairman of the Board of the Company since January 2017. Resolute Holdings since their founding in 2004. company's ...,https://www.resoluteenergy.com/nicholas-j-sutton-2/
2017-05-31,2017,Resolute_Holdings,on the deepening of the economic and monetary union,General_Update,"On 1 March 2017, the European Commission presented a White Paper on the future of Europe. It marked the starting point for a wide debate on the future ...",https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:52017DC0291
2017-06-01,2017,Resolute_Holdings,Лист1,Corporate_Action,"VanEck Vectors Global Spin-Off E. 7339, GDX, US92189F1066, VanEck Vectors Gold Miners ETF. 7340, GRNB, US92189F1710, VanEck Vectors Green Bond ETF. 7341, YMLI ...",https://www.open-broker.com/files/List_of_financial_instruments_for_conclusion_of_REPO_transactions_for_allocation_of_the_Client%E2%80%99s_available_monetary_funds_%D0%95ffective_from_01_06_2017_to_16_06_2017_.xlsx
2017-06-14,2017,Resolute_Holdings,AR (Going Away) Resolute HB RCM,General_Update,Summit Healthcare Services Inc. Other - Operations (Staying). Other Operations (Staying). Other - Operations ... 6/14/2017. Cumberland Consulting Group. 3.,https://gmcboard.vermont.gov/sites/gmcb/files/files/certificate-need/Exhibit%201%20-%20UVMHN%20Current%20System%20Analysis.pdf
2017-06-29,2017,Resolute_Holdings,Reggie Zachariah | Corporate Lawyer | Professionals,Corporate_Action,Representation of Broad Anesthesia Associates and its related entities in connection with their acquisition by Resolute Anesthesia and Pain Solutions.,https://www.gtlaw.com/en/professionals/z/zachariah-reggie
2017-06-30,2017,Resolute_Holdings,FY2017 - FINAL ASSET LISTING.xlsx,Financial_Performance,"FRESB 2017-SB29 A5H. 2,015,227. 30295YAE6. US30295YAE68. FRESB 2017-SB30 A-10F. 386,698. 30295YAB2. US30295YAB20. FRESB 2017-SB30 MORTG SB30 A5H. 4,028,648.",https://www.pa.gov/content/dam/copapwp-pagov/en/psers/documents/transparency/financial-reports/year-end-listing/fy2017%20-%20final%20asset%20listing.pdf
2017-07-06,2017,Resolute_Holdings,"American Fast Freight, Inc., Acquires Grand Worldwide ...",General_Update,"American Fast Freight, Inc., Acquires Grand Worldwide Logistics it had acquired Grand Worldwide Logistics. AFF is currently owned by The Resolute Fund II, L.P. ...",https://www.prnewswire.com/news-releases/american-fast-freight-inc-acquires-grand-worldwide-logistics-300484402.html
2017-07-15,2017,Resolute_Holdings,Kansas Register,General_Update,Please Note: The following list represents business entities forfeited in July. Any business entity listed may have filed for reinstatement and be considered ...,https://sos.ks.gov/publications/register/2017/Vol_36_No_34_August_24_2017_July_2017_Forfeitures.pdf
2017-07-15,2017,Resolute_Holdings,Becoming the “Retail No.1” financial services group,General_Update,"Although the Resona. Group specializes in retail banking businesses, it has a superior cost to income ratio compared to the megabank groups and top-tier ...",https://www.resona-gr.co.jp/holdings/english/investors/financial/integrated/pdf/16/ir17_all.pdf
2017-07-24,2017,Resolute_Holdings,"July 24, 2017 U.S. Securities and Exchange ...",General_Update,"We have audited the accompanying financial statements of Investors' Exchange LLC (the ""Company""), which comprise the statement of financial condition as of ...",https://www.sec.gov/Archives/edgar/vprr/1700/17002618.pdf
2017-07-29,2017,Resolute_Holdings,toro gold Archives,Financial_Performance,The transaction comprised of US$130 million cash and 142.5 million Resolute shares valued on Resolute's 30-day VWAP of A$1.45 per share.,https://www.bailiwickexpress.com/tag/toro-gold/
2017-09-12,2017,Resolute_Holdings,"CoStar Group to Acquire ForRent, Adding Millions of ...",General_Update,"ForRent's revenue for 2017 is expected to be approximately $100 million and EBITDA is estimated at approximately $15 million, for an EBITDA margin of 15%, based ...",https://www.costargroup.com/press-room/2017/costar-group-acquire-forrent-adding-millions-renters-apartmentscom-network
2017-09-22,2017,Resolute_Holdings,Banks Bruce | People | Sidley Austin LLP,General_Update,"Banks Bruce focuses his practice on private equity, financing, and energy transactions, both domestically and internationally.",https://www.sidley.com/en/people/b/bruce-banks
2017-11-09,2017,Resolute_Holdings,ILPA SUMMIT,Financial_Performance,"2017, driven by exceptional operational growth/margin expansion. In 2016, WCAS XII portfolio companies generated consolidated EBITDA growth of 34%. 2017 ...",https://ilpa.org/wp-content/uploads/2017/11/2017-ILPA-Summit-General-Partner-Profiles.pdf
2017-11-16,2017,Resolute_Holdings,CalPERS 2016-2017 Annual Investment Report,General_Update,"On behalf of the CalPERS Investment Office, I am pleased to report on CalPERS' investment performance, operations, and initiatives for the one-year period ...",https://www.calpers.ca.gov/sites/default/files/spf/docs/forms-publications/annual-investment-report-2017.pdf
2017-11-20,2017,Resolute_Holdings,Building momentum on our path to become the premier ...,General_Update,"For the full year, Ashland's adjusted earnings was $2.44 per diluted share, compared to $2.25 per diluted share in fiscal 2016. These results include roughly $ ...",https://www.ashland.com/file_source/Ashland/Proxy/Ashland%202017%20Annual%20%20Report.pdf
2017-12-06,2017,Resolute_Holdings,BRI 2016 Annual Report,Financial_Performance,The themes of BRI's annual reports since 2012 and up to 2016 are indicative of BRI's consistent efforts over those years to ensure sustainable growth based on ...,https://www.ir-bri.com/misc/AR/flipbook/2016/files/assets/common/downloads/publication.pdf
2017-12-07,2017,Resolute_Holdings,"Weber Shandwick acquires Resolute Digital, Bomoda",General_Update,"Weber Shandwick has acquired Resolute Digital and Bomoda to expand its global data science, analytics, search, and performance marketing capabilities.",https://www.prweek.com/article/1452226/weber-shandwick-acquires-resolute-digital-bomoda
2017-12-15,2017,Resolute_Holdings,Financing SDGs South-South Cooperation,Clinical_Milestone,"This study report titled 'South-South Cooperation for Financing SDGs' commissioned by the Economic. Relations Division, and supported by the Knowledge for ...",https://erd.portal.gov.bd/sites/default/files/files/erd.portal.gov.bd/page/83abb6f9_b264_45f9_92c0_2596b2421dc9/South%20South%20Cooperation%20for%20Financing%20SDGs.pdf
2017-12-31,2017,Resolute_Holdings,Integrated Report 2017,General_Update,"Beginning with its report for fiscal 2017, Otsuka Holdings has integrated its Annual Report and CSR Report, issuing as an Integrated Report that brings ...",https://www.otsuka.com/en/ir/library/pdf/annual/2017_a4.pdf
2018-01-01,2018,Resolute_Holdings,ANNUAL REPORT 2024,Financial_Performance,This year also saw a record capital return to shareholders of $47.1 million through increased quarterly dividends and our share buyback program. Page 9. 7.,https://www.sagicor.com/-/media/PDFs/SFC/Annual-Reports/SFCL-2024-Annual-Report.pdf?ts=20250504T1735373339
2018-02-23,2018,Resolute_Holdings,2017 - integrated summary report,Financial_Performance,"1 In 2017, GE returned. $12.1 billion to investors through dividends and buyback. While most of our businesses delivered solid—and, in the cases of Aviation and ...",https://www.ge.com/sites/default/files/GE_ISR2017.pdf
2018-02-26,2018,Resolute_Holdings,Proxy Statement,General_Update,"In February, we announced the 2018 slate, which includes Larry Culp, Tom Horton and Leslie Seidman, who will bring additional insight into capital allocation, ...",https://www.sec.gov/Archives/edgar/data/40545/000120677418000752/ge3334621-def14a.htm
2018-03-06,2018,Resolute_Holdings,Atlantic Investment Management,General_Update,"At half the market exposure, Atlantic's hedge fund strategy has kept up with the S&P 500, annualising at around 10% since 1993. The gap in holdings is far ...",https://thehedgefundjournal.com/atlantic-investment-management/
2018-03-10,2018,Resolute_Holdings,Research on the 150 Largest US Fund Families,General_Update,Introduction The Fund Family 150 report helps thousands of investors evaluate the 150 largest U.S. fund families.,https://morningstardirect.morningstar.com/clientcomm/DueDiligenceReports/FundFamily150.pdf
2018-03-16,2018,Resolute_Holdings,ASMI Annual Report 2017,Financial_Performance,"Last year, we reduced our shareholding in ASMPT from approximately 39% to approximately 25% with the proceeds being used for share buyback programs and a ...",https://www.asm.com/media/o0pl3jbf/2017_asmi_annual_report.pdf
2018-03-31,2018,Resolute_Holdings,Making Life Better. For Everyone.,Clinical_Milestone,We are now focussed on building platforms that will herald the Fourth Industrial Revolution and will create opportunities and avenues for India and all its ...,https://www.ril.com/sites/default/files/2022-12/RIL-AR-2018.pdf
2018-04-16,2018,Resolute_Holdings,Resolute Announces Tentative Agreement with Unifor,General_Update,"(NYSE: RFP) (TSX: RFP) today announced that a tentative four-year agreement has been reached with Unifor, subject to ratification by their members. Unifor ...",https://www.prnewswire.com/news-releases/resolute-announces-tentative-agreement-with-unifor-300630644.html
2018-04-30,2018,Resolute_Holdings,2018 - Annual Report and Accounts,General_Update,"Renewed in April, they bring diverse professional experiences, including vast economic and financial knowledge at both national and international levels.",https://www.unicreditgroup.eu/content/dam/unicreditgroup-eu/documents/en/investors/financial-reports/2018/4Q18/2018-Annual-Report-and-Accounts-General-Meeting-Draft.pdf
2018-05-10,2018,Resolute_Holdings,Investing for Contributors & Beneficiaries,General_Update,"We acquired a 30% stake in BGL Group, the U.K. leading digital distributor of insurance and household financial services, for approximately £525 million.",https://www.cppinvestments.com/wp-content/uploads/2019/09/CPPIB_F2018_Annual_Report_English.pdf
2018-06-12,2018,Resolute_Holdings,Archive: 2018 Acquisition: Capstone Acquires LoadDelivered,Corporate_Action,"LoadDelivered, a leading food and beverage specialized third-party logistics (3PL) firm, announced today that it has been acquired by Capstone Logistics.",https://www.capstonelogistics.com/capstone-logistics-acquires-chicago-based-3pl-loaddelivered-logistics/
2018-06-26,2018,Resolute_Holdings,Loncor Announces Closing of Resolute Mining Transactions,Financial_Performance,"Pursuant to the private placement Transaction, the Company issued 26,000,000 common shares to Resolute at a price of Cdn$0.10 per share for gross proceeds of ...",https://www.loncor.com/media1/announcements/2018/145-loncor-announces-closing-of-resolute-mining-transactions
2018-06-30,2018,Resolute_Holdings,New York City Fire Pension Funds,Financial_Performance,Schedule 3A - Largest Stock Holdings…………………….…..……….…….….….…. Schedule 4A ... This report is prepared by management based on data provided by the investment ...,https://www.nyc.gov/assets/fdny/downloads/pdf/about/fire-pension-fund-cafr.pdf
2018-07-15,2018,Resolute_Holdings,Annual Report 2017-18,General_Update,"During the year ended 31 March 2018, the Holding company has sold off 46% stake in Taurus Tiles Private. Limited ('Taurus') which has resulted in a balance ...",https://kajariaceramics.com/storage/pdf/17-18.pdf
2018-08-15,2018,Resolute_Holdings,2018 Mission Report,General_Update,"Finance revenue recognized in fiscal year 2018 related to non-accrual accounts totaled approximately $12,579 compared to approximately $22,563 in fiscal year ...",https://www.aafes.com/Images/AboutExchange/PublicAffairs/2018-Mission-Report.pdf
2018-09-05,2018,Resolute_Holdings,U.S. recycled pulp mill purchased by paper giant,General_Update,"The largest paper company in China announced Aug. 30 that it will purchase a Fairmont, W.Va. recycled paper mill from Resolute Forest Products. The mill ...",https://resource-recycling.com/recycling/2018/09/05/u-s-recycled-pulp-mill-purchased-by-paper-giant/
2018-09-07,2018,Resolute_Holdings,Company Resolute Mining Limited - MarketScreener,General_Update,"Resolute Mining Ltd is an Australia-based gold miner, developer, and explorer company. The Company owns two producing gold mines.",https://www.marketscreener.com/quote/stock/RESOLUTE-MINING-LIMITED-6492565/company/
2018-09-07,2018,Resolute_Holdings,Paper Giant Nine Dragons to Purchase Resolute Forest ...,General_Update,"The company has entered into a purchase agreement with Resolute Forest Products to buy its recycled pulp mill in Fairmount, West Virginia, for USD 55 million.",https://papermart.in/paper-giant-nine-dragons-to-purchase-resolute-forest-productss-pulp-mill-in-us/
2018-10-01,2018,Resolute_Holdings,New-Indy reaches agreement to acquire Resolute Forest ...,General_Update,"They have reached an agreement to acquire Resolute Forest Products' Catawba paper and pulp mill located on the Catawba River in Catawba, South Carolina.",https://www.schwarzpartners.com/2018/10/01/new-indy-reaches-agreement-to-acquire-resolute-forest-products-catawba-mill/
2018-10-03,2018,Resolute_Holdings,Resolute to sell Catawba paper and pulp mill in US for ...,General_Update,"Resolute Forest Products has signed an agreement to divest its paper and pulp mill in Catawba, South Carolina, US, to New-Indy Containerboard for about $300m.",https://www.packaging-gateway.com/news/resolute-sell-catawba-paper-pulp-mill-us-300m/
2018-10-15,2018,Resolute_Holdings,Fund Asset Class Ticker Security Name CUSIP ...,Financial_Performance,Fund. Asset Class. Ticker. Security Name. CUSIP Number Shares/Par Value. Base Price Amount. Base Market Value. Interest Rate Maturity Date. NQ11 EQUITY.,https://www.vermonttreasurer.gov/sites/treasurer/files/pension-funds/pension-funds-holdings/VPIC_2011-06.pdf
2018-10-19,2018,Resolute_Holdings,Kimmeridge Energy Calls on Resolute Energy to Pursue a ...,General_Update,"Yet since the time we invested in the Company, Resolute has continually failed to deliver on the promises made to the investment community. As a result, the ...",https://www.prnewswire.com/news-releases/kimmeridge-energy-calls-on-resolute-energy-to-pursue-a-sale-or-combination-300734360.html
2018-11-01,2018,Resolute_Holdings,ND Paper Completes Acquisition of Recycled Pulp Mill in ...,Corporate_Action,"ND Paper LLC, a wholly-owned subsidiary of Nine Dragons Paper (Holdings) Limited, today completed its acquisition of the Fairmont, West Virginia recycled pulp ...",https://us.ndpaper.com/nd-paper-completes-acquisition-of-recycled-pulp-mill-in-west-virginia/
2018-11-02,2018,Resolute_Holdings,ND Paper completes acquisition of West Virginia mill,Corporate_Action,ND Paper completes acquisition of West Virginia mill. The company paid $62 million in cash for the Resolute Forest Products Inc. mill.,https://www.recyclingtoday.com/news/nd-paper-nine-dragons-completes-fairmont-mill-acquisition/
2018-11-07,2018,Resolute_Holdings,The Target Report: November 2018,General_Update,"New-Indy Containerboard, based in Ontario, California, has acquired Resolute Forest Products' paper and pulp mill in Catawba, South Carolina. The acquired ...",https://www.thetargetreport.com/2018/11/
2018-11-19,2018,Resolute_Holdings,Cimarex to Acquire Delaware Pure-Play Resolute ...,General_Update,"The consideration represents an approximate 14.8% percent premium to Resolute's closing price of $30.49 on November 16, 2018. Upon closing of the ...",https://www.sec.gov/Archives/edgar/data/1469510/000110465918069071/a18-40414_1ex99d1.htm
2018-11-19,2018,Resolute_Holdings,Cimarex $1.6B Tie-Up with Resolute Builds Permian ...,Financial_Performance,"The cash-and-stock transaction would give Resolute $35/share and assume $710 million in debt, putting the total value at about $1.6 billion. “The Resolute ...",https://naturalgasintel.com/news/cimarex-16b-tie-up-with-resolute-builds-permian-delaware-prospects/
2018-11-28,2018,Resolute_Holdings,ZEMIX,Financial_Performance,The Fund invests in the strong growth opportunities of companies listed and/or operating in emerging markets. It offers a core solution for emerging market ...,https://americanbeaconfunds.com/products/mutual-funds/american-beacon-ninety-one-emerging-markets-equity-fund/zemix/
2018-12-11,2018,Resolute_Holdings,Board of Trustees,General_Update,CEO RODELL began by talking about attending the International Forum of Sovereign Wealth. Funds annual meeting in Marrakesh. She continued that every three ...,https://apfc.org/wp-content/uploads/2018/12/APFC-Quarterly-December-11-12-BOT-Packet.pdf
2018-12-19,2018,Resolute_Holdings,National Defense Authorization Act for Fiscal Year 2015,General_Update,Repeal of annual report on Department of Defense operation and financial support for military museums. ... services during the five-year period preceding the date ...,https://www.govinfo.gov/content/pkg/PLAW-113publ291/html/PLAW-113publ291.htm
2018-12-29,2018,Resolute_Holdings,Clara Miller,General_Update,"On June 15, 2018, Clara beloved wife of the late Irwin (Sonny). Loving mother of Sheldon (Sharon), Eli (Sylvia), Stewart (Joanne), Cindy (Hilary).",https://steelesmemorialchapel.com/condolence/clara-miller-2/
2018-12-31,2018,Resolute_Holdings,Radnor Specialty Insurance Company as of 12-31-2018,Financial_Performance,"As of December 31, 2018, Company records indicated that all 840,000 shares of common stock were issued and outstanding and owned by MVS. There were no changes ...",https://doi.nebraska.gov/sites/default/files/doc/Radnor%20Specialty%20Insurance%20Company%20as%20of%2012-31-2018%20-%20Risk%20Focused.pdf
2018-12-31,2018,Resolute_Holdings,U.S. 2018 Resolution Plan Section 1,General_Update,"Under the Rule, a covered company must submit a resolution plan that provides for the covered company's rapid and orderly resolution (as such term is defined in ...",https://www.federalreserve.gov/supervisionreg/resolution-plans/mizuho-fin-3g-20181231.pdf
2019-01-01,2019,Resolute_Holdings,"Resolute Completes Sale of Catawba, SC, Paper and Pulp ...",General_Update,"The total purchase price of about $300 million consists of $260 million in cash, before customary closing adjustments, and the assumption of approximately $40 ...",https://www.newswire.ca/news-releases/resolute-completes-sale-of-catawba-sc-paper-and-pulp-mill-885302739.html
2019-01-03,2019,Resolute_Holdings,Oil And Gas Investor Ranks Top 50 E&Ps,General_Update,"It will deliver water by pipe to all wells in 2019, savings $500,000 per. A share repurchase program was initiated in September; cash flow positive will be ...",https://www.hartenergy.com/exclusives/oil-and-gas-investor-ranks-top-50-eps-31702/
2019-01-10,2019,Resolute_Holdings,Lazard's 2018 Review of Shareholder Activism,General_Update,1. Companies spun off as part of campaign process counted separately. 2. Calculated as of campaign announcement date. Does not include derivative positions. 3.,https://www.lazard.com/media/m35ntdue/lazards-2018-review-of-shareholder-activism.pdf
2019-01-13,2019,Resolute_Holdings,Fairfax stock positions - The Value Investor's Haven,Financial_Performance,"As of early 2019 the share price is $19 and JPM estimate the NAV is $26 going to $30 in 2020. The dividend is 4.4% and rising, and a buyback is in place. The ...",https://thecobf.com/forum/topic/16427-fairfax-stock-positions/
2019-01-21,2019,Resolute_Holdings,Upstream M&A Deal Activity Surged In Late 2018,Financial_Performance,"Public companies' desire for scale drove mergers and acquisitions that pushed 2018's upstream deal value to $84 billion, the highest total since 2014.",https://www.aogr.com/web-exclusives/exclusive-story/upstream-ma-deal-activity-surged-in-late-2018
2019-01-29,2019,Resolute_Holdings,Resolute Completes Sale of Catawba to New Indy ...,General_Update,Resolute Completes Sale of Catawba to New Indy Containerboard. TM Capital served as exclusive financial advisor to Resolute Forest Products Inc. (NYSE: RFP) in ...,https://tmcapital.com/transactions/resolute-completes-sale-of-catawba-to-new-indy-containerboard/
2019-01-29,2019,Resolute_Holdings,Mills,General_Update,"Paper Excellence acquires Resolute Forest Products. By FDN StaffJuly 8, 2022. Pixelle owner sells Wisconsin mill to larger firm. By FDN StaffApril 11, 2022 ...",https://www.forestdatanetwork.com/news/category/mills
2019-02-08,2019,Resolute_Holdings,Asset Detail,General_Update,"Grand Total. 337,341,374,122.6.. 16,678,734,053.79. ALTERNATIVE INVESTMENTS. 383,172,041.330. 382,375,079.30. ANCHORAGE CAPITAL. 1,974,352.480. 1,974,352.48.",https://www.kyret.ky.gov/Investments/Investments%20Holdings/KTYALL%20Holdings%20as%20of%2031%20December%202018.pdf
2019-02-22,2019,Resolute_Holdings,Corporate Leverage: Par for the Course or Crisis Harbinger?,Financial_Performance,We identified high corporate leverage and growth in BBB-rated debt outstanding as the predominate current risks for domestic credit markets.,https://www.capitaladvisors.com/research/corporate-leverage-par-for-the-course-or-harbinger-of-an-upcoming-crisis/
2019-03-01,2019,Resolute_Holdings,Cimarex announces closing of the acquisition of Resolute ...,Corporate_Action,"Cimarex Energy Co. (NYSE: XEC) announced that it completed its acquisition of Resolute Energy Corporation (NYSE: REN) (Resolute) on March 1, 2019.",https://www.prnewswire.com/news-releases/cimarex-announces-closing-of-the-acquisition-of-resolute-energy-300804956.html
2019-03-08,2019,Resolute_Holdings,We would have had an excellent year in 2018 but a ...,Financial_Performance,"To Our Shareholders: We would have had an excellent year in 2018 but a collapse in stock prices in the fourth quarter, which was reflected.",https://www.fairfax.ca/wp-content/uploads/2018-Shareholders-Letter.pdf
2019-04-01,2019,Resolute_Holdings,2018,Financial_Performance,Strong development in all customer segments and geographical regions. • Record-high adjusted operating profit. • Strengthened balance sheet enables growth.,https://www.annualreport.sandvik/en/2018/servicepages/downloads/files/entire_en_svk_ar18.pdf
2019-04-02,2019,Resolute_Holdings,Cresco Labs to Acquire Origin House in Largest-Ever ...,Corporate_Action,Cresco Labs to Acquire Origin House in Largest-Ever Public Company Acquisition in U.S. Cannabis Sector. The Transaction represents a total consideration of ...,https://www.cannabisbusinesstimes.com/business-issues-benchmarks/mergers-and-acquisitions/news/15698669/cresco-labs-to-acquire-origin-house-in-largest-ever-public-company-acquisition-in-us-cannabis-sector
2019-04-04,2019,Resolute_Holdings,2019 Annual Report and Accounts - ...,Financial_Performance,"UniCredit S.p.A.. A joint stock company. Registered Office and Head Office: Piazza Gae Aulenti, 3 - Tower A - 20154 Milano.",https://www.unicreditgroup.eu/content/dam/unicreditgroup-eu/documents/en/investors/financial-reports/2019/4Q19/2019-Annual-Report-and-Accounts-General-Meeting-Draft.pdf
2019-04-26,2019,Resolute_Holdings,enstar group limited,Financial_Performance,"CPPIB has subsequently acquired additional shares, and its current direct and indirect holdings constitute an economic interest of approximately 17.9%.",https://www.sec.gov/Archives/edgar/data/1363829/000136382919000069/esgr-2019611xdef14a.htm
2019-04-26,2019,Resolute_Holdings,Press release,General_Update,"• The financial outlook, as presented in February 2019, is unchanged with 2019 group revenue of EUR 1,975 - 2,040 million and 2019 group EBITDA of EUR 1,220 ...",https://www.ses.com/sites/default/files/2019-04/2019_Q1_Results_Press%20Release_FINAL.pdf
2019-06-09,2019,Resolute_Holdings,Financial Condition Report 2018,Financial_Performance,"Percentages are based on 17,966,593 ordinary shares outstanding as of March 31, 2019. In addition to voting ordinary shares, there were a total of 3,509,682 ...",https://www.enstargroup.com/wp-content/uploads/2019/06/Financial-Condition-Report-2018.pdf
2019-06-30,2019,Resolute_Holdings,New York City Police,Financial_Performance,"buyback. Members who have already completed a military buyback for time covering the RMS period, will receive a refund for the buyback or the Fund will ...",https://www.nyc.gov/assets/nycppf/downloads/pdf/ACFR-FY2024-Final.pdf
2019-06-30,2019,Resolute_Holdings,POSITIONING FOR A SUSTAINABLE FUTURE,General_Update,"In 2019 we focused on building our skills and capabilities, optimising processes and ensuring safe, stable and environmentally compliant operations. We continue ...",https://www.sasol.com/sites/default/files/2024-08/Sasol%20Integrated%20Report%20Web.pdf
2019-07-01,2019,Resolute_Holdings,BANK OF AMERICA CORPORATION 2019 RESOLUTION ...,General_Update,Derivative and Trading Activities​​ This Executive Summary provides a high-level overview of our confidential 2019 Resolution Plan submitted to the Agencies.,https://www.federalreserve.gov/supervisionreg/resolution-plans/boa-1g-20190701.pdf
2019-07-31,2019,Resolute_Holdings,RESOLUTE TO ACQUIRE TORO GOLD,Financial_Performance,"Second Completion: on 12 August 2019, Resolute will acquire Toro Gold shares from those Toro Gold shareholders who have not signed commitment agreements but ...",https://www.asx.com.au/asxpdf/20190731/pdf/4472sjq57l8vm2.pdf
2019-08-03,2019,Resolute_Holdings,One Equity Partners Completes Sale of Resolute Industrial ...,Clinical_Milestone,"One Equity Partners (OEP), a leading middle market private equity firm, today announced that it has completed the sale of Resolute Industrial Holdings, LLC.",https://www.oneequity.com/news/one-equity-partners-completes-sale-of-resolute-industrial-holdings/
2019-09-05,2019,Resolute_Holdings,N-PX,General_Update,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT ...",https://www.sec.gov/Archives/edgar/data/799127/000114420419042822/tv525419_quantitative0093.htm
2019-09-09,2019,Resolute_Holdings,2019 ICSID Annual Report - World Bank,General_Update,The World Bank Group is fully committed to helping our clients overcome political and regulatory risks that deter private investment from entering new markets.,https://icsid.worldbank.org/sites/default/files/publications/annual-report/en/ICSID_AR19_CRA_Web_Low_DD.pdf
2019-10-15,2019,Resolute_Holdings,Resolute Bank P&A,General_Update,"Indemnitee of the antitrust, branching, banking or bank holding company or securities laws of the United States of America or any state thereof;. (vi) claims ...",https://www.fdic.gov/bank-failures/purchase-assumption-agreement-resolute-bank-maumee-oh
2019-10-30,2019,Resolute_Holdings,THE BOEING 737 MAX,General_Update,get out of a spin. Today you can't do that. An instructor is not allowed to let a stall fully develop. At the first warning—this is what it states in the.,https://www.govinfo.gov/content/pkg/CHRG-116hhrg38282/pdf/CHRG-116hhrg38282.pdf
2019-10-31,2019,Resolute_Holdings,NICOLE MANOS,General_Update,"SUMMARY. Nicole Manos brings 20 years of finance and accounting experience to Resolute. Her areas of expertise include restructuring, forensic.",https://resolutecommercial.com/wp-content/uploads/2019/10/Nicole-Manos-CV-2019.pdf
2019-11-05,2019,Resolute_Holdings,Bruin Capital announces strategic partnership with CVC and ...,Corporate_Action,"The deal gives Bruin access to billions in capital, plus a global network of resources from the partners beginning with an initial combined investment for $600 ...",https://www.cvc.com/media/news/2019/2019-11-05-bruin-capital-announces-strategic-partnership-with-cvc-and-the-jordan-company/
2019-11-25,2019,Resolute_Holdings,Eric Sprott and Tom Stanley lost big yesterday,General_Update,"Assuming that the holdings are unchanged, that's a combined paper loss of ~$250 million. The Resolute fund lost 8.71% yesterday (or since last NAV print).",https://opmwire.com/eric-sprott-and-tom-stanley-lost-big-yesterday/
2019-11-26,2019,Resolute_Holdings,FULLY INTEGRATED RESOLUTE TARGETS PREMIUM ...,General_Update,"“Resolute is a fully integrated manufacturer of quality products, and our tissue operations benefit from this vertical integration. These products are ...",https://www.tissueworldmagazine.com/departments/operations-report/fully-integrated-resolute-targets-premium-and-ultra-premium-production/
2019-12-08,2019,Resolute_Holdings,Stanford University Investment Report,Financial_Performance,"MERGED POOL GROWTH OF $100. (for the period July 1, 1991 to June 30, 2019). Growth of $100. *As reported by Cambridge Associates. Merged Pool. Cambridge ...",https://smc.stanford.edu/assets/Stanford-University-Investment-Report-2019.pdf
2019-12-24,2019,Resolute_Holdings,Resolute to Acquire Conifex's Three U.S. Sawmills,General_Update,CNW Telbec/ - Resolute Forest Products Inc. (NYSE: RFP) (TSX: RFP) today announced it has entered into an agreement to acquire Conifex Timber Inc.'s three.,https://www.newswire.ca/news-releases/resolute-to-acquire-conifex-s-three-u-s-sawmills-870242533.html
2019-12-28,2019,Resolute_Holdings,CSRC Annual Report 2019,Financial_Performance,"The legislative revision tackled a series of critical issues in capital markets, and set new milestones by instituting a registration-based IPO regime, much ...",http://www.csrc.gov.cn/csrc_en/c102063/c1606308/1606308/files/CSRC%20Annual%20Report%202019.pdf
2020-01-01,2020,Resolute_Holdings,Private Equity Buyouts in Healthcare,General_Update,"by E Appelbaum · 2020 · Cited by 137 — In late 2016, CHS announced it would sell more than 12 of its hospitals; earlier, in April, it did a spinoff of 38 small, mostly rural hospitals into Quorum ...",https://www.ineteconomics.org/uploads/papers/WP_118-Appelbaum-and-Batt-2-rb-Clean.pdf
2020-01-01,2020,Resolute_Holdings,Tokenisation: the future of real estate investment?,Corporate_Action,"by A Baum · 2020 · Cited by 157 — Holding in an off-market deal (Medium, 2020). This was a share deal in which a significant part of the purchase price of around €120m was to be paid in ...",https://www.sbs.ox.ac.uk/sites/default/files/2020-01/Tokenisation%20Report.pdf
2020-01-15,2020,Resolute_Holdings,Resolute Mining to sell Ravenswood Gold Mine for total ...,General_Update,Resolute Mining to sell Ravenswood Gold Mine for total proceeds of up to $300 million. Last updated: 17:34 15 Jan 2020 AEDT. First Published: 12:30 15 Jan 2020 ...,https://www.proactiveinvestors.com.au/companies/news/910669/resolute-mining-to-sell-ravenswood-gold-mine-for-total-proceeds-of-up-to-300-million-910669.html
2020-02-27,2020,Resolute_Holdings,SNC-LAVALIN GROUP INC. ANNUAL INFORMATION ...,General_Update,"Statements made in this Annual Information Form that describe the Company's or management's budgets, estimates, expectations, forecasts, objectives, ...",https://www.atkinsrealis.com/~/media/Files/A/atkinsrealis/investor-briefcase/en/2019/annual-info-form-2019-en.pdf
2020-03-06,2020,Resolute_Holdings,To Our Shareholders: We had an excellent year in 2019. ...,Financial_Performance,Our net investment in Resolute is $745 million while the carrying value of our shares is approximately $200 million. 21. Page 18. FAIRFAX FINANCIAL HOLDINGS ...,https://www.fairfax.ca/wp-content/uploads/Fairfax-Financial-Shareholders-Letter.pdf
2020-03-20,2020,Resolute_Holdings,Members of the Coronavirus Task Force Hold a Press ...,Financial_Performance,"I don't want to have stock buybacks. I don't want people spending — I don't want some executives saying, “We're going to buy 200,000 shares of stock.” ...",https://it.usembassy.gov/members-of-the-coronavirus-task-force-hold-a-press-briefing-march-20-2020/
2020-03-31,2020,Resolute_Holdings,"Semiannual Report to Congress - October 1, 2019",General_Update,"This Treasury OIG Semiannual Report to Congress for the 6-month period ended. March 31, 2020, is a testament to my staff's dedication to service. I would like ...",https://oig.treasury.gov/system/files/2020-12/Semiannual_Report_to_Congress_Mar_2020.pdf
2020-03-31,2020,Resolute_Holdings,2020 Three Month Interim Report ( ...,General_Update,GraceKennedy Limited is pleased to report its results for the first quarter of 2020 with reported revenue and profitability for the.,https://gracekennedy.com/report/2020-three-month-interim-report-q1/
2020-04-29,2020,Resolute_Holdings,1 AstraZeneca PLC 29 April 2020 07:00 BST First-quarter ...,General_Update,Variations in performance between quarters can be expected to continue. Financial guidance for FY 2020 is unchanged.,https://www.astrazeneca.com/content/dam/az/PDF/2020/q1-2020/Q1_2020_results_announcement.pdf
2020-04-30,2020,Resolute_Holdings,booklet 2020,General_Update,"In this highly international consortium, PhD students and postdocs will be exposed to the challenges of project management and learn about efficient reporting, ...",https://re-solute.eu/RESOLUTE_booklet.pdf
2020-05-22,2020,Resolute_Holdings,Joint Spin-off Report - Digital Asset Management - Siemens,Corporate_Action,"22 May 2020 (""Spin-off and Transfer Agreement""). The Spin-off and Transfer Agreement and its Annexes are enclosed with this Spin-off Report as Annex. The ...",https://assets.new.siemens.com/siemens/assets/api/uuid:7f7157d6-3d30-4e40-b6d3-60122892d7c9/Joint-Spin-off-Report-Convenience-Translation-22-May-2020.pdf
2020-06-03,2020,Resolute_Holdings,360 Finance Among First Wave of Companies to Register ...,Corporate_Action,"The Company provides tailored online consumer finance products to prime, underserved borrowers funded primarily by its funding partners. The Company's ...",https://ir.qifu.tech/news-releases/news-release-details/360-finance-among-first-wave-companies-register-its-financial
2020-06-07,2020,Resolute_Holdings,Recent Stock Spinoffs,Financial_Performance,"Euroholdings Ltd. Feb 28, 2025, CMPO · RHLD, Composecure Inc, Resolute Holdings Management Inc. Feb 24, 2025, WDC · SNDK, Western Digital Corp, Sandisk Corp.",https://stockanalysis.com/actions/spinoffs/
2020-07-15,2020,Resolute_Holdings,DINESH S SHETTY,Financial_Performance,"Resolute,. Resurgent. We are reimagining our customer- experience efforts, pushing forward on newly created priorities, driving innovation to make ...",https://www.titancompany.in/sites/default/files/2023-08/52-30SENoticeofAGMAnnualReport201920_1.pdf
2020-07-31,2020,Resolute_Holdings,Q3 2020 Deals - PE Hub,Corporate_Action,"Audrey Management Holdings Sarl, Blackstone Group LP, -, NORWAY - Audrey Management Holdings Sarl of Luxembourg, a unit of Blackstone Group LP, acquired the ...",https://media.pehub.com/uploads/2020/07/Q3-2020-Deals.xlsx
2020-08-24,2020,Resolute_Holdings,Registration Statement on Form S-1,Financial_Performance,"... 2020. We generated revenue of $46.1 million and $69.3 million for the six months ended June 30, 2019 and 2020, respectively, representing a growth rate of 50%.",https://www.sec.gov/Archives/edgar/data/1800667/000119312520228195/d841831ds1.htm
2020-08-26,2020,Resolute_Holdings,ASX Announcements,Corporate_Action,Marvel finalises acquisition of South Mali Gold Projects · Proposed issue of Securities - MVL · OKU: Oklo Finalises Divestment of South Mali Projects.,https://marvelgold.com.au/investors/asx-announcements/
2020-08-31,2020,Resolute_Holdings,American Beacon Bridgeway Large Cap Value,General_Update,"Resolute Investment Management, has 212 employees, including 46 investment ... – $5.3 billion in firm assets under management as of June 30, 2020.",https://etf.wi.gov/boards/deferredcompensation/2020/08/31/dcic3/direct
2020-09-17,2020,Resolute_Holdings,Investment Stewardship Annual Report,General_Update,"For 2020, BIS articulated five Engagement Priorities: board quality, environmental risks and opportunities, corporate strategy and capital allocation, human ...",https://www.troutman.com/wp-content/uploads/2025/03/BlackRock.Investment.Stewardship.Annual.Report.2020.pdf
2020-09-30,2020,Resolute_Holdings,Resolution Life completes acquisition of AMP Life,Corporate_Action,"Nippon Life Insurance Company acquired the Resolution Life Group globally, including Resolution Life Australasia, on 30 October 2025, and have established the ...",https://resolutionlife.com.au/newsroom/2020/september/Resolution-Life-completes-acquisition-of-AMP-Life
2020-11-05,2020,Resolute_Holdings,Grifols continues delivering solid revenue and earnings ...,General_Update,"As of September 30, 2020, reported net profit totaled EUR 485.7 million (EUR 423.4 million in 2019), affected mainly by COVID-19 impacts, the operating-expense ...",https://www.grifols.com/en/view-news/-/news/grifols-continues-delivering-solid-revenue-and-earnings-growth-driven-by-the-bioscience-and-diagnostic-divisions
2020-11-05,2020,Resolute_Holdings,Resolute Announces Appointment of Remi G. Lalonde as ...,General_Update,"The board of directors has unanimously selected and appointed Remi G. Lalonde as the company's next president and chief executive officer, effective on the ...",https://www.paperfirst.info/resolute-announces-appointment-of-remi-g-lalonde-as-president-and-ceo-succeeding-yves-laflamme/
2020-11-05,2020,Resolute_Holdings,Resolute Announces Appointment of Remi G. Lalonde as ...,General_Update,The board of directors has unanimously selected and appointed Remi G. Lalonde as the company's next president and chief executive officer.,https://www.newswire.ca/news-releases/resolute-announces-appointment-of-remi-g-lalonde-as-president-and-ceo-succeeding-yves-laflamme-880527127.html
2020-11-06,2020,Resolute_Holdings,Annual Report 2020,General_Update,"We found a new perspective on ourselves, our neighbours, our country and the world. As a Group, we affirmed the hope that we could maintain the lives we built.",https://republictt.com/pdfs/annual-reports/RFHL-AR-2020.pdf
2020-11-16,2020,Resolute_Holdings,2020 OWB Annual Report,General_Update,"In FY 2020, OWB processed more claims than in any other year of the program, and the Commission issued the largest number of Final Orders resolving ...",https://www.sec.gov/files/2020_owb_annual_report.pdf
2020-11-19,2020,Resolute_Holdings,Asset Detail,General_Update,"Grand Total. 200,957,708,381.2.. 19,336,201,320.65. ALTERNATIVE INVESTMENTS. 606,669,040.340. 606,669,038.34. ARROWMARK FUND I. 488,373,010.890.",https://www.kyret.ky.gov/Investments/Investments%20Holdings/KTYALL%20Holdings%20as%20of%2031%20September%202020.pdf
2020-12-15,2020,Resolute_Holdings,"The Jordan Company, L.P. Closes on its Acquisition of ...",Corporate_Action,"The Jordan Company, LP (TJC) is pleased to announce that an affiliate of The Resolute Fund IV, LP (Resolute IV) has closed on its acquisition of Spectrio, LLC.",https://www.spectrio.com/company-news/the-jordan-company-closes-acquisition-spectrio/
2020-12-15,2020,Resolute_Holdings,"The Jordan Company, L.P. Closes Acquisition of Heartland ...",Corporate_Action,"The Jordan Company, LP (TJC) today announced that an affiliate of The Resolute Fund IV, LP (Resolute IV) has acquired Heartland Home Services.",https://www.prnewswire.com/news-releases/the-jordan-company-lp-closes-acquisition-of-heartland-home-services-301193310.html
2020-12-17,2020,Resolute_Holdings,BarkBox To Go Public Via SPAC,Corporate_Action,The company agreed to merge with Northern Star Acquisition Corp. in a $1.6 billion deal that will take the company public.,https://news.crunchbase.com/public/barkbox-to-go-public-via-spac/
2020-12-22,2020,Resolute_Holdings,Co-founder wants me to leave but won't entertain a buy out ...,Corporate_Action,"digitaltrees on Dec 22, 2020 | root | parent | prev | next [–]. This advice will almost certainly result in no deal and leave all parties worse off. Instead ...",https://news.ycombinator.com/item?id=25506593
2020-12-29,2020,Resolute_Holdings,Acquisitive Spectrio Is Itself Acquired By Different PE Firm,Corporate_Action,"NYC-based The Jordan Company (TJC) announced that what I guess is a fund in its portfolio – the Resolute Fund IV – has closed on its acquisition of Spectrio, ...",https://www.sixteen-nine.net/2020/12/29/acquisitive-spectrio-is-itself-acquired-by-different-pe-firm/
2020-12-31,2020,Resolute_Holdings,National Indemnity Company as of 12-31-2020,Financial_Performance,"As of December 31, 2020, Company records indicated that 550,000 shares were issued ... agreement with Resolute Management Services Limited (RMSL), effective April ...",https://doi.nebraska.gov/sites/default/files/doc/National%20Indemnity%20Company%20as%20of%2012-31-2020_0.pdf
2020-12-31,2020,Resolute_Holdings,2020 ANNUAL REPORT,General_Update,"Building on critical organizational accomplishments in recent years, key priorities in 2020 included: monitoring and managing the impact of the coronavirus.",https://www.annualreports.com/HostedData/AnnualReportArchive/f/NASDAQ_BUSE_2020.pdf
2020-12-31,2020,Resolute_Holdings,ANNUAL REPORT,Corporate_Action,"Net profit achieved in 2020 amounted to CHF 699 million. Excluding expenses related to acquisitions or divestments and the taxes on those respective items, ...",https://www.juliusbaer.com/index.php?eID=dumpFile&t=f&f=75197&token=26bcf52ad4576fb076e8ad0e0dcc85d0cb773599
2020-12-31,2020,Resolute_Holdings,Principal® Announces Fourth Quarter and Full Year 2020 ...,General_Update,"(PFG) of $472.6 million, or $1.70 per diluted share. Full year 2020 net income attributable to PFG of $1,395.8 million, or $5.05 per diluted share.",https://investors.principal.com/news-releases/news-release-details/principalr-announces-fourth-quarter-and-full-year-2020-results
2020-12-31,2020,Resolute_Holdings,Annual Report 2020 - European Central Bank,General_Update,"Overall, euro area GDP contracted by 6.6% in 2020. Annual headline inflation declined to 0.3%, from 1.2% in 2019, in large part as a result of falling energy ...",https://www.ecb.europa.eu/press/annual-reports-financial-statements/annual/html/ar2020~4960fb81ae.en.html
2021-01-04,2021,Resolute_Holdings,Resolution Life completes acquisition of Voya Financial's ...,Corporate_Action,"Resolution Life, a global manager of in-force life insurance businesses, is delighted to announce today that it has completed the acquisition of Voya Financial.",https://www.resolutionlife.com/news-and-insights/resolution-life-completes-acquisition-of-voya-financial-s-individual-life-in-force-business/
2021-01-18,2021,Resolute_Holdings,Resolute Announces Appointment of Sylvain A. Girard as ...,General_Update,"Sylvain A. Girard will join the company and be appointed as senior vice president and chief financial officer as of March 2, 2021.",https://resolutefp.mediaroom.com/2021-01-18-Resolute-Announces-Appointment-of-Sylvain-A-Girard-as-Chief-Financial-Officer
2021-02-01,2021,Resolute_Holdings,Monthly Archives: February 2021,General_Update,"The table below identifies the mutual funds which returned 30% or more last year after having trailed 66-100% of their peers in 2019, 2018 and 2017.",https://www.mutualfundobserver.com/2021/02/
2021-02-26,2021,Resolute_Holdings,Gujarat Apollo Industries Limited – Buyback – Draft Letter ...,Financial_Performance,"The Buyback has been authorised by the resolution of the Board of Directors passed at their meeting which was held on February 13, 2021. 9. NECESSITY OF THE ...",https://www.plindia.com/wp-content/uploads/2025/03/40.-Gujarat-Apollo-Industries-Limited-%E2%80%93-Buyback-%E2%80%93-Draft-Letter-of-Offer.pdf
2021-03-02,2021,Resolute_Holdings,Annual report,Clinical_Milestone,"Since January 1, 2021, Industrial Trucks & Services has consisted of three Operating Units: KION. ITS EMEA, which concentrates on Europe, the Middle East, and ...",https://www.kiongroup.com/KION-Website-Main/Investor-Relations/Reports-Presentations/2021-Reports-Presentations/kion_group_report_2020_en_fy.pdf
2021-03-04,2021,Resolute_Holdings,ASMI 2020 Annual report,Financial_Performance,The 2020/2021 program is our seventh consecutive share buyback program. In addition to the. 2019/2020 program the earlier programs included: › On June 5 ...,https://www.asm.com/media/yvnkqann/2020_asmi_annual_report.pdf
2021-03-26,2021,Resolute_Holdings,Euroclear agrees to acquire MFEX Group,General_Update,"Euroclear has agreed to acquire MFEX Group, a leading global digital fund distribution platform, majority owned by Nordic Capital.",https://www.euroclear.com/newsandinsights/en/press/2021/2021-mr-08-euroclear-agrees-to-acquire-mfex-group.html
2021-03-29,2021,Resolute_Holdings,Broadridge Extends Capital Markets Franchise with ...,Corporate_Action,Acquisition will expand Broadridge's capital markets franchise by extending into the front office and enhancing its multi-asset capabilities.,https://www.broadridge.com/press-release/2021/broadridge-agrees-to-acquire-itiviti
2021-03-31,2021,Resolute_Holdings,Financial Results,Financial_Performance,"Equity attributable to stockholders of the parent increased by 22% or $28.8 billion to $162.7 billion as at March 31, 2021. The growth in equity was mainly ...",https://www.myncb.com/NCBFinancialGroup/media/NCB-Financial-Group/Reports/Financials/2020/NCB-Financial-Group-Limited-NCBFG-Unaudited-Financial-Results-Six-Month-Ended-March-31-2021_Final.pdf?ext=.pdf
2021-05-18,2021,Resolute_Holdings,"PE Ratio - Solid Power, Inc.",General_Update,The company's current PE Ratio is -8.61. This represents a change of 116.18% compared to the average of -3.98 of the last 4 quarters.,https://www.wisesheets.io/pe-ratio/SLDP
2021-05-18,2021,Resolute_Holdings,News,General_Update,"Communication Power Companies combines with Innovative Power Products, Inc. October 4, 2024 ; Communication Power Companies Combines with STI-CO Industries.",https://addisoncapitalpartners.com/news/
2021-06-15,2021,Resolute_Holdings,Making Financial Protection Accessible to All,General_Update,"RGA overcame pandemic-driven earnings headwinds in 2021 to maintain profitability, advance strategic initiatives, and finish the year well-positioned for ...",https://www.rgare.com/docs/default-source/investor-relations/rga-annual-review-2021.pdf?sfvrsn=6d963f58_0
2021-06-20,2021,Resolute_Holdings,Investment Committee Semi-Annual Activity Report,General_Update,Fund size $1.25B - closed January 2021. Re-up. Venture Capital fund that will pursue healthcare investments in China and the United States.,https://www.calstrs.com/files/9e1c32352/semi062021P+-+Private+equity.pdf
2021-06-25,2021,Resolute_Holdings,Barbara J. Comly,General_Update,"The undersigned and applicant represent that the information and statements contained herein, including exhibits, schedules, or other documents ...",https://www.sec.gov/Archives/edgar/vprr/2100/21000461.pdf
2021-07-26,2021,Resolute_Holdings,Purpose. Passion. Progress. - Stronger security is required - 3M,Financial_Performance,"Your Company's overall growth rate on a standalone basis declined by 12% for the nancial year ended March. 31, 2021. The operating margin for the current year ...",https://multimedia.3m.com/mws/media/2066316O/annual-report-2020-21-3m-india-ltd.pdf
2021-07-26,2021,Resolute_Holdings,"Dental365 To Be Acquired by The Jordan Company, L.P.",General_Update,"The Jordan Company, LP (TJC) today announced that an affiliate of The Resolute Fund V, LP (Resolute V) has signed a definitive agreement to acquire Dental365.",https://www.regalhcp.com/2021/07/26/dental365-to-be-acquired-by-the-jordan-company-l-p
2021-07-30,2021,Resolute_Holdings,RFP Resolute Forest Products Inc. Earnings Call Transcripts,Financial_Performance,All earnings call transcripts on Resolute Forest Products Inc. (RFP) stock. Read or listen to the conference call. Download the investor presentation ...,https://seekingalpha.com/symbol/RFP-DEFUNCT-17234/earnings/transcripts
2021-08-04,2021,Resolute_Holdings,Asante Gold Announces Acquisition of Resolute's Bibiani,Financial_Performance,"Asante has agreed to buy all of Resolute's interest in Bibiani, through the purchase of 100% of the shares in Mensin Bibiani Pty Ltd., by paying to Resolute ...",https://www.globenewswire.com/news-release/2021/08/05/2275165/0/en/Asante-Gold-Announces-Acquisition-of-Resolute-s-Bibiani-Gold-Mine-in-Ghana-for-US-90-Million-Cash.html
2021-08-17,2021,Resolute_Holdings,Fueling Failure: How Execs at Bankrupt Fossil ...,General_Update,"The company sold off $1 billion in debt as it exited bankruptcy and posted a quarterly profit of $295 million. EXECUTIVE PAYOUTS: On May 5th, 2020, weeks before ...",https://www.citizen.org/article/fueling-failure/
2021-08-19,2021,Resolute_Holdings,Most Recently Listed Stocks,Financial_Performance,Recent and historical listings on the US stock market. Includes both IPOs and stocks listed for other reasons.,https://stockanalysis.com/actions/listed/
2021-08-31,2021,Resolute_Holdings,Report of the OBO/NOBO Working Group to the Staff of the ...,Financial_Performance,The street name system was established to improve the efficiency of securities trading by eliminating the need to transfer paper stock certificates.,https://www.ici.org/files/2021/obonobo.pdf
2021-09-24,2021,Resolute_Holdings,"Resolute Capital Partners Ltd, LLC, et al.",Corporate_Action,Respondents sold equity securities to investors in the form of membership interests in the pooled investment vehicles listed in Figure 1 (“Equity Funds”) below.,https://www.sec.gov/files/litigation/admin/2021/33-10987.pdf
2021-09-30,2021,Resolute_Holdings,Annual Financial Report 2021,Financial_Performance,c) on a resolution to approve the terms of a buy-back agreement (other than a resolution to approve a redemption of the holder's class of preference shares).,https://www.bendigoadelaide.com.au/globalassets/documents/bendigoadelaide/investorcentre/results-and-reporting/annual-reviews/annual-financial-report-2021.pdf
2021-11-12,2021,Resolute_Holdings,"November 12, 2021",Financial_Performance,"On November 5, 2021, the Company issued and sold 96,455 shares of its common stock to certain investors for an aggregate offering price of $1.1 million. The ...",https://www.sec.gov/Archives/edgar/data/1817825/000121390021058770/f10q0921_steelecreek.htm
2021-11-12,2021,Resolute_Holdings,Year to date and Q3 2021 results,Financial_Performance,"Total Revenue in the year to date, including Alexion from 21 July 2021, was $25,406m, representing growth of 32% (28% at CER). Total Revenue in the third ...",https://www.astrazeneca.com/content/dam/az/PDF/2021/q3/Year-to-date_and_Q3_2021_results_announcement.pdf
2021-11-15,2021,Resolute_Holdings,History,Corporate_Action,"Acquisition of Resolute Forest Products. On March 1, the Paper Excellence Group – through its wholly owned subsidiary Domtar Corporation – announced the ...",https://www.domtar.com/about-domtar/history/
2021-11-24,2021,Resolute_Holdings,Partnership to advance Inovalon's mission of empowering ...,Financial_Performance,"In accordance with the terms of the agreement, Inovalon stockholders will receive $41.00 in cash for each share of Class A Common Stock and Class B Common ...",https://www.nordiccapital.com/news-views/press-releases/equity-consortium-led-by-nordic-capital-and-including-insight-partners-completes-acquisition-of-inovalon/
2021-12-01,2021,Resolute_Holdings,SOLVENT WIND-DOWN OF TRADING BOOKS,General_Update,"This document sets out the scope and minimum expectations for SWD planning and potential execution, with the main objectives to (i) adequately prepare, develop ...",https://www.srb.europa.eu/system/files/media/document/2021-12-01_Solvent-wind-down-guidance-for-banks.pdf
2021-12-06,2021,Resolute_Holdings,"SONIC AUTOMOTIVE, INC.",Corporate_Action,"On December 6, 2021 (the “Closing Date”), Sonic Automotive, Inc. (“Sonic”) completed the acquisition of RFJ Auto Partners, Inc (“RFJ Auto”) pursuant to the.",https://ir.sonicautomotive.com/sec-filings/all-sec-filings/content/0001043509-21-000022/0001043509-21-000022.pdf
2021-12-15,2021,Resolute_Holdings,DISSOLUTION REPORT OF AMERICAN SPECIAL RISK ...,General_Update,"The Company's 2020 NAIC Annual Statement, September 30, 2021 NAIC Quarterly. Statement and subsequent transactions were reviewed as part of this examination.",https://insurance.delaware.gov/wp-content/uploads/sites/15/2022/01/AmericanSpecialRiskInsuranceCompany2021web.pdf
2021-12-21,2021,Resolute_Holdings,The Jordan Company Announces $5 Billion Final Close of ...,Corporate_Action,"Resolute V raised approximately $5 billion in capital commitments from a diverse group of limited partners including US public pension funds, sovereign wealth ...",https://www.prnewswire.com/news-releases/the-jordan-company-announces-5-billion-final-close-of-resolute-v-largest-fund-in-the-firms-history-301448656.html
2021-12-22,2021,Resolute_Holdings,Resolute Investment Managers Will Seek a Buyer Again,General_Update,"After selling off several stakes, advisory firm Resolute Investment Managers is going on the block again in 2022.",https://www.barrons.com/articles/resolute-investment-sale-51640200606?gaa_at=eafs&gaa_n=AWEtsqfQ3_BP9apEugZNrXi_2620Xgk-jANeUEYN810zBcDEm2jE3V3E6lYH&gaa_ts=6959dca2&gaa_sig=1rJy-J2xZxRbsIpk3KfNnh9JJiAhW5pWhN5MrDQrSBWDOtHxUXgUUWeNye9-6hZh44Wld3dQkkRJ24aVKuozeA%3D%3D
2021-12-30,2021,Resolute_Holdings,10 Top Performing Canadian Mutual Funds in 2021,General_Update,"As of Jun. 30, there are 20 holdings but about 40% is in Montreal-based Resolute Forest Products (RFP), with about 16% in Bausch Health Companies (BHC) and ...",https://global.morningstar.com/en-ca/funds/10-top-performing-canadian-mutual-funds-in-2021
2021-12-30,2021,Resolute_Holdings,Resolute Forest Products Management,General_Update,Resolute Forest Products Inc. is covered by 12 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report.,https://simplywall.st/stocks/gb/materials/lse-0kw8/resolute-forest-products-shares/management
2021-12-31,2021,Resolute_Holdings,"Finial Reinsurance Company, December 2021",Financial_Performance,"All shares of the Company are owned by Finial Holdings Inc. (FHI), a Delaware ... Effective July I, 2014, the Company and Resolute Management Inc. (RMI) ...",https://portal.ct.gov/-/media/CID/1_Stipulation/FinExam-Finial-Reins-Dec2021.pdf
2021-12-31,2021,Resolute_Holdings,ANNUAL REPORT 2021/22,Financial_Performance,"in 2021, we launched a £150 million share buyback, beginning in December 2021 and completed the programme in March 2022, repurchasing a total of. 8,402,720 ...",https://www.burberryplc.com/content/dam/burberryplc/corporate/documents/investors/annual-report-archive/annual-report-2021-22.pdf
2021-12-31,2021,Resolute_Holdings,Annual Report 2021,Financial_Performance,"On December 31, 2021, the firm had a total of 12,546,701 common shares outstanding with our book value rising to $65.66 per share, as compared to $54.93 at the ...",https://www.oppenheimer.com/annual-report/2021/annual-report-2021
2022-01-21,2022,Resolute_Holdings,Press Releases,General_Update,US $ Q2 GAAP net income of $6 million / $0.07 per diluted share Adjusted EBITDA of $37 million Reduced debt by $191 million; liquidity up $47 million to $396 ...,https://media.domtar.com/press-releases?l=100&o=100
2022-02-23,2022,Resolute_Holdings,Request Quote,General_Update,"Send quote, request, upload documents, contact us for a quote. Resolute Insurance Group 124 West Capitol Avenue, Suite 1886 Little Rock, Arkansas 72201, United ...",https://resoluteinsurancegroup.com/request-quote
2022-03-04,2022,Resolute_Holdings,Best Year in History: Record $3.4B Earned in 2021,General_Update,"An increased focus on wood products paid off in 2021 as lumber prices hit a record high. Resolute used these strong, albeit cyclical, cash flows to reduce debt ...",https://www.fairfax.ca/wp-content/uploads/Fairfax-Financial-Shareholders-Letter-2021-with-attachments.pdf
2022-03-22,2022,Resolute_Holdings,Annual Report,General_Update,"... holdings and/or sector allocations are subject to change at any time and are ... 2022 (ending September 30, 2021), Atlassian reported 57% year-over ...",https://imgpfunds.com/wp-content/uploads/2022/03/LGFT-Annual-Report-12.31.21-Web-Ready.pdf
2022-03-31,2022,Resolute_Holdings,Annual Report,General_Update,"2017. 2018. 2019. 2020. 2021. Bayer Group financial KPIs. Sales. 35,015. 36,742. 43,545. 41,400. 44,081. EBITDA1. 8,563. 9,695. 9,529. (2,910). 6,409.",https://www.bayer.com/sites/default/files/2022-03/Bayer-Annual-Report-2021.pdf
2022-04-12,2022,Resolute_Holdings,ILS Capital renamed as Resolute Global Partners as scope ...,Corporate_Action,"ILS Capital Management is changing its name to Resolute Global Partners, as it expands its scope of investment to include more insurance and reinsurance ...",https://www.artemis.bm/news/ils-capital-renamed-as-resolute-global-partners-as-scope-expands/
2022-04-30,2022,Resolute_Holdings,City of London Investment Group PLC,General_Update,City of London Investment Group PLC is an established asset management group which has built its reputation by specialising in Emerging Market closed-end ...,https://clig.com/wp-content/uploads/2022/04/CoL2019AR.pdf
2022-05-17,2022,Resolute_Holdings,2022 Annual Report | COMMITMENT - CSI,General_Update,"Revenues for fiscal 2022 crossed the $300 million mark, rising 8.7% to a record $316.6 million. We benefited from a 9.9% increase in revenues from.",https://www.csiweb.com/wp-content/themes/csiweb/dist/AR2022_CSIweb.pdf
2022-06-30,2022,Resolute_Holdings,New York City Police Pension Fund,Financial_Performance,"buyback. Members who have already completed a military buyback for time covering the RMS period, will receive a refund for the buyback or the Fund will ...",https://www.nyc.gov/assets/nycppf/downloads/pdf/ACFR%20FY2023%20Final.pdf
2022-07-05,2022,Resolute_Holdings,EX-99.1,Corporate_Action,"The cash portion of the merger consideration represents a premium of approximately 64% to Resolute's closing share price on NYSE on July 5, 2022. The cash ...",https://www.sec.gov/Archives/edgar/data/1393066/000119312522188216/d335342dex991.htm
2022-07-06,2022,Resolute_Holdings,Paper Excellence Group Enters Into Definitive Agreement to ...,Corporate_Action,"The cash portion of the merger consideration represents a premium of approximately 64% to Resolute's closing share price on NYSE on July 5, 2022. The cash ...",https://resolutefp.mediaroom.com/2022-07-06-PAPER-EXCELLENCE-GROUP-ENTERS-INTO-DEFINITIVE-AGREEMENT-TO-ACQUIRE-RESOLUTE-FOR-20-50-PER-SHARE-AND-ONE-CONTINGENT-VALUE-RIGHT-TIED-TO-POTENTIAL-DUTY-DEPOSIT-REFUNDS-OF-UP-TO-500-MILLION
2022-07-06,2022,Resolute_Holdings,Paper Excellence acquires Resolute Forest Products | Work,Financial_Performance,"Fairfax Financial Holdings Limited, which as of July 5, 2022 held approximately 30,548,190 shares (or 40%) of the outstanding shares of Resolute, entered ...",https://www.torys.com/en/work/2022/07/296eef18-d4aa-4451-bd37-acae30a77034
2022-07-06,2022,Resolute_Holdings,Paper Excellence Group Enters into Definitive Agreement ...,Financial_Performance,"Resolute is an ideal fit for our long-term growth strategy. It complements our existing pulp, paper and packaging businesses and adds capabilities in lumber and ...",https://www.paperage.com/2022news/07-06-2022paper-excellence-to-acquire-resolute.html
2022-07-06,2022,Resolute_Holdings,PAPER EXCELLENCE GROUP ENTERS INTO ...,Financial_Performance,"Under the CVR, stockholders will receive any refunds on approximately $500 million of deposits on estimated softwood lumber duties paid by Resolute through June ...",https://www.prnewswire.com/news-releases/paper-excellence-group-enters-into-definitive-agreement-to-acquire-resolute-for-20-50-per-share-and-one-contingent-value-right-tied-to-potential-duty-deposit-refunds-of-up-to-500-million-301581311.html
2022-07-06,2022,Resolute_Holdings,PAPER EXCELLENCE GROUP ENTERS INTO ...,General_Update,"Resolute will become a wholly-owned subsidiary of Domtar, under the auspices of the Group, and continue to operate on a business-as-usual basis under the ...",https://www.domtar.com/paper-excellence-group-enters-into-definitive-agreement-to-acquire-resolute-for-20-50-per-share-and-one-contingent-value-right-tied-to-potential-duty-deposit-refunds-of-up-to-500-million/
2022-07-06,2022,Resolute_Holdings,Resolute to Be Acquired by Paper Excellence Group in ...,Corporate_Action,"Paul, Weiss is advising Resolute Forest Products Inc., a global forest products company, in its acquisition by The Paper Excellence Group.",https://www.paulweiss.com/insights/client-news/resolute-to-be-acquired-by-paper-excellence-group-in-27-billion-deal
2022-07-06,2022,Resolute_Holdings,Paper Excellence Enters Agreement to Acquire Resolute ...,Financial_Performance,"Under the agreement, Domtar will acquire all outstanding shares of Resolute common stock. The transaction is expected to close in the first half of 2023. With ...",https://www.domtar.com/paper-excellence-enters-agreement-to-acquire-resolute-forest-products/
2022-07-06,2022,Resolute_Holdings,Paper Excellence Group to acquire Resolute in US$2.7- ...,General_Update,The Paper Excellence Group is acquiring Resolute Forest Products in a transaction valued at US$2.7 billion. Resolute will become a subsidiary of Domtar and it ...,https://www.northernontariobusiness.com/industry-news/forestry/paper-excellence-group-to-acquire-resolute-in-us27-billion-deal-5552552
2022-07-14,2022,Resolute_Holdings,Domtar Parent to Acquire Resolute Forest Products,General_Update,"Resolute will become a wholly-owned subsidiary of Domtar, under the auspices of the Group, and continue to operate on a business-as-usual basis under the ...",https://www.piworld.com/article/domtar-parent-acquires-resolute-forest-products/
2022-07-29,2022,Resolute_Holdings,Integrated Report,General_Update,"*2 Effective April 1, 2022, the Company's Cement Business and related businesses, etc. were split off in an absorption-type split with Mitsubishi UBE Cement ...",https://ir.mmc.co.jp/en/ir/news/news20220729102934.html
2022-09-20,2022,Resolute_Holdings,DEFM14A,Financial_Performance,"The accompanying proxy statement is dated September 20, 2022 and is first being mailed to the Company's stockholders on or about September 20, 2022. Table of ...",https://www.sec.gov/Archives/edgar/data/1393066/000119312522247759/d329267ddefm14a.htm
2022-09-30,2022,Resolute_Holdings,Investcorp Annual Report 2022,Financial_Performance,"Despite rising inflation and ongoing economic headwinds, during the past year the business delivered 14% growth in AUM and reached a record high of US$42.7 ...",https://www.investcorp.com/wp-content/uploads/2022/09/Investcorp-Annual-Report-2022.pdf
2022-10-05,2022,Resolute_Holdings,Papering over corporate control Paper Excellence's ...,General_Update,"9 And this year (2022) Paper Excellence announced the purchase for US$2.7 billion of Resolute Forest. Products10, which has pulp, paper, and lumber mills in the ...",https://www.greenpeace.org/static/planet4-canada-stateless/2022/10/ddb2befa-report_papering_over_corporate_control.pdf
2022-10-18,2022,Resolute_Holdings,Honoring our PACT Act of 2022,General_Update,"... date of the enactment of this Act, a report on the establishment of the Working Group under subsection (a). (2) Not later than two years after the date of ...",https://www.congress.gov/117/plaws/publ168/PLAW-117publ168.htm
2022-10-27,2022,Resolute_Holdings,Paper Excellence Group and Resolute Announce Intention to ...,Financial_Performance,"Beginning on September 20, 2022, Resolute mailed the definitive proxy statement and a proxy card to each stockholder entitled to vote at the special meeting ...",https://resolutefp.mediaroom.com/2022-10-27-Paper-Excellence-Group-and-Resolute-Announce-Intention-to-Sell-Thunder-Bay-Pulp-and-Paper-Mill
2022-10-28,2022,Resolute_Holdings,Resolute Forest Products - News Releases,Financial_Performance,"Sep 21, 2022. Resolute to Hold a Special Meeting of Stockholders on October 31, 2022. Aug 4, 2022. Resolute Reports Second Quarter 2022 Results. Jul 25, 2022.",https://resolutefp.mediaroom.com/news-releases?l=100
2022-10-28,2022,Resolute_Holdings,Resolute Forest Products - News Releases,General_Update,"Nov 4, 2024. Domtar Acquires Iconex Paper's Point-of-Sale Receipt Business in North America ; Oct 24, 2024. Paper Excellence Group Rebrands as Domtar ; Oct 4, ...",https://resolutefp.mediaroom.com/
2022-10-31,2022,Resolute_Holdings,HPE - 2022 Annual Report Form 10K,Financial_Performance,"The number of shares of Hewlett Packard Enterprise Company common stock outstanding as of December 2, 2022 was 1,281,816,851 shares.",https://investors.hpe.com/~/media/Files/H/HP-Enterprise-IR/documents/2022-annual-report-form-10k.pdf
2022-10-31,2022,Resolute_Holdings,Resolute Forest Products Inc. Press Releases | Cision,General_Update,"Feb 03, 2022, 07:00 ET Resolute Reports Preliminary Fourth Quarter and 2021 Results ... US $ Q4 GAAP net loss of $128 million / net income of $307 million for ...",https://www.newswire.ca/news/resolute-forest-products-inc/
2022-11-02,2022,Resolute_Holdings,Paper Excellence: The making of a new forestry giant,Corporate_Action,"The Resolute Forest Products acquisition would make it more of an integrated forestry company, with sawmills and woodlands added to its assets. Resolute's ...",https://www.timescolonist.com/business/paper-excellence-the-making-of-a-new-forestry-giant-6047535
2022-11-03,2022,Resolute_Holdings,Buy Resolute Forest Products Stock – RFP ... - Public Investing,Financial_Performance,"RFP (RFP) reported Q3 2022 earnings per share (EPS) of $1.08, missing estimates of $1.17 by 7.69%. In the same quarter last year, RFP's earnings per share (EPS) ...",https://public.com/stocks/rfp
2022-11-04,2022,Resolute_Holdings,Resolute Mining Limited (ASX:RSG) - Intelligent Investor,General_Update,"Resolute Mining Limited (ASX:RSG) share price, share research, charts, announcements, dividends, director trades and news at IntelligentInvestor.com.au.",https://www.intelligentinvestor.com.au/shares/asx-rsg/resolute-mining-limited
2022-11-30,2022,Resolute_Holdings,Annual Report 2022,General_Update,Investing in our future differentiator businesses that are positioned to win in faster growing markets. 2022 highlights. $6.2B. Reported net income. 14.0%.,https://www.cibc.com/content/dam/cibc-public-assets/about-cibc/investor-relations/pdfs/quarterly-results/2022/ar-22-en.pdf
2022-12-15,2022,Resolute_Holdings,Resolute Holdings Management,General_Update,Resolute Holdings is an alternative asset management platform led by David Cote and Tom Knott that will provide operating management services.,https://cbonds.com/company/594951/
2022-12-31,2022,Resolute_Holdings,securities and exchange commission,Financial_Performance,"The reverse stock split was effective on October 18, 2022, and its ... buybacks after December 31, 2022. We do not expect this to have a material ...",https://www.sec.gov/Archives/edgar/data/1009891/000121390023040540/f10k2022_airindust.htm
2022-12-31,2022,Resolute_Holdings,Computacenter - Final Results 2022 - Investors,Corporate_Action,"Group gross invoiced income grew by 30.7 per cent including the effects of acquisitions made in the middle of 2022, and by 27.1 per cent in constant currency2.",https://investors.computacenter.com/news-releases/news-release-details/computacenter-final-results-2022
2023-01-04,2023,Resolute_Holdings,"Update: Paper Excellence, Domtar acquire Resolute Forest ...",Financial_Performance,"Domtar will acquire all outstanding shares of Resolute common stock in the transaction, which is expected to close in the first half of next year.",https://www.recyclingtoday.com/news/paper-excellence-domtar-acquire-resolute-in-billion-dollar-deal/
2023-01-12,2023,Resolute_Holdings,Resolute Wealth Management | Company Overview & News,General_Update,"Merrill offers a broad range of brokerage, investment advisory and other services. There are important differences between brokerage and investment advisory ...",https://www.forbes.com/companies/resolute-wealth-management/
2023-01-13,2023,Resolute_Holdings,Bold action in an era of unprecedented change.,Financial_Performance,... buyback for the value of `120 billion ($1.5 billion) at the price of `445 per equity share. This is the biggest buyback in Wipro's history. We were tested ...,https://www.wipro.com/content/dam/nexus/staticsites/annual-report-2023/pdf/Wipro-Limited-IAR-22-23.pdf
2023-02-14,2023,Resolute_Holdings,Why Fairfax Stock Surged 84% in The 2022 Bear Market?,Financial_Performance,Fairfax has 15.7% of its holdings in pulp and paper company Resolute Forest Products. Forestry is a mature industry that is consolidating. Fairfax is selling ...,https://ca.finance.yahoo.com/news/why-fairfax-stock-surged-84-173000215.html
2023-03-01,2023,Resolute_Holdings,Paper Excellence Welcomes Resolute Into Its Family of ...,Corporate_Action,"The acquisition of Domtar in 2021 and Resolute today significantly increases the Group's scale, overall product offering and geographic reach. ""We are thrilled ...",https://www.prnewswire.com/news-releases/paper-excellence-welcomes-resolute-into-its-family-of-companies-301759524.html
2023-03-01,2023,Resolute_Holdings,Paper Excellence completes acquisition of Resolute Forest ...,Corporate_Action,"Paper Excellence has finalized the purchase of Resolute Forest Products, bringing a number of northwestern Ontario assets under its ownership.",https://www.northernontariobusiness.com/industry-news/forestry/paper-excellence-completes-acquisition-of-resolute-forest-products-6631067
2023-03-10,2023,Resolute_Holdings,To our Shareholders: We had an outstanding year in 2022 ...,Financial_Performance,"As at March 3,. 2023, the total market value exceeded the total year-end carrying value by approximately $900 million. Common Stock Holdings as at December 31, ...",https://www.fairfax.ca/wp-content/uploads/Fairfax-Financial-s-Shareholders-Letter-2022-updated-with-attachments.pdf
2023-03-24,2023,Resolute_Holdings,Resolute Forest Products Inc's Suppliers - RFP,General_Update,"Resolute Forest Products Inc's Suppliers recorded an increase in sales by 7.45 % year on year in Q3 2022, from the previous quarter, sales fell by -5.41 % ...",https://csimarket.com/stocks/suppliers_glance.php?code=RFP
2023-04-13,2023,Resolute_Holdings,The Banker Investment Banking Awards 2009,General_Update,The Banker awards focus on the kind of innovations that provide tangible benefits for their client base and for markets.,https://www.thebanker.com/content/15b130f9-ecd6-55b1-8afa-be3d3869d124
2023-05-05,2023,Resolute_Holdings,HSBC shareholders reject break-up calls,General_Update,Special resolution calling for us to spin off Asian businesses defeated at AGM.,https://www.hsbc.com/news-and-views/news/hsbc-news-archive/hsbc-shareholders-reject-break-up-calls
2023-05-16,2023,Resolute_Holdings,2023 Annual Report,General_Update,"Our rigorous approach enabled us to deliver a one-year rate of return of 4.4% for fiscal 2023, exceeding the 0.2% rate of return of our Reference Portolio* and ...",https://www.investpsp.com/media/filer_public/03-our-performance/03-annual-report-2023/pdf/PSP-2023-annual-report-en.pdf
2023-05-26,2023,Resolute_Holdings,Resolute Completes Sale of Thunder Bay Pulp and Paper ...,General_Update,"Resolute will continue to operate its sawmills and woodlands operations in Northwestern Ontario. With the closing of the transaction, the parties have entered ...",https://www.domtar.com/press_releases/resolute-completes-sale-of-thunder-bay-pulp-and-paper-mill/
2023-05-30,2023,Resolute_Holdings,Resolute Announces Asset Purchase Agreement to Sell ...,General_Update,"Resolute Announces Asset Purchase Agreement to Sell the Thunder Bay Pulp and Paper Mill. May 30, 2023. MONTRÉAL, May 30, 2023 /CNW/ - Resolute Forest Products ...",https://media.domtar.com/2023-05-30-Resolute-Announces-Asset-Purchase-Agreement-to-Sell-the-Thunder-Bay-Pulp-and-Paper-Mill
2023-05-30,2023,Resolute_Holdings,Atlas Holdings to Acquire Thunder Bay Mill from Resolute ...,General_Update,"Atlas to acquire Resolute's pulp, newsprint and directory paper mill operations (“Thunder Bay”) in Thunder Bay, Ontario.",https://www.atlasholdingsllc.com/news/atlas-holdings-to-acquire-thunder-bay-mill-from-resolute-fp-canada-inc/
2023-05-30,2023,Resolute_Holdings,Domtar Corporation Acquires Resolute Forest Products,Corporate_Action,"On March 1, 2023, the Merger became effective, resulting in Resolute becoming a wholly-owned subsidiary of Domtar. At the time the Merger became effective, each ...",https://mcmillan.ca/deals-cases/domtar-corporation-acquires-resolute-forest-products/
2023-05-30,2023,Resolute_Holdings,Resolute Forest Products signs deal to sell pulp and paper ...,Corporate_Action,"Paper Excellence completed its acquisition of Resolute through its Domtar subsidiary on March 1. This report by The Canadian Press was first published May 30, ...",https://toronto.citynews.ca/2023/05/30/resolute-forest-products-signs-deal-to-sell-pulp-and-paper-mill-in-thunder-bay-ont/
2023-07-17,2023,Resolute_Holdings,Resolute's lenders take ownership of $80bn asset ...,Corporate_Action,"Debtwire previously reported that Resolute was facing impending loan maturities in 2024 and 2025. Under the terms of the deal, the asset manager's first-lien ...",https://citywire.com/pro-buyer/news/resolutes-lenders-take-ownership-of-80bn-asset-manager-in-debt-for-equity-deal/a2421862
2023-07-28,2023,Resolute_Holdings,Paper Excellence announces corporate reorganization,Corporate_Action,"Paper Excellence announces corporate reorganization. Corporate shuffle follows acquisition of Domtar, Resolute Forest Products. Nelson Bennett Jul 28, 2023 ...",https://www.biv.com/news/resources-agriculture/paper-excellence-announces-corporate-reorganization-8272737
2023-08-01,2023,Resolute_Holdings,Thunder Bay Pulp and Paper Acquires ...,General_Update,"Thunder Bay Pulp and Paper Acquires Thunder Bay Mill from Resolute FP Canada. Major Pulp and Paper Operation in Thunder Bay, Ontario Joins Atlas Holdings' ...",https://www.atlasholdingsllc.com/news/thunder-bay-pulp-and-paper-acquires-thunder-bay-mill-from-resolute-fp-canada/
2023-08-01,2023,Resolute_Holdings,Thunder Bay Pulp and Paper Acquires ...,General_Update,"Thunder Bay Pulp and Paper Acquires Thunder Bay Mill from Resolute. Aug. 1, 2023 - Atlas Holdings today announced the closing of the previously announced ...",https://www.ifpta.org/thunder-bay-pulp-and-paper-acquires-thunder-bay-mill-from-resolute
2023-08-03,2023,Resolute_Holdings,Here's what's next for Resolute after debt-for-equity deal,Corporate_Action,"Under the terms of the deal, the company will exchange its $538m first-lien loan for debt of $350m that now will come due in 2027, as well as 86.5% of ...",https://citywire.com/pro-buyer/news/heres-whats-next-for-resolute-after-debt-for-equity-deal/a2422034
2023-08-15,2023,Resolute_Holdings,FORESIGHT GROUP HOLDINGS LIMITED,General_Update,by proposing a special resolution at the 2023 AGM albeit increasing the thresholds to those permitted by the. Statement of Principles on Disapplying Pre ...,https://www.foresight.group/media/p3alsk4e/02_web_fghl_ar23.pdf
2023-09-21,2023,Resolute_Holdings,2023 Annual Report,General_Update,"Our FY23 results demonstrated our resolute commitment to transform our business into a more nimble, efficient, and profitable network. We successfully reduced ...",https://s21.q4cdn.com/665674268/files/doc_downloads/2023/09/2023-Annual-Report.pdf
2023-09-22,2023,Resolute_Holdings,REPORT AND ACCOUNTS,Financial_Performance,"facility, no buybacks were undertaken in the year ended 30 June 2023. ... these 16 holdings was £10.8m as at 30 June 2023 (2022: £9.6m), consisting ...",https://www.bsx.com/CompanyDocuments/1099939343/UILAR23%20FINAL.pdf
2023-09-25,2023,Resolute_Holdings,Accrol Group Holdings Plc Annual Report & Accounts 2023,General_Update,"The Group has performed strongly in another challenging year, gaining further market share through its great value product range, broad retailer base, and new ...",https://thenavigatorcompany.com/external/alpha-project/docs/scheme-circular/12_Accrol_Group_Holdings_plc_Annual_Report_and_Accounts_2023.pdf
2023-10-11,2023,Resolute_Holdings,Full-Year 2023 US Corporate Rating Actions Tracker,General_Update,"For each issuer, we include its rank as of the most recent U.S. BSL CLO Top Obligors And Industries Report to give an indication of how widely held the issuer's ...",https://www.spglobal.com/ratings/en/regulatory/article/230118-u-s-bsl-clo-obligors-corporate-rating-actions-tracker-2023-s12614380
2023-10-25,2023,Resolute_Holdings,The world's largest 500 asset managers,Financial_Performance,"Median AUM for the Top 500 landed at USD 56 trillion in 2022, down 9.4% since 2021. For 2022, there is a significant downturn, with the total AUM growth ...",https://www.thinkingaheadinstitute.org/content/uploads/2023/10/PI-500-2023-1.pdf
2023-10-31,2023,Resolute_Holdings,Resolute Resources announces operational update and ...,General_Update,"Resolute Resources announces operational update and leadership transition. October 31, 2023 2:00 AM Newsfile.",https://boereport.com/2023/10/31/resolute-resources-announces-operational-update-and-leadership-transition/
2023-11-15,2023,Resolute_Holdings,Peter Glicklich,Corporate_Action,"He advises on the tax implications of mergers and acquisitions, joint ventures, cross-border financings, restructurings, reorganizations, spinoffs and ...",https://www.dwpv.com/en/People/Peter-A-Glicklich
2023-11-20,2023,Resolute_Holdings,"Mergers, Acquisitions and Shareholder Rights Panel ...",Financial_Performance,"– The 2023 federal budget introduced draft legislation to implement a new 2% tax on share buybacks (the “Buyback Tax”). As drafted, the Buyback Tax is ...",https://www.capitalmarketstribunal.ca/sites/default/files/2023-11/20231123_Mergers-Acquisitions-and-Shareholder-Rights-Panel-Resource-Material.pdf
2023-12-05,2023,Resolute_Holdings,JPMorgan Japanese Investment Trust plc,Financial_Performance,repurchase of shares at a discount to their underlying NAV enhances the NAV of the remaining shares. Resolution 15 gives the Company authority to repurchase its.,https://am.jpmorgan.com/content/dam/jpm-am-aem/emea/gb/en/regulatory/annual-report/japanese-annual-report-2023.pdf
2023-12-21,2023,Resolute_Holdings,New York City Fire Pension Funds,General_Update,Notes to Combining Financial Statements Years Ended 2023 and 2022…………….... Required Supplementary Information (Unaudited):. Schedule 1 - Schedules of Changes in ...,https://www.nyc.gov/assets/actuary/downloads/pdf/FIRE_FY2023_ACFR.pdf
2023-12-31,2023,Resolute_Holdings,Financial review,General_Update,"2023 was a year of execution. Alongside delivering our strategic agenda, business performance was robust. Simon Woods. Group Chief Financial ...",https://www.resolutionlife.com/media/zmaktpeb/resolution-life_annual-report-2023-simon-woods.pdf
2023-12-31,2023,Resolute_Holdings,Annual Report 2023,General_Update,"The financial calendar is subject to change. ... Overall, we signifi- cantly exceeded almost all financial goals we had set ourselves at the beginning of 2023.",https://carbonaccountingfinancials.com/files/institutions_downloads/AR2023-FINAL-en.pdf
2023-12-31,2023,Resolute_Holdings,10-K: Annual report pursuant to Section 13 and 15(d),General_Update,"These disclosures include major components used to calculate the LCR and NSFR (e.g., high-quality liquid assets, cash outflows and inflows for the LCR, and ...",https://investor.pnc.com/sec-filings/all-sec-filings/content/0000713676-24-000028/pnc-20231231.htm
2024-01-04,2024,Resolute_Holdings,Resolute Investment Managers Inc. Upgraded To 'B',General_Update,"Through restructuring, Resolute reduced its total debt by $274 million or 44%, and extended the maturity on its remaining debt by about three years. In doing so ...",https://www.spglobal.com/ratings/en/regulatory/article/-/view/type/HTML/id/3107216
2024-01-23,2024,Resolute_Holdings,"Alex Moore, Toronto",Corporate_Action,"Alex's practice focuses on mergers and acquisitions, capital markets, and corporate governance. Clients value his practical approach and strategic advice.",https://www.blakes.com/people/find-a-person/alex-moore/
2024-02-22,2024,Resolute_Holdings,Cheniere Reports Fourth Quarter and Full Year 2023 ...,Financial_Performance,"In January 2024, Cheniere declared a dividend with respect to the fourth quarter 2023 of $0.435 per share of common stock, which is payable on February 23, 2024 ...",https://lngir.cheniere.com/news-events/press-releases/detail/293/cheniere-reports-fourth-quarter-and-full-year-2023-results
2024-03-08,2024,Resolute_Holdings,2023 Annual Report,General_Update,... 2024 the holding company made cash contributions of. $140.0 to Run-off to augment its capital. Run-off's cash flows may be volatile as to timing and amount ...,https://www.fairfax.ca/wp-content/uploads/FFH_Fairfax-Financial-2023-Annual-Report.pdf
2024-03-09,2024,Resolute_Holdings,Resolute Holdings Management,Financial_Performance,"Growth: A business that has attractive growth prospects, both on an organic basis and inorganically through acquisition. Free Cash Flow: A business that has ...",https://resoluteholdings.com/
2024-03-21,2024,Resolute_Holdings,notice-of-meeting-and-proxy-statement-2024.pdf,Financial_Performance,We returned more than $730 million directly to our shareholders through base dividends and share buybacks. Our business performance was driven by the consistent.,https://filecache.investorroom.com/mr5ircnw_encana/1059/notice-of-meeting-and-proxy-statement-2024.pdf
2024-03-29,2024,Resolute_Holdings,Funding Costs Will Remain High As Maturities Rise,General_Update,"Only $6 billion in debt from NBFIs is maturing in 2024, but the debt maturity wall will quickly rise to around $20 billion in 2025 and $37 billion in 2026.",https://www.spglobal.com/ratings/en/regulatory/article/240329-funding-costs-will-remain-high-as-maturities-rise-for-north-american-nonbank-financial-institutions-s13052987
2024-04-01,2024,Resolute_Holdings,04/01/2024 - Cummins Inc.,Corporate_Action,Donaldson was removed from the peer group due to our spin-off of Atmus into a separate publicly traded company. Page 41. TABLE OF CONTENTS. EXECUTIVE ...,https://investor.cummins.com/sec-filings/all-sec-filings/content/0001104659-24-041821/0001104659-24-041821.pdf
2024-05-01,2024,Resolute_Holdings,Canfor Southern Pine grows in Arkansas with acquisition ...,Corporate_Action,"The US$73 million acquisition, including working capital, will create synergies and vertical integration opportunities given its complementary geographic fit ...",https://www.canfor.com/newsroom/2024-05-01/canfor-southern-pine-grows-in-arkansas-with-acquisition-from-resolute
2024-05-07,2024,Resolute_Holdings,Universal Registration Document 2023,General_Update,"The Universal Registration Document was filed on May 3, 2024, with the AMF, in its capacity as competent authority under Regulation (EU) 2017/1129, ...",https://www.actusnews.com/en/download/vusiongroup/2024/05/07/85743-vusiongroup_2023_urd_en.pdf
2024-05-09,2024,Resolute_Holdings,NOTICE OF 2024 ANNUAL GENERAL MEETING OF ...,General_Update,"The Circular contains information relating to the receipt of Cascades' consolidated financial statements, the election of directors, the appointment of the ...",https://www.cascades.com/sites/default/files/Investor/Investors-Kit/2023-Management-Circular-Cascades.pdf
2024-08-07,2024,Resolute_Holdings,Resolute Holdings to Acquire Majority Interest in ...,Financial_Performance,"CompoSecure has a high-quality management team led by CEO Jon Wilk, a leading market position in its industry, attractive long-term growth prospects, ...",https://finance.yahoo.com/news/resolute-holdings-acquire-majority-interest-200000483.html
2024-08-07,2024,Resolute_Holdings,"CompoSecure (NYSE:CMPO) Dividend Yield, History and ...",Financial_Performance,"completed the Spin-Off of Resolute Holdings Management, Inc. (NasdaqGM:RHLD). Feb 28. CompoSecure, Inc. to Report Q4, 2024 Results on Mar 05, 2025. Feb 26 ...",https://simplywall.st/stocks/us/tech/nyse-cmpo/composecure/dividend
2024-08-07,2024,Resolute_Holdings,Resolute Holdings to Acquire Majority Interest in ...,General_Update,The David Cote Family is investing $372 million through Resolute and Dave Cote will become the executive chairman of the board of directors of CompoSecure.,https://ir.composecure.com/news-releases/news-release-details/resolute-holdings-acquire-majority-interest-composecure-372
2024-08-07,2024,Resolute_Holdings,Resolute to Acquire CompoSecure,Corporate_Action,"Paul, Weiss is advising Resolute Holdings I, LP, and its affiliates in their acquisition of a majority interest in CompoSecure, Inc.",https://www.paulweiss.com/insights/client-news/resolute-to-acquire-composecure
2024-08-29,2024,Resolute_Holdings,2024 Half Year Financial Results,General_Update,"Financial Performance​​ We expect further reduction in AISC across both operation during the second half of 2024 to reach full year cost guidance of $1,300 – 1, ...",https://www.rml.com.au/wp-content/uploads/2024/08/RSG-ASX-H1-24-Financial-Results.pdf
2024-08-29,2024,Resolute_Holdings,Resolute HY Report,General_Update,"Revenue for H1 2024 was $341.5 million, from gold sales of 157,321oz at an average realised price of $2,170/oz. EBITDA was $116.4 million which is a 14% ...",https://www.rml.com.au/wp-content/uploads/2024/08/Resolute-HY-Report-29-August-2024_Updated.pdf
2024-09-10,2024,Resolute_Holdings,Resolute Holdings Management (RHLD) News Flow,General_Update,Resolute Holdings Management (RHLD) · High. 211.850 · Low. 197.250 · Volume. 69.84K · Open. 211.850 · Prev Close. 207.060 · Turnover. 14.31M · Turnover Ratio. 1.90% · P ...,https://www.moomoo.com/stock/RHLD-US/news
2024-09-17,2024,Resolute_Holdings,Resolute Holdings Completes Acquisition of Majority Interest ...,Financial_Performance,"Resolute has now acquired 49.3 million Class A shares, representing approximately 60% of CompoSecure's outstanding shares.",https://ir.composecure.com/news-releases/news-release-details/resolute-holdings-completes-acquisition-majority-interest
2024-09-17,2024,Resolute_Holdings,Resolute Holdings Completes Acquisition of Majority ...,Financial_Performance,"Resolute has now acquired 49.3 million Class A shares, representing approximately 60% of CompoSecure's outstanding shares.",https://finance.yahoo.com/news/resolute-holdings-completes-acquisition-majority-200500765.html
2024-09-17,2024,Resolute_Holdings,Resolute Holdings Completes Acquisition of Majority ...,Corporate_Action,"The transaction, valued at approximately $372 million, was completed on September 17, 2024. David Cote and Tom Knott said, “We are excited to begin working with ...",https://www.llrpartners.com/resolute-holdings-completes-acquisition-of-majority-interest-in-composecure/
2024-12-30,2024,Resolute_Holdings,CompoSecure Announces Plan to Spin-Off Resolute Holdings ...,Corporate_Action,"Resolute Holdings anticipates limited profitability in fiscal year 2025 as it establishes operations and builds out infrastructure, including adding to its ...",https://ir.composecure.com/news-releases/news-release-details/composecure-announces-plan-spin-resolute-holdings-management-inc
2024-12-30,2024,Resolute_Holdings,"Resolute Holdings Management, Inc.",Financial_Performance,"(“Vertiv”), the stock price of which increased 1,100% during his tenure (as of December 20, 2024). Mr.",https://www.sec.gov/Archives/edgar/data/2039497/000110465924132493/tm2425234d6_ex99-1.htm
2024-12-30,2024,Resolute_Holdings,CompoSecure To Spin-Off Resolute Holdings Management,Corporate_Action,CompoSecure Inc. (CMPO) said that it plans to spin-off a newly formed subsidiary called Resolute Holdings Management Inc.,https://www.nasdaq.com/articles/composecure-spin-resolute-holdings-management
2024-12-31,2024,Resolute_Holdings,CompoSecure Reports Fourth Quarter and Full Year 2024 ...,General_Update,"FY 2024 Net Sales up 8% to $420.6 million — In-Line with Preliminary Results on February 10, 2025. FY 2024 Cash Flow from Operations up 24% to $129.6 ...",https://ir.composecure.com/news-releases/news-release-details/composecure-reports-fourth-quarter-and-full-year-2024-financial
2024-12-31,2024,Resolute_Holdings,CompoSecure to Spin-Off Resolute Holdings Management,Corporate_Action,"Resolute Holdings anticipates limited profitability in fiscal year 2025 as it establishes operations and builds out infrastructure, including adding to its ...",https://www.citybiz.co/article/642614/composecure-to-spin-off-resolute-holdings-management/
2024-12-31,2024,Resolute_Holdings,FinTech Market Update Q4 2024,General_Update,Houlihan Lokey's dedicated FinTech Group builds on the firm's leading technology and financial services expertise and underscores.,https://www2.hl.com/pdf/2025/hl-fintech-update-q4-2024.pdf
2025-01-01,2025,Resolute_Holdings,"Everyday investors, hedge funds, or politicians. ...",Financial_Performance,He recently disclosed a purchase of compost secure in early 2025 ... Spin-Off of Resolute Holdiag AND BUYBACK PROGRAM Authorizes Expanded Share epurchase .,https://www.instagram.com/reel/DR0oUZVCmyS/
2025-01-02,2025,Resolute_Holdings,CompoSecure Plans to Spin Off Newly Formed Subsidiary,General_Update,"Resolute Holdings anticipates limited profitability in fiscal year 2025 as it establishes operations and builds out infrastructure, including adding to its ...",https://njbmagazine.com/njb-news-now/composecure-plans-to-spin-off-newly-formed-subsidiary/
2025-02-10,2025,Resolute_Holdings,CompoSecure Board of Directors Approves Spin-Off of ...,Corporate_Action,"Resolute Holdings anticipates limited profitability in fiscal year 2025 as it establishes operations and builds out infrastructure, including adding to its ...",https://ir.composecure.com/news-releases/news-release-details/composecure-board-directors-approves-spin-resolute-holdings-and
2025-02-16,2025,Resolute_Holdings,CompoSecure's Spin-Off of Resolute Holdings: A Strategic ...,Financial_Performance,"With a planned distribution date of February 28, 2025, CompoSecure shareholders will receive shares of RHLD on a pro rata basis. Additionally, CompoSecure has ...",https://www.tradingcalendar.com/post/composecure-s-spin-off-of-resolute-holdings-a-strategic-move-for-future-growth-cmpo-rhld
2025-02-20,2025,Resolute_Holdings,Resolute Holdings Management Inc (RHLD),Financial_Performance,"As of Jan 02, 2026, Resolute Holdings Management (RHLD) is trading at a price of 206.43, with a previous close of 206.43. The stock has fluctuated within a day ...",https://www.investing.com/equities/resolute-holdings-management
2025-02-28,2025,Resolute_Holdings,CompoSecure Completes Spin-Off of Resolute Holdings as ...,Financial_Performance,"As part of the transaction, CompoSecure (Nasdaq: CMPO), stockholders of record as of February 20, 2025, received one share of Resolute Holdings common stock for ...",https://www.roi-nj.com/2025/02/28/finance/composecure-completes-spin-off-of-resolute-holdings-as-independent-public-company/
2025-03-06,2025,Resolute_Holdings,PROXY STATEMENT,General_Update,Proposal 1: Elect our Board's 13 nominees named in the accompanying proxy statement for a one-year term expiring at the 2026. Annual Meeting of Shareholders.,https://www.l3harris.com/sites/default/files/2025-03/L3Harris-2025-Proxy-Statement--.pdf
2025-03-31,2025,Resolute_Holdings,Form 10-K for Resolute Holdings Management INC filed 03/31 ...,Corporate_Action,"Resolute Holdings. Until the completion of the Spin-Off on February 28, 2025, Resolute Holdings had neither engaged in any operations nor generated any revenues ...",https://ir.composecure.com/static-files/7d18d548-17ee-4fe7-a68a-17d9611ae60d
2025-04-07,2025,Resolute_Holdings,Resolute Annual Report 2024,Financial_Performance,"... holdings of U.S. assets are approximately. $1.5 trillion, of which half is ... buyback program has not used up all of our capital generation and why our.",https://www.jpmorganchase.com/content/dam/jpmc/jpmorgan-chase-and-co/investor-relations/documents/annualreport-2024.pdf
2025-05-12,2025,Resolute_Holdings,"Resolute Holdings Management, Inc. - Investor Relations",General_Update,Resolute Holdings Reports First Quarter 2025 Results ... Earnings per share are useful to investors in evaluating Resolute Holdings' financial performance.,https://ir.composecure.com/static-files/e81eb7aa-de30-4799-b5c4-3521478d2dd6
2025-05-13,2025,Resolute_Holdings,Resolute Holdings Reports Second Quarter 2025 Results,Financial_Performance,"Resolute Holdings Reports Second Quarter 2025 Results ; Common stock, $0.0001 par value; 1,000,000,000 shares authorized, 8,525,998 and 0 shares issued and ...",https://resoluteholdings.com/resolute-holdings-reports-second-quarter-2025-results/
2025-07-14,2025,Resolute_Holdings,"Press release, dated July 14, 2025, issued by Resolute ...",General_Update,"Resolute Holdings Enhances Board of Directors with the Appointment of Two Additional Independent Directors. NEW YORK, NY, July 14, 2025 (GLOBE NEWSWIRE) ...",https://www.sec.gov/Archives/edgar/data/2039497/000095014225001883/eh250653292_ex9901.htm
2025-08-06,2025,Resolute_Holdings,CIO Views: The trade war that will not happen,Corporate_Action,Group CIO Yves Bonzon breaks down the EU-US trade deal and explores its broader significance for the global economy.,https://www.juliusbaer.com/en/insights/market-insights/cio-views/cio-views-the-trade-war-that-will-not-happen/
2025-08-07,2025,Resolute_Holdings,CompoSecure (NYSE:CMPO) - Stock Analysis,Financial_Performance,"Provides Earnings Guidance for 2025. Mar 06. CompoSecure, Inc. completed the Spin-Off of Resolute Holdings Management, Inc. (NasdaqGM:RHLD). Feb 28 ...",https://simplywall.st/stocks/us/tech/nyse-cmpo/composecure
2025-08-07,2025,Resolute_Holdings,"Tranche Update on Resolute Holdings Management, Inc.'s ...",Financial_Performance,"From April 1, 2025 to June 30, 2025, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the ...",https://www.marketscreener.com/news/tranche-update-on-resolute-holdings-management-inc-s-equity-buyback-plan-announced-on-may-12-2025-ce7d51dad08df626
2025-08-22,2025,Resolute_Holdings,Resolute HY 2025 Report,General_Update,"We have reviewed the accompanying half-year financial report of Resolute Mining Limited (the Company) and its subsidiaries (collectively the Group), which ...",https://www.rml.com.au/wp-content/uploads/2025/08/Resolute-HY-2025-Report-1.pdf
2025-09-09,2025,Resolute_Holdings,Transactions,General_Update,"Advising Baker Hughes Co. on the sale of their PSI business to Crane Co. $1,150. June 6, 2025. Pending.",https://www.evercore.com/our-transactions/
2025-10-13,2025,Resolute_Holdings,Corporate Action Updates,General_Update,"We track mandatory corporate actions for you and provide the list here. Where we can, we add the details that we have received.",https://help.stockpile.com/en/articles/1971817-corporate-action-updates
2025-11-03,2025,Resolute_Holdings,Resolute Holdings Reports Third Quarter 2025 Results,Financial_Performance,Resolute Holdings reported third quarter earnings per share attributable to common stockholders of ($0.03) and Non-GAAP Fee-Related Earnings per share of $0.13.,https://finance.yahoo.com/news/resolute-holdings-reports-third-quarter-100000411.html
2025-11-03,2025,Resolute_Holdings,CompoSecure Reports Strong 3Q25 Financial Results and ...,Financial_Performance,Strong operating performance delivered double-digit growth on both the top and bottom line; Raising full year 2025 guidance and issuing full year 2026 ...,https://ir.composecure.com/news-releases/news-release-details/composecure-reports-strong-3q25-financial-results-and-announces
2025-11-03,2025,Resolute_Holdings,Resolute Holdings (RHLD) Net Profit Margin Decreases ...,General_Update,"Resolute Holdings Management (RHLD) reported a net profit margin of 24.6%, down from 25.9% a year earlier, as the company experienced negative earnings ...",https://finance.yahoo.com/news/resolute-holdings-rhld-net-profit-011557565.html
2025-11-03,2025,Resolute_Holdings,"Resolute Holdings Management, Inc. - Investor Relations",General_Update,"On November 3, 2025, Resolute Holdings Management, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine ...",https://ir.composecure.com/static-files/ad030ada-484a-4212-adc2-3a0d93f0fa77
2025-11-03,2025,Resolute_Holdings,Resolute Holdings Earnings Dates & Reports,General_Update,"Resolute Holdings Management (RHLD) Earnings Dates, Reports & Conference Call. RHLD 2025 Q3 Earnings Dates & Summary. Currency：USD· -- ...",https://www.moomoo.com/stock/RHLD-US/earnings
2025-11-03,2025,Resolute_Holdings,Resolute Holdings Reports Third Quarter 2025 Results,Corporate_Action,"Resolute Holdings Reports Third Quarter 2025 Results. November 03, 2025 05 ... acquisitions, limited profitability for the year ending December 31, 2025 ...",https://www.globenewswire.com/news-release/2025/11/03/3178948/0/en/Resolute-Holdings-Reports-Third-Quarter-2025-Results.html
2025-11-03,2025,Resolute_Holdings,CompoSecure and Husky Technologies To Merge,Corporate_Action,"As a result of the spin-off of Resolute Holdings Management, Inc. (“Resolute Holdings”) on February 28, 2025 and the execution of the management agreement ...",https://www.citybiz.co/article/766526/composecure-and-husky-technologies-to-merge/
2025-11-04,2025,Resolute_Holdings,Resolute Holdings Management (RHLD): Net Margin Slips ...,Financial_Performance,"Resolute Holdings Management (RHLD) posted a net profit margin of 24.6%, slipping from 25.9% a year earlier, with negative earnings growth over the past ...",https://simplywall.st/stocks/us/commercial-services/nyse-rhld/resolute-holdings-management/news/resolute-holdings-management-rhld-net-margin-slips-challenge
2025-11-17,2025,Resolute_Holdings,Is Resolute Holdings Stock a Buy After a Member of the ...,Financial_Performance,"Resolute Holdings Management, Inc. is a New York-based alternative asset management platform company with 7 employees. It reported a net income of $106.05 ...",https://www.fool.com/coverage/filings/2025/11/17/is-resolute-holdings-stock-a-buy-after-a-member-of-the-board-of-directors-initiates-a-usd1-million-stake/
2025-11-17,2025,Resolute_Holdings,CompoSecure Holdings LLC Rated 'B+' On Proposed A,Corporate_Action,"On Nov. 3, 2025, CompoSecure Inc., direct parent of CompoSecure Holdings LLC (Holdings), announced its proposed acquisition of Husky Technologies Ltd. Husky ...",https://www.spglobal.com/ratings/en/regulatory/article/-/view/type/HTML/id/3480140
2025-11-20,2025,Resolute_Holdings,RHLD Stock Rating & Analysis,Financial_Performance,"The stock has a 52% probability of outperforming the market in the next 3 months, which is 0% higher than the average probability of any stock (52%) ...",https://danelfin.com/stock/RHLD
2025-12-09,2025,Resolute_Holdings,Expert Insights on Merger Arbitrage and Special Situations ...,Financial_Performance,"Buyback Announcement: On December 31, 2025, Weibo Corporation (WB) announced new $200M buyback (7.94% of market cap), for 19,569,472 shares at the market price.",https://www.insidearbitrage.com/
2026-01-01,2026,Resolute_Holdings,Resolute Holdings Management (NYSE:RHLD) Sees ...,Financial_Performance,This trade represents a 90.00% increase in their ownership of the stock. ... The Exact Date That Could Make the Biggest Move in the Stock Market in 2026.,https://www.marketbeat.com/instant-alerts/resolute-holdings-management-nyserhld-sees-unusually-high-trading-volume-should-you-buy-2026-01-02/
2026-01-01,2026,Resolute_Holdings,"resolute holdings management, inc. (rhld)",Financial_Performance,2026 predictions: This mega-cap stock will top them all in terms of total. The Motley Fool · in 16 ...,https://www.msn.com/en-us/money/markets?id=cfzfh7&tab=TopGainers&ocid=ue01dhp
2026-01-01,2026,Resolute_Holdings,Resolute Holdings Management (RHLD) Competitors,Financial_Performance,"Should you be buying Resolute Holdings Management stock or one of its competitors? ... But this $2 Gold Stock Before May 20, 2026. You need to own this company ...",https://www.marketbeat.com/stocks/NYSE/RHLD/competitors-and-alternatives/
2026-01-01,2026,Resolute_Holdings,"January 1, 2026",General_Update,Their conservative model portfolio – shifting to 40% equity/60% bonds with commodities and inflation-linked assets – projects 3.5% real returns with a Sharpe ...,https://www.mutualfundobserver.com/2026/01/january-1-2026/
2026-01-01,2026,Resolute_Holdings,The budget has been christened the “Budget of Resilience ...,Financial_Performance,The budget has been christened the “Budget of Resilience for Growth and Development.” Rivers Exco Approves ₦1.8trn 2026 Budget Proposal. CHANNELSTV.COM.,https://www.facebook.com/channelsforum/posts/the-budget-has-been-christened-the-budget-of-resilience-for-growth-and-developme/1529502595204153/
2026-01-01,2026,Resolute_Holdings,Warren Buffett's Final Day as Berkshire Hathaway CEO ...,General_Update,"Greg Abel will assume the CEO role in 2026, carrying forward Berkshire's core philosophy of value investing and long-term discipline, with Buffett remaining ...",https://www.facebook.com/61555047992625/posts/warren-buffetts-final-day-as-berkshire-hathaway-ceobehindthemoney-warrenbuffett-/122242978724168266/
2026-01-01,2026,Resolute_Holdings,Richardson's Resolute Recruitment: LKAB's Leadership Leap,General_Update,"The timing of Richardson's appointment, announced in December 2025 for Q1 2026 commencement, provides adequate transition periods enabling knowledge ...",https://www.oreaco.com/news-1/richardson's-resolute-recruitment%3A-lkab's-leadership-leap
